Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 727
Encontrada(s) 8 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation

  • Rodríguez Barbosa, José Ignacio
  • Ferreras Estrada, María Del Carmen
  • Buhler, Leo
  • Jones, N. D.
  • Schneider, P.
  • Pérez Simón, José Antonio
  • Río González, María Luisa del
[EN]Natural killer (NK) cells are a population of innate type I lymphoid cells essential for early anti-viral responses and are known to modulate the course of humoral and cellular-mediated T cell responses. We assessed the role of NK cells in allogeneic CD8 T cell-mediated responses in an immunocompetent mouse model across an MHC class I histocompatibility barrier to determine its impact in therapeutic clinical interventions with polyclonal or monoclonal antibodies (mAbs) targeting lymphoid cells in transplantation. The administration of an NK cell depleting antibody to either CD8 T cell replete or CD8 T cell-depleted naïve C57BL/6 immunocompetent mice accelerated graft rejection. This accelerated rejection response was associated with an in vivo increased cytotoxic activity of CD8 T cells against bm1 allogeneic hematopoietic cells and bm1 skin allografts. These findings show that NK cells were impli-cated in the control host anti-donor cytotoxic responses, likely by competing for common cell growth factors in both CD8 T cell replete and CD8 T cell-depleted mice, the latter reconstituting in response to lymphopenia. Our data calls for precaution in solid organ transplantation under tolerogenic protocols involving extensive depletion of lymphocytes. These pharmacological biologics with depleting proper-ties over NK cells may accelerate graft rejection and promote aggressive CD8 T cell cytotoxic allore-sponses refractory to current immunosuppression., SI, This work has been supported by grant FIS PI# 1300029 (Fondo de Investigaciones Sanitarias, Ministry of Health, Spanish Government and co-funded by European Union ERDF/ESF, “Investing in your future”), LE093U13 and Unit of Excellence Research UIC #012 (Department of Education of the Regional Government, Junta de Castilla y Leon) and Gerencia Regional de Salud (BIO/01/15) to JIRB, and by Miguel Servet National Grant (Health National Organization Research) CP12/03063, CPII17/00002 and FIS PI16/00002 (Instituto de Salud Carlos III and co-funded by European Union ERDF/ESF, “Investing in your future”), and Gerencia Regional de Salud GRS963/A/2014, GRS1142/A/2015 and GRS 1505/A/2017 to M.L.R.G., This work has been partially funded by the National Network CIBER-ONC (oncology research) CB16/12/00480. P.S. is funded by grant 31003A-17-6256 of the Swiss National Science Foundation. We thank University of Leon for providing funding to cover publication expenses.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells

  • Río González, María Luisa del
  • Fernández Renedo, Carlos
  • Chaloin, Olivier
  • Scheu, Stefanie
  • Pfeffer, Klaus
  • Shintani, Yasushi
  • Pérez Simón, José Antonio
  • Schneider, Pascal
  • Rodríguez Barbosa, José Ignacio
[EN] Tumor necrosis factor (TNF)/TNF receptor (TNFR) superfamily members play essential roles in the development of the different phases of the immune response. Mouse LIGHT (TNFSF14) is a type II transmembrane protein with a C-terminus extracellular TNF homology domain (THD) that assembles in homotrimers and regulates the course of the immune responses by signaling through 2 receptors, the herpes virus entry mediator (HVEM, TNFSFR14) and the lymphotoxin β receptor (LTβR, TNFSFR3). LIGHT is a membrane-bound protein transiently expressed on activated T cells, natural killer (NK) cells and immature dendritic cells that can be proteolytically cleaved by a metalloprotease and released to the extracellular milieu. The immunotherapeutic potential of LIGHT blockade was evaluated in vivo. Administration of an antagonist of LIGHT interaction with its receptors attenuated the course of graft-versus-host reaction and recapitulated the reduced cytotoxic activity of LIGHT-deficient T cells adoptively transferred into non-irradiated semiallogeneic recipients. The lack of LIGHT expression on donor T cells or blockade of LIGHT interaction with its receptors slowed down the rate of T cell proliferation and decreased the frequency of precursor alloreactive T cells, retarding T cell differentiation toward effector T cells. The blockade of LIGHT/LTβR/HVEM pathway was associated with delayed downregulation of interleukin-7Rα and delayed upregulation of inducible costimulatory molecule expression on donor alloreactive CD8 T cells that are typical features of impaired T cell differentiation. These results expose the relevance of LIGHT/LTβR/HVEM interaction for the potential therapeutic control of the allogeneic immune responses mediated by alloreactive CD8 T cells that can contribute to prolong allograft survival., SI, This work has been supported by grants of the Spanish Ministry of Health (Fondo de Investigaciones Sanitarias, PI13/00029), Department of Education of Castilla and Leon Regional Government (Grant# LE093U13) and Mutua Madrile~na Foundation (Basic research grants 2012) to J.I.R.B; by Miguel Servet National Grant (Health National Organization Research Program) CP12/03063 and by Gerencia Regional de Salud GRS963/A/2014 and GRS1142/A/2015 to M.L.R.G; and by the Swiss National Science Foundation to PS.
Docta Complutense
Publicación Artículo científico (JournalArticle)

A “fluorescence switch” technique increases the sensitivity of proteomic detection and identification of S‐nitrosylated proteins

  • Tello, Daniel
  • Tarín, Carlos
  • Ahicart, Patricia
  • Bretón‐Romero, Rosa
  • Lamas, Santiago
  • Martínez Ruiz, Antonio
Protein S-nitrosylation is a reversible post-translational modification of protein cysteines that is increasingly being considered as a signal transduction mechanism. The ‘‘biotin switch’’ technique marked the beginning of the study of the S-nitrosoproteome, based on the specific replacement of the labile S-nitrosylation by a more stable biotinylation that allowed further detection and purification. However, its application for proteomic studies is limited by its relatively low sensitivity. Thus, typical proteomic experiments require high quantities of protein extracts, which precludes the use of this method in a number of biological settings. We have developed a ‘‘fluorescence switch’’ technique that, when coupled to 2-DE proteomic methodologies, allows the detection and identification of S-nitrosylated proteins by using limited amounts of starting material, thus significantly improving the sensitivity. We have applied this methodology to detect proteins that become S-nitrosylated in endothelial cells when exposed to S-nitroso-L-cysteine, a physiological S-nitrosothiol, identifying already known S-nitrosylation targets, as well as proteins that are novel targets. This ‘‘fluorescence switch’’ approach also allowed us to identify several proteins that are denitrosylated by thioredoxin in cytokine-activated RAW264.7 (murine macrophage) cells. We believe that this method represents an improvement in order to approach the identification of S-nitrosylated proteins in physiological conditions.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Enhancing diagnostic accuracy: Direct immunofluorescence assay as the gold standard for detecting Giardia duodenalis and Cryptosporidium spp. in canine and feline fecal samples

  • Barrera, Juan P
  • Miró Corrales, Guadalupe
  • Carmena, David
  • Foncubierta, Carlos
  • Sarquis, Juliana
  • Estévez Sánchez, Efrén
  • Bailo, Begoña
  • Checa Herráiz, Rocío
  • Montoya Matute, Ana
  • Marino, Valentina
The enteric protozoan parasites Giardia duodenalis and Cryptosporidium spp. are common cause of diarrhea in pet dogs and cats, affecting primarily young animals. This comparative study evaluates the diagnostic performance of conventional and molecular methods for the detection of G. duodenalis and Cryptosporidium spp. infection in dogs and cats. The compared diagnostic assays included merthiolate-iodine-formalin (MIF) method, lateral flow immunochromatography rapid test (ICT) and real-time PCR; using direct immunofluorescence assay (DFA) as golden standard. The study included the analysis of 328 fecal samples from different dog (n = 225) and cat (n = 103) populations. According to DFA, the overall prevalence of G. duodenalis was 24.4% (80/328, 95% CI: 19.8–29.4), varying from 11.6% (12/103, 95% CI: 6.2–19.5) in cats to 30.2% (68/225, 95% CI: 24.3–36.7) in dogs. The overall prevalence of Cryptosporidium spp. was 4.0% (13/328, 95% CI: 2.1–6.7), varying from 2.9% (3/103, 95% CI: 0.6–8.3) in cats to 4.4% (10/225, 95% CI: 2.1–8.0) in dogs. MIF was only used for the detection of G. duodenalis, which was identified by this method in 22.7% of dogs and 7.8% of cats, respectively. DFA was the most sensitive technique for detecting G. duodenalis in samples from dogs and cats (p-value: < 0.001), followed by real-time PCR. Identification of Cryptosporidium infections was most effectively accomplished by the combination of DFA and PCR technique (p-value: < 0.001). In addition, epidemiological (sex, age, origin) and clinical (fecal consistency) variables were collected to assess their potential associations with an increased likelihood of infection by G. duodenalis and/or Cryptosporidium spp. Breeder dogs were more likely to harbor G. duodenalis infection (p-value: 0.004), whereas female cats were significantly more infected with Cryptosporidium (p-value: 0.003). In conclusion, DFA (alone or in combination with PCR) has been identified as the most accurate and cost-effective method for detecting G. duodenalis and Cryptosporidium spp. in fecal samples from pet dogs and cats. This highlights their importance in both veterinary and clinical settings for enabling prompt treatment and preventing potential transmission to humans.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Differential redox proteomics allows identification of proteins reversibly oxidized at cysteine residues in endothelial cells in response to acute hypoxia

  • Izquierdo-Álvarez, Alicia
  • Ramos, Elena
  • Villanueva, Joan
  • Hernansanz-Agustín, Pablo
  • Fernández-Rodríguez, Rubén
  • Tello, Daniel
  • Carrascal, Montserrat
  • Martínez Ruiz, Antonio
Adaptation to decreased oxygen availability (hypoxia) is crucial for proper cell function and survival. In metazoans, this is partly achieved through gene transcriptional responses mediated by hypoxia-inducible factors (HIFs). There is abundant evidence that production of reactive oxygen species (ROS) increases during hypoxia, which contributes to the activation of the HIF pathway. In addition to altering the cellular redox balance, leading to oxidative stress, ROS can transduce signals by reversibly modifying the redox state of cysteine residues in certain proteins. Using the “redox fluorescence switch” (RFS), a thiol redox proteomic technique that fluorescently labels reversibly oxidized cysteines, we analyzed endothelial cells subjected to acute hypoxia and subsequent reoxygenation. We observed a general increase in cysteine oxidation during hypoxia, which was reversed by reoxygenation, and two-dimensional electrophoresis revealed the differential oxidation of specific proteins. Using complementary derivatization techniques, we confirmed the modification of individual target proteins and identified specific cysteine residues that were oxidized in hypoxic conditions, thereby overcoming several limitations associated with fluorescence derivatization. These findings provide an important basis for future studies of the role of these modifications in HIF activation and in other acute adaptive responses to hypoxia.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma.

  • Martín Ruiz Valdepeñas, María Asunción
  • Fiuza Luces, C.
  • Rincón Castanedo, C.
  • Fernández Moreno, D.
  • González Gálvez, Beatriz
  • Martínez Martínez, Ernesto
  • Martín Acosta, P.
  • Coronado, M. J.
  • Franco Luzón, L.
  • González Murillo, A.
  • Ramírez, M.
  • Provencio, M.
  • Lucia, A.
Background: Lung cancer has the highest incidence and mortality rate in the world. One of the most promising new cancer therapies in recent years is immunotherapy, which is based on the blockade of immune checkpoints such as programmed cell death protein 1 (PD-1). Exercise training is beneficial to maintain and improve the quality of life of cancer patients, and it might also modulate the anti-tumoral efficiency of some chemotherapeutic agents. However, the potential of exercise combined with immunotherapy as a cancer therapy remains to be elucidated. Here, we examined the effects of exercise on tumor growth and its possible adjuvant effects when combined with anti-PD-1 immunotherapy (nivolumab) in a patient derived xenograft (PDX) model of non-small-cell lung carcinoma (NSCLC). Methods: We generated a PDX model using NOD-SCID gamma mice with subcutaneous grafts from tumor tissue of a patient with NSCLC. Animals were randomly assigned to one of four groups: non-exercise + isotype control (n=5), exercise + isotype control (n=5), non-exercise + nivolumab (n=6) or exercise + nivolumab (n=6). The animals undertook an 8- week moderate-intensity training regimen (treadmill aerobic exercise and strength training). Immunotherapy (nivolumab) or an isotype control was administered 2 days/week, for 6 weeks. Several tumor growth and microenvironment parameters were measured after the intervention. Results: Improvements in aerobic capacity and muscle strength (p=0.027 and p=0.005) were noted in exercised animals. Exercise alone reduced the tumor growth rate with respect to non-exercised mice (p=0.050). The double intervention (exercise + nivolumab) increased tumor necrosis and reduced apoptosis with respect to controls (p=0.026; p=0.030). All interventions achieved a reduction in proliferation compared with the control group (p=0.015, p=0.011, and p=0.011). Exercise alone increased myeloid tumor infiltrates (mostly neutrophils) with respect to the nivolumab only group (p=0.018). Finally, Vegf-a expression was higher in the nivolumab groups (in combination or not with exercise) than in exercise + isotype control group (p=0.045 and p=0.047, respectively). No other significant effects were found. Conclusions: Our results would suggest that aerobic and strength training should be studied as an adjuvant to cancer immunotherapy treatment.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Identification of six cardiovascular risk biomarkers in the young population: A promising tool for early prevention

  • Martínez Santos, Paula
  • Baldán Martín, Montserrat
  • López, Juan A.
  • Martín Lorenzo, Marta
  • Santiago Hernández, Aránzazu
  • Agudiez, Marta
  • Cabrera Sierra, Martha
  • Calvo, Eva
  • Vázquez, Jesús
  • Ruiz Hurtado, Gema
  • Vivanco, Fernando
  • Ruilope Urioste, Luis Miguel
  • Barderas, María G.
  • Álvarez Llamas, Gloria
Background and aims The predictive value of traditional CV risk calculators is limited. Novel indicators of CVD progression are needed particularly in the young population. The main aim of this study was the identification of a molecular profile with added value to classical CV risk estimation. Methods: Eighty-one subjects (30–50 years) were classified in 3 groups according to their CV risk: healthy subjects; individuals with CV risk factors; and those who had suffered a previous CV event. The urine proteome was quantitatively analyzed and significantly altered proteins were identified between patients' groups, either related to CV risk or established organ damage. Target-MS and ELISA were used for confirmation in independent patients’ cohorts. Systems Biology Analysis (SBA) was carried out to identify functional categories behind CVD. Results: 4309 proteins were identified, 75 of them differentially expressed. ADX, ECP, FETUB, GDF15, GUAD and NOTCH1 compose a fingerprint positively correlating with lifetime risk estimate (LTR QRISK). Best performance ROC curve was obtained when ECP, GDF15 and GUAD were combined (AUC = 0.96). SBA revealed oxidative stress response, dilated cardiomyopathy, signaling by Wnt and proteasome, as main functional processes related to CV risk. Conclusions: A novel urinary protein signature is shown, which correlates with CV risk estimation in young individuals. Pending further confirmation, this six-protein-panel could help in CV risk assessment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2

  • Safont Gonzalez, Guillem|||0000-0001-8174-4279
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Smalchuk, Daria
  • Stojanovic, Zonan
  • Marín, Alicia|||0000-0002-9358-2120
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Pérez-Cano, Cristina
  • López-Martínez, Anabel
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Solis, Alan Jhunior
  • Arméstar, Fernando|||0000-0002-6374-1418
  • Matllo, Joan
  • Díaz-Fernández, Sergio
  • Romero, Iris
  • Casas, Irma|||0000-0002-5902-5777
  • Strecker, Kevin
  • Preyer, Rosemarie
  • Rosell Gratacos, Antoni|||0000-0003-0877-7191
  • Latorre, Irene|||0000-0001-8159-2455
  • Domínguez, José|||0000-0001-7888-0309
The study of specific T-cell responses against SARS-CoV-2 is important for understanding long-term immunity and infection management. The aim of this study was to assess the dual IFN-γ and IL-2 detection, using a SARS-CoV-2 specific fluorescence ELISPOT, in patients undergoing acute disease, during convalescence, and after vaccination. We also evaluated humoral response and compared with T-cells with the aim of correlating both types of responses, and increase the number of specific response detection. Blood samples were drawn from acute COVID-19 patients and convalescent individuals classified according to disease severity; and from unvaccinated and vaccinated uninfected individuals. IgGs against Spike and nucleocapsid, IgMs against nucleocapsid, and neutralizing antibodies were also analyzed. Our results show that IFN-γ in combination with IL-2 increases response detection in acute and convalescent individuals (p = 0.023). In addition, IFN-γ detection can be a useful biomarker for monitoring severe acute patients, as our results indicate that those individuals with a poor outcome have lower levels of this cytokine. In some cases, the lack of cellular immunity is compensated by antibodies, confirming the role of both types of immune responses in infection, and confirming that their dual detection can increase the number of specific response detections. In summary, IFN-γ/IL-2 dual detection is promising for characterizing and assessing the immunization status, and helping in the patient management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro

  • Reyes-Farias, Marjorie|||0000-0001-9179-7251
  • Fernández-García, Pablo|||0000-0001-8018-5954
  • Corrales, Patricia|||0000-0002-9817-8389
  • González, Lorena
  • Soria-Gondek, Andrea|||0000-0002-7210-0073
  • Martínez, Ester
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Tarascó, Jordi
  • Moreno Santabarbara, Pablo|||0000-0002-6652-120X
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Medina-Gómez, Gema|||0000-0001-8169-681X
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Herrero, Laura|||0000-0003-4244-4673
Introduction: Obesity is a chronic condition associated with low-grade inflammation mainly due to immune cell infiltration of white adipose tissue (WAT). WAT is distributed into two main depots: subcutaneous WAT (sWAT) and visceral WAT (vWAT), each with different biochemical features and metabolic roles. Proinflammatory cytokines including interleukin (IL)-16 are secreted by both adipocytes and infiltrated immune cells to upregulate inflammation. IL-16 has been widely studied in the peripheral proinflammatory immune response; however, little is known about its role in adipocytes in the context of obesity. Aim & Methods: We aimed to study the levels of IL-16 in WAT derived from sWAT and vWAT depots of humans with obesity and the role of this cytokine in palmitate-exposed 3T3-L1 adipocytes. Results: The results demonstrated that IL-16 expression was higher in vWAT compared with sWAT in individuals with obesity. In addition, IL-16 serum levels were higher in patients with obesity compared with normal-weight individuals, increased at 6 months after bariatric surgery, and at 12 months after surgery decreased to levels similar to before the intervention. Our in vitro models showed that IL-16 could modulate markers of adipogenesis (Pref1), lipid metabolism (Plin1, Cd36, and Glut4), fibrosis (Hif1a, Col4a, Col6a, and Vegf), and inflammatory signaling (IL6) during adipogenesis and in mature adipocytes. In addition, lipid accumulation and glycerol release assays suggested lipolysis alteration. Discussion: Our results suggest a potential role of IL-16 in adipogenesis, lipid and glucose homeostasis, fibrosis, and inflammation in an obesity context.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development and Evaluation of an NTM-IGRA to Guide Pediatric Lymphadenitis Diagnosis

  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Latorre, Irene|||0000-0001-8159-2455
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Martínez-Planas, Aina
  • Minguell Domingo, Laura
  • Vallmanya, Teresa
  • Méndez Hernández, Maria|||0000-0001-5697-2763
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Baquero-Artigao, Fernando|||0000-0002-6903-3826
  • Rodríguez-Molino, Paula
  • Guillén-Martín, Sara
  • Toro Rueda, Carlos
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Sabriá, Josefina
  • Santos, José Ramón|||0000-0002-0886-7114
  • Puig, Jordi|||0000-0002-4075-0346
  • Domínguez-Álvarez, Marisol
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Altet, Neus
  • Galea, Yolanda
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • García-García, Esther
  • Bach Griera, Marc|||0000-0001-9845-7225
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Julián, Esther|||0000-0002-6558-3978
  • Torrelles, Jordi B.|||0000-0001-7702-5941
  • Rodrigo Gonzalo de Líria, Carlos|||0000-0003-1140-2585
  • Domínguez, José|||0000-0001-7888-0309
Background: Diagnosis of nontuberculous mycobacteria (NTM) infections remains a challenge. In this study, we describe the evaluation of an immunological NTM-interferon (IFN)-γ release assay (IGRA) that we developed using glycopeptidolipids (GPLs) as NTM-specific antigens. Methods: We tested the NTM-IGRA in 99 samples from pediatric patients. Seventy-five were patients with lymphadenitis: 25 were NTM confirmed, 45 were of unknown etiology but compatible with mycobacterial infection and 5 had lymphadenitis caused by an etiologic agent other than NTM. The remaining 24 samples were from control individuals without lymphadenitis (latently infected with M.Tuberculosis, uninfected controls and active tuberculosis patients). Peripheral blood mononuclear cells were stimulated overnight with GPLs. Detection of IFN-γ producing cells was evaluated by enzyme-linked immunospot assay. Results: NTM culture-confirmed lymphadenitis patient samples had a significantly higher response to GPLs than the patients with lymphadenitis of unknown etiology but compatible with mycobacterial infection (P < 0.001) and lymphadenitis not caused by NTM (P < 0.01). We analyzed the response against GPLs in samples from unknown etiology lymphadenitis but compatible with mycobacterial infection cases according to the tuberculin skin test (TST) response, and although not statistically significant, those with a TST ≥5 mm had a higher response to GPLs when compared with the TST <5 mm group. Conclusions: Stimulation with GPLs yielded promising results in detecting NTM infection in pediatric patients with lymphadenitis. Our results indicate that the test could be useful to guide the diagnosis of pediatric lymphadenitis. This new NTM-IGRA could improve the clinical handling of NTM-infected patients and avoid unnecessary misdiagnosis and treatments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma

  • Mariñas-Pardo, Luis
  • Mirones, Isabel
  • Amor-Carro, Oscar|||0009-0009-0696-5739
  • Fraga-Iriso, Rebeca
  • Lema-Costa, Beatriz
  • Cubillo, Isabel María
  • Rodríguez Milla, Miguel Ángel
  • García-Castro, Javier
  • Ramos-Barbón, David|||0000-0002-9615-6557
Background Mesenchymal stem cells may offer therapeutic potential for asthma due to their immunomodulatory properties and host tolerability, yet prior evidence suggests that bloodborne progenitor cells may participate in airway remodeling. Here, we tested whether mesenchymal stem cells administered as anti-inflammatory therapy may favor airway remodeling and therefore be detrimental. Methods Adipose tissue-derived mesenchymal stem cells were retrovirally transduced to express green fluorescent protein and intravenously injected into mice with established experimental asthma induced by repeat intranasal house dust mite extract. Controls were house dust mite-instilled animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving mesenchymal stem cells. Data on lung function, airway inflammation, and remodeling were collected at 72 h after injection or after 2 weeks of additional intranasal challenge. Results The mesenchymal stem cells homed to the lungs and rapidly downregulated airway inflammation in association with raised T-helper-1 lung cytokines, but such effect declined under sustained allergen challenge despite a persistent presence of mesenchymal stem cells. Conversely, airway hyperresponsiveness and contractile tissue underwent a late reduction regardless of continuous pathogenic stimuli and inflammatory rebound. Tracking of green fluorescent protein did not show mesenchymal stem cell integration or differentiation in airway wall tissues. Conclusions Therapeutic mesenchymal stem cell infusion in murine experimental asthma is free of unwanted pro-remodeling effects and ameliorates airway hyper-responsiveness and contractile tissue remodeling. These outcomes support furthering the development of mesenchymal stem cell-based asthma therapies, although caution and solid preclinical data building are warranted. © 2014 The Authors. Allergy published by John Wiley & Sons Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Updated recommendations, An assessment of NICE clinical guidelines

  • Martínez García, Laura|||0000-0003-0126-8706
  • McFarlane, Emma
  • Barnes, Steven
  • Sanabria, Andreu Juliana
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Alderson, Philip
Background: Updating is important to ensure clinical guideline (CG) recommendations remain valid. However, little research has been undertaken in this field. We assessed CGs produced by the National Institute for Health and Care Excellence (NICE) to identify and describe updated recommendations and to investigate potential factors associated with updating. Also, we evaluated the reporting and presentation of recommendation changes.Methods: We performed a descriptive analysis of original and updated CGs and recommendations, and an assessment of presentation formats and methods for recording information. We conducted a case-control study, defining cases as original recommendations that were updated ('new-replaced' recommendations), and controls as original recommendations that were considered to remain valid ('not changed' recommendations). We performed a comparison of main characteristics between cases and controls, and we planned a multiple regression analysis to identify potential predictive factors for updating.Results: We included nine updated CGs (1,306 recommendations) and their corresponding original versions (1,106 recommendations). Updated CGs included 812 (62%) recommendations 'not reviewed', 368 (28.1%) 'new' recommendations, 104 (7.9%) 'amended' recommendations, and 25 (1.9%) recommendations reviewed but unchanged. The presentation formats used to indicate the changes in recommendations varied widely across CGs. Changes in 'amended', 'deleted', and 'new-replaced' recommendations (n = 296) were reported infrequently, mostly in appendices. These changes were recorded in 167 (56.4%) recommendations; and were explained in 81 (27.4%) recommendations. We retrieved a total of 7.1% (n = 78) case recommendations ('new-replaced') and 2.4% (n = 27) control recommendations ('not changed') in original CGs. The updates were mainly from 'Fertility CG', about 'gynaecology, pregnancy and birth' topic, and 'treatment' or 'prevention' purposes. We did not perform the multiple regression analysis as originally planned due to the small sample of recommendations retrieved.Conclusion: Our study is the first to describe and assess updated CGs and recommendations from a national guideline program. Our results highlight the pressing need to standardise the reporting and presentation of updated recommendations and the research gap about the optimal way to present updates to guideline users. Furthermore, there is a need to investigate updating predictive factors. © 2014 Martínez García et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Reseña (Review)

Guidance for updating clinical practice guidelines, A systematic review of methodological handbooks

  • Vernooij, Robin W. M.|||0000-0001-5734-4566
  • Sanabria, Andrea Juliana
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Martínez García, Laura|||0000-0003-0126-8706
Background: Updating clinical practice guidelines (CPGs) is a crucial process for maintaining the validity of recommendations. Methodological handbooks should provide guidance on both developing and updating CPGs. However, little is known about the updating guidance provided by these handbooks.Methods: We conducted a systematic review to identify and describe the updating guidance provided by CPG methodological handbooks and included handbooks that provide updating guidance for CPGs. We searched in the Guidelines International Network library, US National Guidelines Clearinghouse and MEDLINE (PubMed) from 1966 to September 2013. Two authors independently selected the handbooks and extracted the data. We used descriptive statistics to analyze the extracted data and conducted a narrative synthesis.Results: We included 35 handbooks. Most handbooks (97.1%) focus mainly on developing CPGs, including variable degrees of information about updating. Guidance on identifying new evidence and the methodology of assessing the need for an update is described in 11 (31.4%) and eight handbooks (22.8%), respectively. The period of time between two updates is described in 25 handbooks (71.4%), two to three years being the most frequent (40.0%). The majority of handbooks do not provide guidance for the literature search, evidence selection, assessment, synthesis, and external review of the updating process.Conclusions: Guidance for updating CPGs is poorly described in methodological handbooks. This guidance should be more rigorous and explicit. This could lead to a more optimal updating process, and, ultimately to valid trustworthy guidelines. © 2014 Vernooij et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Brain correlates of impaired goal management in bipolar mania

  • Madre Rull, Mercè|||0000-0002-4660-3216
  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Palau, Pol
  • Sáez, Naia
  • Moro, Noemí
  • Blanch, Clara
  • Verdolini, Norma|||0000-0001-9488-2881
  • Garcia-Leon, María Ángeles
  • Feria, Isabel
  • Munuera, Josep|||0000-0001-5154-1796
  • Sarró, Salvador|||0000-0003-1835-2189
  • Radua, Joaquim|||0000-0003-1240-5438
  • McKenna, Peter
  • Salvador, Raymond|||0000-0001-5557-1562
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
Although executive impairment has been reported in mania, its brain functional correlates have been relatively little studied. This study examined goal management, believed to be more closely related to executive impairment in daily life than other executive tasks, using a novel functional magnetic resonance imaging (fMRI) paradigm in patients in this illness phase. Twenty-one currently manic patients with bipolar disorder and 30 matched healthy controls were scanned while performing the Computerized Multiple Elements Test (CMET). This requires participants to sequentially play four simple games, with transition between games being made either voluntarily (executive condition) or automatically (control condition). CMET performance was impaired in the manic patients compared to the healthy controls. Manic patients failed to increase activation in the lateral frontal, cingulate and inferior parietal cortex when the executive demands of the task increased, while this increase was observed in the healthy controls. Activity in these regions was associated with task performance. Manic patients show evidence of impaired goal management, which is associated with a pattern of reduced medial and lateral frontal and parietal activity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW), A study protocol

  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Carrasco-Labra, Alonso|||0000-0003-3546-3526
  • Brignardello-Petersen, Romina|||0000-0002-6010-9900
  • Neumann, Ignacio|||0000-0001-8406-6880
  • Akl, Elie A.|||0000-0002-3444-8618
  • Sun, Xin
  • Johnston, Bradley C.|||0000-0001-8872-8626
  • Briel, Matthias|||0000-0002-2070-5230
  • Busse, Jason|||0000-0002-0178-8712
  • Glujovsky, Demian|||0000-0002-0586-9341
  • Granados, Carlos E.|||0000-0002-1663-4273
  • Iorio, Alfonso|||0000-0002-3331-8766
  • Irfan, Affan B.
  • Martínez García, Laura|||0000-0003-0126-8706
  • Mustafa, Reem|||0000-0002-2091-0875
  • Ramirez-Morera, Anggie
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Tikkinen, Kari A. O.
  • Ebrahim, Shanil
  • Vandvik, Per Olav|||0000-0001-8958-2710
  • Zhang, Yuqing
  • Selva, Anna|||0000-0002-2754-3158
  • Sanabria, Andrea Juliana
  • Zazueta, Oscar E.|||0000-0001-5374-3906
  • Vernooij, Robin W. M.|||0000-0001-5734-4566
  • Schünemann, Holger J.
  • Guyatt, Gordon|||0000-0003-2352-5718
Background: Clinicians, providers and guideline panels use absolute effects to weigh the advantages and downsides of treatment alternatives. Relative measures have the potential to mislead readers. However, little is known about the reporting of absolute measures in systematic reviews. The objectives of our study are to determine the proportion of systematic reviews that report absolute measures of effect for the most important outcomes, and ascertain how they are analyzed, reported and interpreted. Methods/design: We will conduct a methodological survey of systematic reviews published in 2010. We will conduct a 1:1 stratified random sampling of Cochrane vs. non-Cochrane systematic reviews. We will calculate the proportion of systematic reviews reporting at least one absolute estimate of effect for the most patient-important outcome for the comparison of interest. We will conduct multivariable logistic regression analyses with the reporting of an absolute estimate of effect as the dependent variable and pre-specified study characteristics as the independent variables. For systematic reviews reporting an absolute estimate of effect, we will document the methods used for the analysis, reporting and interpretation of the absolute estimate. Discussion: Our methodological survey will inform current practices regarding reporting of absolute estimates in systematic reviews. Our findings may influence recommendations on reporting, conduct and interpretation of absolute estimates. Our results are likely to be of interest to systematic review authors, funding agencies, clinicians, guideline developers and journal editors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessing the Impact of the Way of Saint James on Psychological Distress and Subjective Well-being, The Ultreya Study

  • Feliu-Soler, Albert|||0000-0003-2810-7670
  • Royuela-Colomer, Estíbaliz|||0000-0001-9912-9610
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Jørgensen, Nanna Natalia
  • Mariño, Manu
  • Demarzo, Marcelo|||0000-0002-7447-1839
  • Soler, Joaquim|||0000-0001-8077-3641
  • Garcia-Campayo, Javier|||0000-0002-3797-4218
  • Montero-Marín, Jesús|||0000-0001-5677-1662
  • Luciano, Juan Vicente|||0000-0003-0750-1599
This study aimed to examine the impact of a pilgrimage on the Way of St. James on psychological distress and subjective well-being, and to compare these outcomes with a control group on non-pilgrimage vacations. Additionally, the study explored psychological process variables that may mediate the pilgrimage's beneficial effects. A nonrandomized pretest-posttest design was used, involving 444 pilgrims and 124 controls. Participants completed baseline and post-experience self-reported measures of psychological distress, subjective well-being, and psychological processes (i.e., mindfulness, nonattachment, engaged living). A 3-month follow-up was conducted only in the pilgrim group. Mediation analyses examined psychological processes as potential mediators of pre-post change in the pilgrim group (vs. control). Within-group analyses revealed that the pilgrim group experienced improvements in psychological distress, subjective well-being, and psychological processes immediately post-experience, with most measures sustaining improvement at the 3-month follow-up. Compared to the control group, pilgrims showed significantly greater increases in positive affect, life satisfaction, and valued living, alongside greater reductions in anxiety, depression, and perceived stress. Valued living partially mediated the relationship between pilgrimage and positive affect, and fully mediated the effects on perceived stress, negative affect, life satisfaction, and subjective happiness. Pilgrimage on the Way of St. James effectively reduced psychological distress and enhanced subjective well-being, with greater benefits observed compared to a non-pilgrimage vacation control group. Consistent with the concept of pilgrimage as a transformative experience, significant improvements in valued living were noted, which mediated some of the positive outcomes post-pilgrimage. The Way of St. James may serve as a valuable complementary approach for alleviating distress and promoting well-being. Further studies exploring the effects of this pilgrimage on specific populations and using more robust study designs are warranted. Trial Registration ClinicalTrials.gov Identifier NCT04141813.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration

  • Fernández-Calvet, Ariadna|||0000-0002-3340-703X
  • Matilla-Cuenca, Leticia|||0000-0003-1822-0151
  • Izco, María|||0000-0003-4807-6779
  • Navarro, Susanna|||0000-0001-8160-9536
  • Serrano, Miriam
  • Ventura, Salvador|||0000-0002-9652-6351
  • Blesa, Javier|||0000-0002-4257-1325
  • Herráiz, Maite
  • Alkorta-Aranburu, Gorka
  • Galera, Sergio
  • Ruiz de los Mozos, Igor|||0000-0003-4097-6422
  • Mansego, María Luisa|||0000-0001-8914-7890
  • Toledo-Arana, Alejandro|||0000-0001-8148-6281
  • Alvarez-Erviti, Lydia|||0000-0002-1238-9442
  • Valle, Jaione|||0000-0003-3115-0207
Age-related neurodegenerative diseases involving amyloid aggregation remain one of the biggest challenges of modern medicine. Alterations in the gastrointestinal microbiome play an active role in the aetiology of neurological disorders. Here, we dissect the amyloidogenic properties of biofilm-associated proteins (BAPs) of the gut microbiota and their implications for synucleinopathies. We demonstrate that BAPs are naturally assembled as amyloid-like fibrils in insoluble fractions isolated from the human gut microbiota. We show that BAP genes are part of the accessory genomes, revealing microbiome variability. Remarkably, the abundance of certain BAP genes in the gut microbiome is correlated with Parkinson's disease (PD) incidence. Using cultured dopaminergic neurons and Caenorhabditis elegans models, we report that BAP-derived amyloids induce α-synuclein aggregation. Our results show that the chaperone-mediated autophagy is compromised by BAP amyloids. Indeed, inoculation of BAP fibrils into the brains of wild-type mice promote key pathological features of PD. Therefore, our findings establish the use of BAP amyloids as potential targets and biomarkers of α-synucleinopathies. The microbiota of the intestinal tract is considered a large biofilm formed by myriads bacteria that have a considerable impact in health and disease. Here, the authors show that biofilm-associated proteins from intestinal microbiota form amyloid-like structures that exacerbate alpha-synuclein pathologies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas

  • Kamieniak, Marta M.
  • Muñoz-Repeto, Ivan
  • Rico, Daniel|||0000-0002-6561-2310
  • Osorio, Ana|||0000-0001-8124-3984
  • Urioste, Miguel|||0000-0001-7583-7305
  • García Donas, J.|||0000-0001-7731-3601
  • Hernando, Susana
  • Robles-Díaz, Luis|||0000-0002-8909-8520
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Cazorla-Jiménez, Alicia|||0000-0002-9534-8418
  • Sáez, Raquel
  • García-Bueno, José María|||0000-0003-3892-8894
  • Domingo, Samuel
  • Borrego, Salud|||0000-0002-2513-6161
  • Palacios, José|||0000-0002-6730-5066
  • Van De Wiel, Mark A.
  • Ylstra, Bauke
  • Benitez, Javier|||0000-0002-0923-7202
  • García, M. J.
Background: Few studies have attempted to characterise genomic changes occurring in hereditary epithelial ovarian carcinomas (EOCs) and inconsistent results have been obtained. Given the relevance of DNA copy number alterations in ovarian oncogenesis and growing clinical implications of the BRCA-gene status, we aimed to characterise the genomic profiles of hereditary and sporadic ovarian tumours.Methods:High-resolution array Comparative Genomic Hybridisation profiling of 53 familial (21 BRCA1, 6 BRCA2 and 26 non-BRCA1/2) and 15 sporadic tumours in combination with supervised and unsupervised analysis was used to define common and/or specific copy number features.Results:Unsupervised hierarchical clustering did not stratify tumours according to their familial or sporadic condition or to their BRCA1/2 mutation status. Common recurrent changes, spanning genes potentially fundamental for ovarian carcinogenesis, regardless of BRCA mutations, and several candidate subtype-specific events were defined. Despite similarities, greater contribution of losses was revealed to be a hallmark of BRCA1 and BRCA2 tumours.Conclusion:Somatic alterations occurring in the development of familial EOCs do not differ substantially from the ones occurring in sporadic carcinomas. However, some specific features like extensive genomic loss observed in BRCA1/2 tumours may be of clinical relevance helping to identify BRCA-related patients likely to respond to PARP inhibitors. © 2013 Cancer Research UK. All rights reserved.
Dipòsit Digital de Documents de la UAB
Publicación

Changes in glucagon-like peptide 1 and 2 levels in people with obesity after a diet-induced weight-loss intervention are related to a specific microbiota signature, A prospective cohort study

  • Rodríguez-Peña, M-Mar
  • Astiarraga, Brenno|||0000-0003-2216-8974
  • Seco, Jesus|||0000-0002-4049-8873
  • Ceperuelo Mallafré, Victòria|||0000-0002-4460-9761
  • Caballé Mestres, Adrià|||0000-0002-2388-4713
  • Pérez-Brocal Vicente|||0000-0002-1927-9676
  • Attolini, Camille Stephan-Otto
  • Moya, Andrés|||0000-0002-2867-1119
  • Llauradó, Gemma|||0000-0002-3237-6366
  • Megía, Ana|||0000-0002-5101-9452
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Strategies to assess the validity of recommendations, A study protocol

  • Martínez García, Laura|||0000-0003-0126-8706
  • Sanabria, Andrea Juliana
  • Araya, Ignacio
  • Lawson, Jennifer
  • Haynes, R.Brian
  • Rigau, David|||0000-0003-0828-4872
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Díaz del Campo, Petra
  • Estrada Sabadell, M. Dolors
  • Etxeandia-Ikobaltzeta, Itziar|||0000-0001-6606-649X
  • García Álvarez, Elvira
  • Gracia, Javier
  • Kotzeva, Anna
  • Louro González, Arturo|||0000-0002-8334-9210
  • Salcedo-Fernandez, Flavia
  • Trujillo-Martín, Maria Mar
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Background: Clinical practice guidelines (CPGs) become quickly outdated and require a periodic reassessment of evidence research to maintain their validity. However, there is little research about this topic. Our project will provide evidence for some of the most pressing questions in this field: 1) what is the average time for recommendations to become out of date?; 2) what is the comparative performance of two restricted search strategies to evaluate the need to update recommendations?; and 3) what is the feasibility of a more regular monitoring and updating strategy compared to usual practice?. In this protocol we will focus on questions one and two.Methods: The CPG Development Programme of the Spanish Ministry of Health developed 14 CPGs between 2008 and 2009. We will stratify guidelines by topic and by publication year, and include one CPG by strata.We will develop a strategy to assess the validity of CPG recommendations, which includes a baseline survey of clinical experts, an update of the original exhaustive literature searches, the identification of key references (reference that trigger a potential recommendation update), and the assessment of the potential changes in each recommendation.We will run two alternative search strategies to efficiently identify important new evidence: 1) PLUS search based in McMaster Premium LiteratUre Service (PLUS) database; and 2) a Restrictive Search (ReSe) based on the least number of MeSH terms and free text words needed to locate all the references of each original recommendation.We will perform a survival analysis of recommendations using the Kaplan-Meier method and we will use the log-rank test to analyse differences between survival curves according to the topic, the purpose, the strength of recommendations and the turnover. We will retrieve key references from the exhaustive search and evaluate their presence in the PLUS and ReSe search results.Discussion: Our project, using a highly structured and transparent methodology, will provide guidance of when recommendations are likely to be at risk of being out of date. We will also assess two novel restrictive search strategies which could reduce the workload without compromising rigour when CPGs developers check for the need of updating. © 2013 Martínez García et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Applying a School-Based Mindfulness and Compassion Program ("Escuelas Despiertas") in Spanish Secondary Schools to Reduce Psychological Distress in Adolescents, A Randomized Controlled Trial

  • Aguilera, Pilar
  • Navarro, Mayte
  • Pérez-Aranda, Adrián|||0000-0002-1602-3413
  • Armas Landata, Carilene Enelram
  • Beltrán-Ruiz, María|||0000-0003-0786-535X
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Camarero-Grados, L.
  • Garcia-Campayo, Javier|||0000-0002-3797-4218
  • Montero-Marín, Jesús|||0000-0001-5677-1662
Adolescents present high risk of developing mental health problems. Different school-based programs have been designed to prevent and treat the psychological distress that they often experience with disparate results. In this study, we tested the efficacy of a school-based program framed into the "Escuelas Despiertas" initiative that teaches adolescents mindfulness and compassion to improve their mental health. In this randomized controlled trial, high school students from four Spanish secondary education centers (N = 277) were randomly assigned to a school-based 10-session mindfulness and compassion program ("Escuelas Despiertas") or a relaxation program. Participants were assessed at baseline, posttreatment, and at 6-month follow-up. The main outcome was psychological distress (General Health Questionnaire, GHQ-12). Classroom climate and relaxation habits, among others, were assessed as secondary outcomes. Students who underwent the "Escuelas Despiertas" program experienced small within group improvements posttreatment in GHQ-12 scores (p = 0.001, d = 0.31) and in relaxation habits (p = 0.001, d = 0.35), although these were not significant compared to the control group. Classroom climate presented a small deterioration in the "Escuelas Despiertas" group compared to the relaxation group in the follow-up assessment, but this effect was not statistically significant after correcting for multiple comparisons. In conclusion, the "Escuelas Despiertas" program produced small short-term improvements in psychological distress and relaxation habits in adolescents which were not significant compared to a relaxation intervention. In line with previous studies, it seems that punctual interventions delivered during some weeks might not be the best approach for adolescents, for whom mindfulness- and-compassion-based programs may not be engaging enough for different reasons.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy, a study protocol

  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Ebrahim, Shanil
  • Guyatt, Gordon|||0000-0003-2352-5718
  • Tikkinen, Kari A.O.
  • Eckman, Mark H.
  • Neumann, Ignacio|||0000-0001-8406-6880
  • McDonald, Sarah D.
  • Akl, Elie A.|||0000-0002-3444-8618
  • Bates, Shannon
Background: Pregnant women with prior venous thromboembolism (VTE) are at risk of recurrence. Low molecular weight heparin (LWMH) reduces the risk of pregnancy-related VTE. LMWH prophylaxis is, however, inconvenient, uncomfortable, costly, medicalizes pregnancy, and may be associated with increased risks of obstetrical bleeding. Further, there is uncertainty in the estimates of both the baseline risk of pregnancy-related recurrent VTE and the effects of antepartum LMWH prophylaxis. The values and treatment preferences of pregnant women, crucial when making recommendations for prophylaxis, are currently unknown. The objective of this study is to address this gap in knowledge.Methods: We will perform a multi-center cross-sectional interview study in Canada, USA, Norway and Finland. The study population will consist of 100 women with a history of lower extremity deep vein thrombosis (DVT) or pulmonary embolism (PE), and who are either pregnant, planning pregnancy, or may in the future consider pregnancy (women between 18 and 45 years). We will exclude individuals who are on full dose anticoagulation or thromboprophylaxis, who have undergone surgical sterilization, or whose partners have undergone vasectomy. We will determine each participant's willingness to receive LMWH prophylaxis during pregnancy through direct choice exercises based on real life and hypothetical scenarios, preference-elicitation using a visual analog scale (" feeling thermometer"), and a probability trade-off exercise. The primary outcome will be the minimum reduction (threshold) in VTE risk at which women change from declining to accepting LMWH prophylaxis. We will explore possible determinants of this choice, including educational attainment, the characteristics of the women's prior VTE, and prior experience with LMWH. We will determine the utilities that women place on the burden of LMWH prophylaxis, pregnancy-related DVT, pregnancy-related PE and pregnancy-related hemorrhage. We will generate a " personalized decision analysis" using participants' utilities and their personalized risk of recurrent VTE as inputs to a decision analytic model. We will compare the personalized decision analysis to the participant's stated choice.Discussion: The preferences of pregnant women at risk of VTE with respect to the use of antithrombotic therapy remain unexplored. This research will provide explicit, quantitative expressions of women's valuations of health states related to recurrent VTE and its prevention with LMWH. This information will be crucial for both guideline developers and for clinicians. © 2012 Alonso-Coello et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Medical students' perceptions and attitudes about family practice, A qualitative research synthesis

  • Selva, Anna|||0000-0002-2754-3158
  • Martín Zurro, Amando
  • Jiménez Villa, Josep|||0000-0002-2560-0833
  • Monreal Hijar, Antonio
  • Mundet-Tudurí, Xavier|||0000-0002-0318-8657
  • Otero Puime, Ángel|||0000-0001-7967-4961
  • Mas Dalmau, Gemma|||0000-0003-3720-0797
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Background: During the last decade medical students from most Western countries have shown little interest in family practice. Understanding the factors that influence medical students to choose family medicine is crucial. Objective. To systematically review and synthesize published evidence about medical students' attitudes and perceptions towards family practice. Methods. A qualitative systematic review. The literature search was undertaken in July 2010 in PubMed, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Social Science Citation Index (SSCI), and ProQuest Dissertations & Theses. Two authors independently selected the studies for their inclusion and assessed their quality. The selected studies were thoroughly read. Key themes and categories were identified. A matrix was created for allowing the comparison of each theme across studies. Results: Ten studies were finally included. Seven broad themes were identified across them: 1) Scope and context of practice was a broad theme comprising linked sub-themes: perception of a varied specialty, broad practice, holistic perspective and flexibility that allows having a family; 2) Lower interest or intellectually less challenging: treating common disease, repetitive, quasi administrative job; 3) Influence of role models, either positive and negative, and society: negative comments from other professionals, peers and family; 4) Lower prestige; 5) Poor remuneration; 6) Medical school influences, being important both the length and quality of the exposure; 7) Post graduate training, where the shorter duration and the lower intensity were perceived as positive aspects. After identifying these seven key themes, were also looked into patterns in the distribution of these themes among studies. Conclusions: Our qualitative review provides a comprehensive picture of medical students' attitudes towards family practice in the available literature. In general, although some students find family medicine appealing, it is regarded as a career of low interest and prestige. More research is needed on the influence of role models, medical school and post graduate training. © 2012 Selva Olid et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Medical student attitudes towards family medicine in Spain, A statewide analysis

  • Martín Zurro, Amando
  • Jiménez Villa, Josep|||0000-0002-2560-0833
  • Moral Hijar, Antonio
  • Mundet-Tudurí, Xavier|||0000-0002-0318-8657
  • Otero Puime, Ángel|||0000-0001-7967-4961
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Background: Family and community medicine (FM) became a recognized specialty in Spain in 1978; however, most medical schools in Spain still lack mandatory core courses in FM. In order to explore the perceptions, expectations and level of information amongst medical students in Spain in relation to FM and PC, and the training in these areas in the curriculum of the Medical Schools, a survey was developed to be administered in medical schools every two years. This article presents data from the first questionnaire administration. Methods: The study population was all first-, third-, and fifth-year students (20092010) in 22 participating medical schools in Spain (of 27 total). The 83-item survey had three sections: personal data, FM training, professional practice expectations, and preferences). Chi-squared test or analyses of variance were used, as appropriate. Results: We had a 41.8% response rate (n = 5299/12924); 89.8% considered the social role of FM to be essential, while only 20% believed the specialty was well respected within the medical profession. The appeal of FM increased with years of study, independent of student characteristics or medical school attended. Among third and fifth-year students, 54.6% said their specialty preferences had changed during medical school; 73.6% felt that FM specialists should teach FM courses, and 83.3% thought that FM rotations in primary care centres were useful. Conclusions: Students valued the social role of FM more highly than its scientific standing. The vast majority believe that FM training should be mandatory. Only 25% of first-year students have clear preferences for a specialization. Interest in FM increases moderately over their years of study. Working conditions in FM have decisive influence in choosing a specialty. © 2012 Martn Zurro et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers

  • Salvat-Rovira, Nil|||0009-0005-8515-3819
  • Vázquez-Oliver, Anna|||0000-0002-9842-7656
  • Rivas Asensio, Elisa|||0009-0006-1645-0059
  • Herrero-Lorenzo, Marina|||0000-0003-2693-0700
  • Gámez-Valero, Ana|||0000-0002-9530-2751
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Izquierdo, Cristina
  • Campolongo, Antonia|||0000-0002-7962-3264
  • Martí, Eulàlia|||0000-0002-1030-3158
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Pérez-González, Rocío|||0000-0002-0641-2001
Extracellular vesicles (EVs) in cerebrospinal fluid (CSF) represent a valuable source of biomarkers for central nervous system (CNS) diseases, offering new pathways for diagnosis and monitoring. However, existing methods for isolating EVs from CSF often prove to be labor-intensive and reliant on specialized equipment, hindering their clinical application. In this study, we present a novel, clinically compatible method for isolating EVs from CSF. We optimized the use of ExoGAG, a commercially available reagent that has been tested in plasma, urine and semen, and compared it directly with differential ultracentrifugation using Western blotting, protein quantification, nanoparticle tracking analysis, and cryogenic electron microscopy. Additionally, we analyzed the presence of specific microRNAs (miRNAs) known to be present in CSF-derived EVs. Our data demonstrate that ExoGAG is an effective method for isolating EVs from CSF, yielding a higher amount of EVs compared to traditional ultracentrifugation methods, and with comparable levels of specific miRNAs. In conclusion, the use of ExoGAG in a clinical setting may facilitate the testing of biomarkers essential for tracking brain pathology in CNS diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity

  • Cuyàs, Elisabet|||0000-0001-5353-440X
  • Pedarra, Stefano
  • Verdura, Sara|||0000-0001-8980-0423
  • Pardo-Cea, Miguel Ángel|||0000-0003-4823-6613
  • Espin Garcia, Roderic|||0000-0003-2494-0964
  • Serrano-Hervás, Eila|||0000-0002-9477-0350
  • Llop-Hernández, Àngela
  • Teixidor, Eduard
  • Bosch-Barrera, J.|||0000-0002-0893-7821
  • López-Bonet, Eugeni
  • Martin-Castillo, Begoña
  • Lupu, Ruth|||0000-0002-5564-3172
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Sardanyés, Josep|||0000-0001-7225-5158
  • Alarcón Cor, Tomás|||0000-0002-8566-3676
  • Menéndez, Javier A.|||0000-0001-8733-4561
Fatty acid synthase (FASN)-catalyzed endogenous lipogenesis is a hallmark of cancer metabolism. However, whether FASN is an intrinsic mechanism of tumor cell defense against T cell immunity remains unexplored. To test this hypothesis, here we combined bioinformatic analysis of the FASN-related immune cell landscape, real-time assessment of cell-based immunotherapy efficacy in CRISPR/Cas9-based FASN gene knockout (FASN KO) cell models, and mathematical and mechanistic evaluation of FASN-driven immunoresistance. FASN expression negatively correlates with infiltrating immune cells associated with cancer suppression, cytolytic activity signatures, and HLA-I expression. Cancer cells engineered to carry a loss-of-function mutation in FASN exhibit an enhanced cytolytic response and an accelerated extinction kinetics upon interaction with cytokine-activated T cells. Depletion of FASN results in reduced carrying capacity, accompanied by the suppression of mitochondrial OXPHOS and strong downregulation of electron transport chain complexes. Targeted FASN depletion primes cancer cells for mitochondrial apoptosis as it synergizes with BCL-2/BCL-X-targeting BH3 mimetics to render cancer cells more susceptible to T-cell-mediated killing. FASN depletion prevents adaptive induction of PD-L1 in response to interferon-gamma and reduces constitutive overexpression of PD-L1 by abolishing PD-L1 post-translational palmitoylation. FASN is a novel tumor cell-intrinsic metabolic checkpoint that restricts T cell immunity and may be exploited to improve the efficacy of T cell-based immunotherapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A phenome-wide association and Mendelian randomisation study of alcohol use variants in a diverse cohort comprising over 3 million individuals

  • Jennings, Mariela V.
  • Martínez-Magaña, José Jaime
  • Courchesne-Krak, Natasia S.
  • Cupertino , Renata B.
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Bianchi, Sevim B.
  • Hatoum, Alexander S.
  • Atkinson, Elizabeth G.
  • Giusti-Rodriguez, Paola
  • Montalvo-Ortiz, Janitza L.|||0000-0002-7657-8365
  • Gelernter, Joel|||0000-0002-4067-1859
  • Soler Artigas, María|||0000-0002-3213-1107
  • Elson, Sarah L.
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Fontanillas, Pierre
  • Palmer, Abraham A.
  • Sánchez Roige, Sandra|||0000-0001-6137-5699
Alcohol consumption is associated with numerous negative social and health outcomes. These associations may be direct consequences of drinking, or they may reflect common genetic factors that influence both alcohol consumption and other outcomes. We performed exploratory phenome-wide association studies (PheWAS) of three of the best studied protective single nucleotide polymorphisms (SNPs) in genes encoding ethanol metabolising enzymes (ADH1B : rs1229984-T, rs2066702-A; ADH1C : rs698-T) using up to 1109 health outcomes across 28 phenotypic categories (e.g., substance-use, mental health, sleep, immune, cardiovascular, metabolic) from a diverse 23andMe cohort, including European (N ≤ 2,619,939), Latin American (N ≤ 446,646) and African American (N ≤ 146,776) populations to uncover new and perhaps unexpected associations. These SNPs have been consistently implicated by both candidate gene studies and genome-wide association studies of alcohol-related behaviours but have not been investigated in detail for other relevant phenotypes in a hypothesis-free approach in such a large cohort of multiple ancestries. To provide insight into potential causal effects of alcohol consumption on the outcomes significant in the PheWAS, we performed univariable two-sample and one-sample Mendelian randomisation (MR) analyses. The minor allele rs1229984-T, which is protective against alcohol behaviours, showed the highest number of PheWAS associations across the three cohorts (N = 232, European; N = 29, Latin American; N = 7, African American). rs1229984-T influenced multiple domains of health. We replicated associations with alcohol-related behaviours, mental and sleep conditions, and cardio-metabolic health. We also found associations with understudied traits related to neurological (migraines, epilepsy), immune (allergies), musculoskeletal (fibromyalgia), and reproductive health (preeclampsia). MR analyses identified evidence of causal effects of alcohol consumption on liability for 35 of these outcomes in the European cohort. Our work demonstrates that polymorphisms in genes encoding alcohol metabolising enzymes affect multiple domains of health beyond alcohol-related behaviours. Understanding the underlying mechanisms of these effects could have implications for treatments and preventative medicine. MVJ, NCK, SBB, SSR and AAP were supported by T32IR5226 and 28IR-0070. SSR was also supported by DP1DA054394. NCK and RBC were also supported by R25MH081482. ASH was supported by funds from NIAAA K01AA030083. JLMO was supported by VA 1IK2CX002095. JLMO and JJMM were also supported by R21DA050160. JJMM was also supported by the for Academic Diversity. EGA was supported by K01MH121659 from the /, the and the at . MSA was supported by the and co-funded by the : (FSE+) (P19/01224, PI22/00464 and CP22/00128).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Premature Death, Suicide, and Nonlethal Intentional Self-Harm After Psychiatric Discharge

  • Mortier, Philippe|||0000-0003-2113-6241
  • Conde, Susana
  • Alayo, Itxaso|||0000-0002-7333-3450
  • Amigo, Franco|||0000-0002-3602-5168
  • Ballester, Laura
  • Cirici Amell, Roser
  • Guinart, Daniel
  • Contaldo, Salvatore Fabrizio
  • Ferrer Forés, Maria Montserrat|||0000-0001-9867-7391
  • Leis, Angela
  • Mayer, Miguel Angel|||0000-0003-0362-6298
  • Portillo-Van Diest, Ana|||0000-0001-7199-8339
  • Puértolas-Gracia, Beatriz
  • Ramírez-Anguita, Juan Manuel|||0000-0002-8509-0927
  • Peña-Salazar, Carlos
  • Sanz, Ferran|||0000-0002-7534-7661
  • Kessler, Ronald|||0000-0003-4831-2305
  • Palao, Diego|||0000-0002-3323-6568
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Mehlum, Lars|||0000-0003-2813-0045
  • Qin, Ping
  • Vilagut, Gemma|||0000-0002-3714-226X
  • Alonso, Jordi|||0000-0001-8627-9636
This cohort study estimates rates of all-cause premature death, suicide, and nonlethal intentional self-harm after discharge from a psychiatric hospitalization among patients in Spain and investigates associations of these outcomes with variables including sex and mental disorders. What is the risk for premature death, suicide, and nonlethal intentional self-harm following discharge from psychiatric hospitalization? In this cohort study including 49 108 patients, risk for postdischarge premature death (age <70 years) and suicide was significantly higher compared with the general population. Premature death was associated with cognitive disorders and alcohol-related disorders in both sexes; suicide was associated with postdischarge nonlethal intentional self-harm in both sexes, with depressive and adjustment disorders in males, and with bipolar disorder in females. The findings suggest individuals discharged from psychiatric inpatient care constitute a vulnerable population for premature death and suicidal behavior. There is a need for representative research on serious adverse outcomes following discharge from psychiatric hospitalization. To compare rates of premature death, suicide, and nonlethal intentional self-harm after psychiatric discharge with rates in the general population and investigate associations of these outcomes with relevant variables associated with the index psychiatric hospitalization. This retrospective cohort study included all residents from Catalonia, Spain (7.6 million population), who had psychiatric hospitalizations between January 1, 2014, and December 31, 2018, and were older than 10 years at the index (first) hospitalization. Follow-up was until December 31, 2019. Statistical analysis was performed from December 1, 2022, through April 11, 2024. Socioeconomic status, psychiatric diagnoses, duration of index hospitalization, and number of previous psychiatric hospitalizations. Postdischarge premature death (ie, all-cause death before age 70 years) and suicide (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10] code range X60-X84), identified using mortality data, and postdischarge nonlethal intentional self-harm, identified using electronic health record and self-harm case register data. Standardized mortality ratios (SMRs) compared rates of premature death and suicide between the cohort and the general population. Fully adjusted, multivariable, cause-specific Cox proportional hazards regression models for the 3 outcomes were fitted. A total of 49 108 patients discharged from psychiatric hospitalization were included (25 833 males [52.6%]; mean [SD] age at discharge, 44.2 [18.2] years). During follow-up, 2260 patients (4.6%) died prematurely, 437 (0.9%) died by suicide, and 4752 (9.7%) had an episode of nonlethal intentional self-harm. The overall SMR for premature death was 7.5 (95% CI, 7.2-7.9). For suicide, SMR was 32.9 (95% CI, 29.9-36.0) overall and was especially high among females (47.6 [95% CI, 40.2-54.9]). In fully adjusted sex-stratified hazard models, postdischarge premature death was associated with cognitive disorders (adjusted hazard ratio [AHR], 2.89 [95% CI, 2.24-3.74] for females; 2.59 [95% CI, 2.17-3.08] for males) and alcohol-related disorders (AHR, 1.41 [95% CI, 1.18-1.70] for females; 1.22 [95% CI, 1.09-1.37] for males). Postdischarge suicide was associated with postdischarge intentional self-harm (AHR, 2.83 [95% CI, 1.97-4.05] for females; 3.29 [95% CI, 2.47-4.40] for males), with depressive disorders (AHR, 2.13 [95% CI, 1.52-2.97]) and adjustment disorders (AHR, 1.94 [95% CI, 1.32-2.83]) among males, and with bipolar disorder among females (AHR, 1.94 [95% CI, 1.21-3.09]). Postdischarge intentional self-harm was associated with index admissions for intentional self-harm (AHR, 1.95 [95% CI, 1.73-2.21] for females; 2.62 [95% CI, 2.20-3.13] for males) as well as for adjustment disorders (AHR, 1.48 [95% CI, 1.33-1.65] for females; 1.99 [95% CI, 1.74-2.27] for males), anxiety disorders (AHR, 1.24 [95% CI, 1.10-1.39] for females; 1.36 [95% CI, 1.18-1.58] for males), depressive disorders (AHR, 1.54 [95% CI, 1.40-1.69] for females; 1.80 [95% CI, 1.58-2.04] for males), and personality disorders (AHR, 1.59 [95% CI, 1.46-1.73] for females; 1.43 [95% CI, 1.28-1.60] for males). In this cohort study of patients discharged from psychiatric hospitalization, risk for premature death and suicide was significantly higher compared with the general population, suggesting individuals discharged from psychiatric inpatient care are a vulnerable population for premature death and suicidal behavior.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Surpassing protein specificity in biomimetics of bacterial amyloids

  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Parladé, Eloi|||0000-0001-5750-550X
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
In nature, nontoxic protein amyloids serve as dynamic, protein-specific depots, exemplified by both bacterial inclusion bodies and secretory granules from the endocrine system. Inspired by these systems, chemically defined and regulatory-compliant artificial protein microgranules have been developed for clinical applications as endocrine-like protein repositories. This has been achieved by exploiting the reversible coordination between histidine residues and divalent cations such as Zn, that promotes protein-protein interactions. While stereospecificity is a main architectonic feature of natural amyloids, the potential for synthetic approaches to create hybrid protein materials remains unexplored. Such materials could enable the occurrence and synchronized local application of diverse proteins in predefined molar ratios, for coupled enzymatic reactions or delivery of synergistically acting polypeptides. Here, we report on the fabrication of artificial protein granules with amyloidal architecture formed by combining two structurally distinct polypeptides. Specifically, we tested co-aggregation of the pairs GFP/IRFP and GFP/β-galactosidase. The formation of hybrid microparticles was confirmed through FRET and complementary methodologies, demonstrating that the His-Zn clustering technology does not require sequential or structural homologies between aggregating polypeptides. This approach opens new avenues for the development of functional depots that capitalize on synergistic protein functionalities, paving the way for next-generation functional materials.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of Genetic Loci Associated With Intracerebral Hemorrhage Using a Multitrait Analysis Approach

  • Muiño, Elena|||0000-0001-5839-7328
  • Cárcel-Márquez, Jara|||0000-0002-6949-0699
  • Llucià-Carol, Laia|||0000-0002-7732-0665
  • Gallego Fabrega, Cristina|||0000-0003-3229-5512
  • Cullell, Natalia|||0000-0001-5118-1014
  • Lledós, Miquel|||0000-0001-8832-789X
  • Martín-Campos, Jesús María|||0000-0003-0414-037X
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Sierra-Marcos, Alba|||0000-0001-6570-9318
  • Ros-Castelló, Victoria|||0000-0002-9523-3012
  • Aguilera-Simón, Ana|||0000-0003-1428-8212
  • Martí-Fàbregas, Joan|||0000-0001-9229-8649
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
Background and Objectives Genome-wide association studies (GWASs) have only 2 loci associated with spontaneous intracerebral hemorrhage (ICH): APOE for lobar and 1q22 for nonlobar ICH. We aimed to discover new loci through an analysis that combines correlated traits (multi-trait analysis of GWAS [MTAG]) and explore a gene-based analysis, transcriptome-wide association study (TWAS), and proteome-wide association study (PWAS) to understand the biological mechanisms of spontaneous ICH providing potential therapeutic targets. Methods We use the published MTAG of ICH (patients with spontaneous intraparenchymal bleeding) and small-vessel ischemic stroke. For all ICH, lobar ICH, and nonlobar ICH, a pairwise MTAG combined ICH with traits related to cardiovascular risk factors, cerebrovascular diseases, or Alzheimer disease (AD). For the analysis, we assembled those traits with a genetic correlation ≥0.3. A new MTAG combining multiple traits was performed with those traits whose pairwise MTAG yielded new GWAS-significant single nucleotide polymorphisms (SNPs), with a posterior-probability of model 3 (GWAS-pairwise) ≥0.6. We perform TWAS and PWAS that correlate the genetic component of expression or protein levels with the genetic component of a trait. We use the ICH cohort from UK Biobank as replication. Results For all ICH (1,543 ICH, 1,711 controls), the mean age was 72 ± 2 in cases and 70 ± 2 in controls, and half of them were women. Replication cohort: 700 ICH and 399,717 controls. Novel loci were found only for all ICH (the trait containing lobar and nonlobar ICH), combining data of ICH and small vessel stroke, white matter hyperintensities volume, fractional anisotropy, mean diffusivity, and AD. We replicated 6 SNPs belonging to 2q33.2 (ICA1L, β = 0.20, SE = 0.03, p value = 8.91 × 10), 10q24.33 (OBFC1, β = -0.12, SE = 0.02, p value = 1.67 × 10), 13q34 (COL4A2, β = 0.02, SE = 0.02, p value = 2.34 × 10), and 19q13.32 (APOC1, β = -0.19, SE = 0.03, p value = 1.38 × 10; APOE, β = 0.21, SE = 0.03, p value = 2.70 × 10; PVRL2:CTB-129P6.4, β = 0.15, SE = 0.03, p value = 1.38 × 10); 2 genes (SH3PXD2A, Z-score = 4.83, p value = 6.67 × 10; and APOC1, Z-score: = 5.11, p value = 1.60 × 10); and ICA1L transcript (Z-score = 6.8, p value = 9.1 × 10) and protein levels (Z-score = -5.8, p value = 6.7 × 10).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Citrate-Assisted Regulation of Protein Stability and Secretability from Synthetic Amyloids

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Chellou-Bakkali, Sara|||0009-0007-1643-4558
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Parladé, Eloi|||0000-0001-5750-550X
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Corchero Nieto, José Luis|||0000-0002-6109-144X
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
The mammalian endocrine system uses functional amyloids as dynamic depots to store and release protein hormones into the bloodstream. Such depots, acting as secretory granules within the microscale, are formed in specialized cells by the coordination between the ionic, divalent form of zinc (Zn2+) and the imidazole ring from accessible His residues. The reversibility of such cross-linking events allows for the release of monomeric or oligomeric forms of the functional protein for biological activity. In vitro, and mimicking such a natural coordination process, synthetic amyloidal granules with secretory properties can be fabricated using selected therapeutic proteins as building blocks. Then, these microparticles act as delivery systems for endocrine-like, sustained protein release, with proven applicability in vaccinology, cancer therapy, regenerative medicine, and as antimicrobial agents. While the temporal profile in which the protein is leaked from the material might be highly relevant to clinically oriented applications, the fine control of such parameters remains unclear. We have explored here how the kinetics of protein release can be regulated by intervening in the storage formulation of the granules, through the concentration of citrate not only as a buffer component and protein stabilizer but also as a chelating agent. The citrate-assisted, time-prolonged regulatable release of proteins, in their functional form, opens a spectrum of possibilities to adjust the preparation of synthetic secretory granules to specific clinical needs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Trans-Mediated, Cis-Inhibited Paradoxal Activity of Clostridium perfringens Enterotoxin (c-CPE) in Modulating Epithelial Permeability

  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Parladé, Eloi|||0000-0001-5750-550X
  • Di Somma, Angela|||0000-0003-4916-7875
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Villaverde, Antonio|||0000-0002-2615-4521
In the context of transdermal delivery, favoring the drug permeability of epithelia through convenient formulations would open new opportunities for local versus systemic drug delivery, envisaging higher patient comfort and an enhanced therapeutic effect. Ligands of tight junctions are interesting agents that enhance epithelial permeability by relaxing the protein complexes that form them. The C-terminal domain of Clostridium perfringens enterotoxin (c-CPE), which binds claudins, one of the tight junction (TJ) components, has been explored here as a functional domain in modular recombinant proteins, to evaluate its ability to self-promote its paracellular epithelial passage in a Caco-2 cell monolayer model. c-CPE-containing fusion proteins bind cells in the absence of internalization and cytotoxicity and support the passage, in trans, of other fusion proteins devoid of c-CPE. However, c-CPE-carrying proteins fail to cross the epithelia by themselves, probably because their affinity for TJs immobilizes them in the intercellular space. Therefore, while recombinant c-CPE versions have been here confirmed as convenient epithelial-permeabilizing agents, a paradoxical behavior has been observed where this effect is only successful when applied in trans, specifically on entities that lack c-CPE. Then, c-CPE itself inhibits the paracellular mobility of carrier molecules, not being suited as a self-driver (in c-CPE-drug complexes) for drug delivery through epithelia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blastocystis occurrence and subtype diversity in European wild boar (Sus scrofa) from the Iberian Peninsula

  • Köster, Pamela C.|||0000-0001-5963-8824
  • Figuereido, Ana M.
  • Maloney, Jenny G.|||0000-0002-6405-883X
  • Dashti, Alejandro|||0000-0001-8707-5731
  • Bailo, Begoña|||0000-0002-9453-9431
  • Tinoco Torres, Rita|||0000-0003-4570-459X
  • Fonseca, Carlos|||0000-0001-6559-7133
  • Mysterud, Atle|||0000-0001-8993-7382
  • Habela, Miguel Ángel
  • Rivero-Juarez, Antonio|||0000-0002-5813-6889
  • Vicente, Joaquín|||0000-0001-8416-3672
  • Serrano Ferron, Emmanuel|||0000-0002-9799-9804
  • Arnal, Maria C.|||0000-0002-6770-3400
  • Fernández de Luco, Daniel|||0000-0003-3289-4267
  • Armenteros, José A.|||0000-0001-8776-1299
  • Balseiro, Ana|||0000-0002-5121-7264
  • Cardona, Guillermo A.|||0000-0002-4156-4174
  • Carvalho, João|||0000-0002-3166-450X
  • Hipólito, Dário|||0000-0002-2985-1314
  • Fernandes, Joana M.|||0000-0001-5602-1490
  • Palmeira, Josman Dantas
  • Calero-Bernal, Rafael|||0000-0003-2323-0135
  • González-Barrio, David|||0000-0001-5083-8854
  • Santín, Mónica
  • Carmena, David|||0000-0002-4015-8553
The ongoing increase in wild boar populations across Europe has fostered human-wildlife conflicts, including the transmission of emerging pathogens with zoonotic importance. Blastocystis is a ubiquitous, faecal-oral transmitted protist that can cause gastrointestinal illnesses and is observed in humans and animals worldwide. The role of wildlife in the epidemiology of Blastocystis is insufficiently understood. Thus, we investigated the occurrence and subtype diversity of Blastocystis in free-ranging wild boars from the Iberian Peninsula using conventional PCR and next-generation amplicon sequencing of a fragment of the ssu RNA gene. A total of 459 wild boar faecal samples were collected across Spain (n = 360) and Portugal (n = 99) between 2014 and 2021. Blastocystis was present in 15.3% (70/459; 95% CI 12.1-18.9) of the wild boars analysed, and its occurrence was significantly higher in Portugal (34.3%, 34/99; 95% CI 25.1-44.6) than in Spain (10.0%, 36/360; 95% CI 7.1-13.6). Seven Blastocystis subtypes (ST5, ST10b, ST13-ST15, ST24b, and ST43) were detected among the surveyed wild boar populations, with greater variability detected in Portuguese samples. ST5 was identified in all the Blastocystis-positive animals, whereas 14.3% of them harboured ST mixed colonisations. Our results demonstrate that Blastocystis ST5 is particularly adapted to infect wild boars. The additional identification of zoonotic STs reinforces the role of wild boars as spreaders of zoonotic infections with public health significance.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Attitudes and perceptions of medical students about family medicine in Spain, Protocol for a cross-sectional survey

  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Jiménez Villa, Josep|||0000-0002-2560-0833
  • Hijar, A.M.
  • Mundet-Tudurí, Xavier|||0000-0002-0318-8657
  • Puime, A.O.
  • Martín Zurro, Amando
Background: Despite the fact that family medicine (FM) has become established as a specialty in the past 25 years, this has not been reflected in the inclusion of the specialty in the majority of medical schools in Spain. Almost 40% of the students will work in primary care but, in spite of this, most universities do not have an assessed placement as such. There are only specific practice periods in health centres or some student-selected components with little weight in the overall curricula. Objectives: To evaluate the attitudes and perceptions of medical students about FM in the health system and their perception about the need for specific training in FM at the undergraduate level. To explore change over time of these attitudes and perceptions and to examine potential predictive factors for change. Finally, we will review what teaching activity in FM is offered across the Spanish schools of medicine. Methods: Descriptive cross-sectional survey. Each one of the different analyses will consist of two surveys: one for all the students in the first, third and fifth year of medical school in all the Spanish schools of medicine asking about their knowledge, perceptions and attitudes in relation to primary care and FM. There will be an additional survey for the coordinating faculty of the study in each university about the educational activities related to FM that are carried out in their centres. The repetition of the study every 2 years will allow for an analysis of the evolution of the cohort of students until they receive their degree and the potential predictive factors. Discussion: This study will provide useful information for strategic planning decisions, content and educational methodology in medical schools in Spain and elsewhere. It will also help to evaluate the influence of the ongoing changes in FM, locally and at the European level, on the attitudes and perceptions of the students towards FM in Spain.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effectiveness of a patient-centred complex intervention to improve Initial Medication Adherence to cardiovascular disease and diabetes treatments in primary care (the IMA-cRCT study), a pragmatic cluster randomised controlled trial using real-world data

  • Corral-Partearroyo, Carmen|||0000-0001-9517-4916
  • Sánchez-Viñas, Alba|||0000-0001-5020-7534
  • Aznar-Lou, Ignacio|||0000-0002-6780-5968
  • Peñarrubia-María, María Teresa
  • Gil-Girbau, Montserrat|||0000-0002-4396-6492
  • Gallardo-González, Carmen|||0000-0003-0688-1366
  • Olmos-Palenzuela, María del Carmen
  • Rubio-Valera, Maria|||0000-0003-2856-1697
INTRODUCTION: Non-adherence to cardiovascular disease and diabetes treatments contributes to suboptimal clinical outcomes and higher cost. The initial medication adherence (IMA) intervention is a multidisciplinary primary care (PC) intervention based on shared decision-making (SDM). The IMA-cluster-randomised controlled trial (cRCT) study evaluated the impact of the IMA intervention on medication initiation, secondary adherence and clinical outcomes compared with usual care (UC). METHODS: This was a pragmatic cRCT with a hybrid effectiveness-implementation design which randomised 24 PC centres in Spain to intervention or UC. Patients receiving a new prescription of antihypertensive, lipid-lowering, antiplatelet and/or oral/injectable antidiabetic medication at the intervention centres (March 2022-September 2022) were attended by general practitioners (GPs), nurses and community pharmacists who had been trained in SDM and given decision aids (leaflets and website). Real-world data from prescription and dispensing records-used to assess medication initiation and secondary adherence (correct dosing and continued use)-and clinical outcome data from electronic health records were collected up to 18 months after initial prescription and analysed using multilevel regression models. RESULTS: Overall, 4910 prescriptions were issued to 3629 patients (Intervention=2148; UC=1481) by 150 GPs (Intervention=91; UC=59). No differences were detected between groups in medication initiation or secondary adherence. Among clinical outcomes, only blood pressure outcomes favoured the IMA intervention, reflecting a small but clinically meaningful improvement. CONCLUSIONS: The IMA intervention had limited overall impact, with no effect on adherence, but showed potential benefits in blood pressure. However, SDM, as an ethically grounded approach, may enhance patients and professional experiences, supporting its consideration for broader implementation. Future efforts should prioritise these benefits by investing in professional training and patient support, addressing implementation challenges and deepening understanding of SDM effects, which would warrant further evaluation. Trial registration number NCT05026775.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Internal structure, reliability and cross-cultural validity of the Warwick-Edinburgh Mental Wellbeing Scale in three European populations

  • Yadav, Prateek
  • Arias de la Torre, Jorge|||0000-0001-6908-9611
  • Bakolis, Ioannis|||0000-0002-4800-1630
  • Bartoll, Xavier|||0000-0001-6865-8034
  • Casajuana Kogel, Cristina
  • Colom, Joan
  • Dregan, Alex
  • Garcia Forero, Carlos
  • Botella-Juan, Lorena
  • Martín, Vicente|||0000-0003-0552-2804
  • Molina de la Torre, Antonio José
  • Mortier, Philippe|||0000-0003-2113-6241
  • Nielsen, Line
  • Pérez, Catherine|||0000-0001-5892-2807
  • Puertolas, Beatriz
  • Ronaldson, Amy|||0000-0001-8369-9168
  • Santini, Ziggi
  • Schiaffino, Anna|||0000-0001-8787-2634
  • Serrano-Blanco, Antoni|||0000-0001-6123-0633
  • Stewart-Brown, Sarah
  • Valderas, Jose M.|||0000-0002-9299-1555
  • Alonso, Jordi|||0000-0001-8627-9636
  • Vilagut, Gemma|||0000-0002-3714-226X
The Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS), a questionnaire designed for the assessment of mental well-being, is widely used in different countries and cultures worldwide. However, there is a lack of studies examining its metric performance and measurement invariance across countries. This study aims to examine the internal structure, reliability and cross-country validity of the WEMWBS in three European populations. WEMWBS data collected in 2016 from three representative population health surveys from an autonomous region in Spain (Catalonia) and two countries (Denmark and the UK) were used (n=13 940). The mean WEMWBS Scores were compared between populations. The internal consistency (ω coefficients), internal structure (confirmatory factor analyses (CFA) and bifactor exploratory structural equation models), reliability (item response theory models, item and test information functions), and cross-cultural comparability (multigroup CFA) of the WEMWBS were assessed. Differences in mean scores observed between regions merit further study. The WEMWBS showed high internal consistency across countries (ω=0.942). The unidimensionality of the scale was confirmed overall and for each population. Evidence of reliability and of measurement invariance at the configural, scalar and metric levels was found. The results support the use of the WEMWBS in different cultures to inform the understanding of population well-being in public health and its possible use as an outcome measure in clinical studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of endoplasmic reticulum stress-associated lncRNAs influencing inflammation and VSMC function in abdominal aortic aneurysm

  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Cáncer, Susana
  • Pérez-Marlasca, Elvira|||0000-0001-9815-198X
  • Medina-Gómez, Gema|||0000-0001-8169-681X
  • Martínez-González, José|||0000-0002-3894-7166
  • Garcia Redondo, Ana B.|||0000-0002-5815-3320
  • Galán, María|||0000-0002-4758-8388
Endoplasmic reticulum (ER) stress plays a critical role in the abdominal aortic aneurysm (AAA), a life-threatening disease characterized by inflammation, destructive remodeling, and vascular smooth muscle cells (VSMCs) dysfunction. The current therapy relies on surgical repair, but no effective pharmacological strategies are available to limit aneurysm progression. Long non-coding RNAs (lncRNAs) are essential factors in health and disease; however, their specific contribution to AAA development and its relationship with ER stress remain unexplored. Here, we have performed a whole-genome transcriptomic analysis characterizing the expression profile of lncRNAs in AAA. RNA sequencing was carried out in abdominal aorta from patients with AAA and healthy donors. We identified 6576 differentially expressed (DE)-mRNAs and 1283 DE-lncRNAs. Interestingly, bioinformatic analysis revealed a set of 368 DE-lncRNAs related to ER stress. The differential expression of the most induced lncRNAs (IL-21-AS1, ITPKB-IT, PCED1B-AS1, TCL-6, LINC00494, LINC00582, LINC00626, LINC00861, and LINC00892) was validated in a large cohort of patients with AAA. The ability of these selected lncRNAs to discriminate patients with AAA from healthy subjects was established by receiveroperating characteristic curves and logistic regression analysis. In human aortic VSMC and Jurkat T-cells, tunicamycin-induced ER stress triggered the expression of IL21-AS1, LINC00626, LINC00494, LINC00892, PCED1B-AS1, ITPKB-IT, and TCL-6, while tauroursodeoxycholic acid counteracted these effects. Finally, an integrated analysis of mRNA-lncRNA co-expression revealed the correlation between the selected lncRNAs and the DE-mRNAs involved in immune response and muscle contraction. Therefore, these DE-lncRNAs potentially implicated in the ER stress response, a pathological process in AAA, could be considered as potential therapeutic target to handle AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's disease

  • Bernhardt, Alexander Maximilian
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Aldecoa, Iban|||0000-0001-5774-7453
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Arriola Infante, José Enrique|||0000-0002-3298-4601
  • Maure Blesa, Lucia|||0000-0001-5643-7971
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Longen, Sebastian
  • Trossbach, Svenja Verena
  • Giese, Armin
  • Matthias, Torsten
  • Benejam, Bessy|||0000-0002-6789-8615
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Hoyo Soriano, Laura del|||0000-0003-4372-1599
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Sanjuan, Aída
  • Fernández, Susana|||0000-0002-9777-1156
  • Vaqué-Alcázar, Lídia|||0000-0002-6776-6559
  • Aranha, Mateus|||0000-0001-9594-292X
  • Morcillo Nieto, Alejandra O.|||0000-0003-2202-3521
  • Nübling, Georg|||0000-0003-4492-7302
  • Wagemann, Olivia
  • Stockbauer, Anna
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Lleó, Alberto|||0000-0002-2568-5478
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Molina-Porcel, Laura|||0000-0003-4068-8578
  • Fortea, Juan|||0000-0002-1340-638X
  • Levin, Johannes|||0000-0001-5092-4306
Alpha-synuclein (αSyn) seed amplification assay (SAA) enables in vivo study of αSyn but remains underexplored in Down syndrome-associated Alzheimer's disease (DSAD). We analyzed αSyn-SAA in cerebrospinal fluid (CSF) from 270 adults with Down syndrome, from the Down Alzheimer Barcelona Neuroimaging Initiative and from the AD21 cohort from the Department of Neurology at the University Hospital, Ludwig Maximilian University of Munich, Germany. Neuropathological examinations were conducted in 19 brain donors (five with ante mortem CSF). Participants were classified as asymptomatic or symptomatic (prodromal/dementia) Alzheimer's disease (AD). CSF Aβ1-42/1-40, CSF and plasma p-Tau181, and neurofilament light chain (NfL) levels were measured. Neuropathological evaluations assessed AD neuropathological changes and Lewy body pathology (LBP). ΑSyn-SAA was positive in 9.2% of cases, independent of age or cognitive status. Symptomatic αSyn-positive cases exhibited higher plasma NfL levels than αSyn-negative cases (31 vs 21 pg/mL, p = 0.027). LBP was observed in 47% of necropsies. The individual with severe neocortical LBP was αSyn-SAA-positive. These findings highlight LBP prevalence in DSAD but suggest current SAA may fail to detect limited αSyn deposition.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Influence of personality traits on emotion expression in Bulimic Spectrum Disorders, a pilot Study

  • Giner Bartolomé, Cristina|||0000-0003-3129-5326
  • Steward, Trevor|||0000-0003-3116-8175
  • Wolz, Ines|||0000-0001-8338-3948
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Tárrega Larrea, Salomé|||0000-0002-5820-6795
  • Fernandez Formoso, Jose Antonio|||0000-0001-5310-1655
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Facial expressions are understood to be universal across cultures and are critical in forming social bonds and in signaling one's emotional state to others. In eating disorder patients, impairments in facial emotion expression and recognition have been associated with eating psychopathology severity and are believed to serve as a maintenance factor and to contribute to poor social functioning. Little research however has been carried out on how patients with a bulimic spectrum disorder (BSD) spontaneously express facial emotions. Our aim was to investigate facial emotion expression in BSD patients and to explore the influence of personality traits on the facial emotion expression. Our study comprised 28 women with a BSD disorder and 15 age-matched healthy controls. Facial expressions were recorded while participants played a serious video game. Expressions of anger and joy were used as outcome measures. Overall, BSD participants displayed less facial expressiveness compared to healthy controls. Among BSD women, facial expressions of joy were positively associated with reward dependence, novelty seeking and self-directedness, while facial expressions of anger were associated with lower self-directedness. Our findings suggest that altered emotion facial expression and related personality traits may support the social impairments seen in patients with BSD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass

  • Hernández-Montoliu, Laura
  • Rodríguez-Peña, M.Mar
  • Puig, Rocío
  • Astiarraga, Brenno|||0000-0003-2216-8974
  • Guerrero-Pérez, Fernando
  • Virgili, Nuria
  • López-Urdiales, Rafael|||0000-0002-2355-3041
  • Osorio, Javier|||0000-0002-0889-4585
  • Monseny, Rosa
  • Lazzara, Claudia
  • Sobrino, Lucía
  • Pérez-Maraver, Manuel|||0000-0003-4427-7581
  • Pérez-Prieto, María
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
  • Vilarrasa, Nuria|||0000-0003-3188-1990
Objective: To determine changes in incretins, systemic inflammation, intestinal permeability and microbiome modifications 12 months after metabolic RYGB (mRYGB) in patients with type 2 diabetes (T2D) and their relationship with metabolic improvement. Materials and methods: Prospective single-center non-randomized controlled study, including patients with class II-III obesity and T2D undergoing mRYGB. At baseline and one year after surgery we performed body composition measurements, biochemical analysis, a meal tolerance test (MTT) and lipid test (LT) with determination of the area under the curve (AUC) for insulin, C-peptide, GLP-1, GLP-2, and fasting determinations of succinate, zonulin, IL-6 and study of gut microbiota. Results: Thirteen patients aged 52.6 ± 6.5 years, BMI 39.3 ± 1.4 kg/m, HbA 7.62 ± 1.5% were evaluated. After mRYGB, zonulin decreased and an increase in AUC after MTT was observed for GLP-1 (pre 9371 ± 5973 vs post 15788 ± 8021 pM, P<0.05), GLP-2 (pre 732 ± 182 vs post 1190 ± 447 ng/ml, P<0.001) and C- peptide, as well as after LT. Species belonging to Streptococaceae, Akkermansiacea, Rickenellaceae, Sutterellaceae, Enterobacteriaceae, Oscillospiraceae, Veillonellaceae, Enterobacterales_uc, and Fusobacteriaceae families increased after intervention and correlated positively with AUC of GLP-1 and GLP-2, and negatively with glucose, HbA, triglycerides and adiposity markers. Clostridium perfringens and Roseburia sp. 40_7 behaved similarly. In contrast, some species belonging to Lachnospiraceae, Erysipelotricaceae, and Rumnicocaceae families decreased and showed opposite correlations. Higher initial C-peptide was the only predictor for T2D remission, which was achieved in 69% of patients. Conclusions: Patients with obesity and T2D submitted to mRYGB show an enhanced incretin response, a reduced gut permeability and a metabolic improvement, associated with a specific microbiota signature.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Association Between the Mediterranean Diet and Fatty Acids in Red Blood Cells of Spanish Adolescents

  • Ayala-Aldana, Nicolas|||0000-0002-3530-6734
  • Lafuente, David
  • Lázaro, Iolanda|||0000-0002-6172-9845
  • Pinar-Martí, Ariadna|||0000-0002-2602-3396
  • Manidis, Alexios
  • Bernardo-Castro, Sara|||0000-0001-8809-5101
  • Fernández-Barrés, Sílvia|||0000-0002-9977-2291
  • Healy, Darren|||0000-0002-0084-2289
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Sala-Vila, Aleix|||0000-0002-5038-2794
  • Júlvez, Jordi|||0000-0003-0818-4003
Objective: The Mediterranean diet (MedDiet) is characterized by its emphasis on plant-based foods, olive oil, and fish products, and has been associated with providing relevant fatty acids (FAs) for adolescent physiology. This study aims to investigate the relationship between adherence to the MedDiet and the FA composition of red blood cell (RBC) membranes in an adolescent population. Methods: The current research examines the relationship between MedDiet adherence, assessed using the KIDMED questionnaire, and the composition of RBC membranes, specifically measuring 22 FAs in a cross-sectional analysis of adolescents from two cohorts (mean age = 14.55). Baseline data from 552 participants with complete dietary adherence and FA information were analyzed using multivariable regression models and principal component analysis (PCA) as confirmatory analysis. All regression models were adjusted by age, sex, body mass index, physical activity, maternal education and cohort enrollment. Results: Main results shown that "Good adherence" to the MedDiet was positively associated with omega-3 FAs, including eicosapentaenoic acid (β = 0.34; 95% CI: 0.17, 0.52; p -value < 0.001) and docosahexaenoic acid (β = 0.29; 95% CI: 0.11, 0.46; p -value = 0.001), and inversely associated with specific omega-6 FAs, such as arachidonic acid (β = -0.28; 95% CI: -0.46, -0.11; p -value = 0.002) and adrenic acid (β = -0.19; 95% CI: -0.30, -0.08; p -value < 0.001). PCA identified distinct FA patterns, with "Good adherence" to the MedDiet being associated with an increase in the omega-3 FAs pattern (β = 0.32; 95% CI: 0.14, 0.49; p -value < 0.001). These findings remained robust after multiple test comparisons. Conclusions: This study underscores the potential of the MedDiet to promote optimal RBC FA composition in healthy adolescents, characterized by high levels of omega-3 FAs and reduced levels of arachidonic acid and adrenic acid in RBC membranes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

  • Llorens-Revull, Meritxell|||0000-0002-8671-8907
  • Martínez-González, Brenda|||0000-0002-4482-5181
  • Quer, Josep|||0000-0003-0014-084X
  • Esteban Mur, Juan Ignacio|||0000-0001-5085-917X
  • Núñez-Moreno, Gonzalo|||0000-0001-5982-570X
  • Minguez, Pablo|||0000-0003-4099-9421
  • Burgui, Idoia
  • Ramos-Ruiz, Ricardo|||0000-0002-6331-9786
  • Soria Benito, María Eugenia|||0000-0002-4719-3351
  • Rico, Angie
  • Riveiro Barciela, Mar|||0000-0001-9309-2052
  • Sauleda, Silvia|||0000-0001-7343-9557
  • Piron, Maria|||0000-0001-6858-9374
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Rodríguez Frías, Francisco|||0000-0002-9128-7013
  • Rando-Segura, Ariadna|||0000-0003-4555-7286
  • Ramírez Serra, Clara|||0000-0001-8971-1711
  • Camós Anguila, Sílvia|||0000-0002-0478-8494
  • Domingo, Esteban
  • Bes, Marta|||0000-0001-6103-072X
  • Perales Viejo, Celia|||0000-0003-1618-1937
  • Costafreda Salvany, Maria Isabel|||0000-0002-3114-3034
MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early-Stage Breast Cancer Detection in Breast Milk

  • Saura Manich, Cristina|||0000-0001-8296-5065
  • Ortiz, Carolina|||0000-0002-5523-829X
  • Matito, Judit|||0000-0001-7560-7737
  • Arenas, Enrique J.|||0000-0001-7076-2666
  • Suñol Camas, Anna
  • Martín, Ágatha|||0000-0003-4818-6433
  • Cordoba Cardona, Octavi|||0000-0002-9591-7430
  • Martínez-Sabadell, Alex|||0000-0002-9477-1396
  • Garcia-Ruiz, Itziar|||0000-0002-0717-7795
  • Miranda, Ignacio|||0000-0002-4813-5946
  • Morales-Comas, Clara|||0000-0001-6771-6749
  • Carrasco, Estela|||0000-0003-1964-7675
  • Viaplana, Cristina|||0000-0001-8904-4330
  • Peg, Vicente|||0000-0002-5203-6166
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Bayó-Puxan, Neus|||0000-0001-9909-1499
  • González Medina, Alberto, 1990-|||0000-0002-2819-9053
  • Miquel, Josep M.|||0000-0002-9262-4464
  • Gómez-Rey, Marina|||0000-0002-9636-3281
  • Villacampa Javierre, Guillermo|||0000-0003-4868-6585
  • Arévalo, Silvia|||0000-0001-8169-1322
  • Espinosa-Bravo, Martín|||0000-0002-4293-3875
  • Balmaña Gelpí, Judith|||0000-0002-0762-6415
  • Dienstmann, Rodrigo|||0000-0001-5997-318X
  • Arribas, Joaquín V.|||0000-0002-0504-0664
  • Tabernero, Josep|||0000-0002-2495-8139
  • Vivancos, Ana|||0000-0003-2888-6512
  • Sansó, Miriam|||0000-0001-7155-4041
The presence of cell-free tumor DNA was reported in breast milk from patients with breast cancer, and its use as a screening method surpassed plasma liquid biopsy in terms of detecting and molecularly profiling early-stage tumors, even prior to diagnosis. For the first time, we show that BM obtained from patients with breast cancer carries ctDNA, surpassing plasma-based liquid biopsy for detection and molecular profiling of early-stage breast cancer, even prior to diagnosis by image.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Self-disintegrating protein-leaking microparticles for topical protein delivery

  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Martínez-Cuentra, Genís Josep
  • Contreras, Estefanía|||0000-0002-8645-2790
  • Di Somma, Angela|||0000-0003-4916-7875
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Advanced drug delivery systems, if engineered to enhance drug stability and extend its kinetic bioavailability, are expected to expand the spectrum of local therapeutic approaches for dermatological conditions. In this context, the objective of this study was to explore whether artificial secretory granules, namely nontoxic, microscale granular Zn-assisted protein depots that leak the forming protein in a time-prolonged way, could be suited as functional agents in topical delivery. A model, recombinant form of the human fibroblast growth factor 2 (FGF-2), formulated as secretory granules, promoted efficient tissue repair and wound healing in a rat skin injury model faster than the natural repair process. The kinetic and histological analysis of FGF-2-treated wounds revealed that the package of the protein as secretory granules improves skin regeneration over the soluble version, and that it conduces to a more ordered construction of the extracellular matrix with limited risk of fibrosis. On the other hand, the addition of a claudin-binding peptide (c-CPE) as a fused protein segment slightly delays wound healing but offers functional and histological particularities that modulate the skin regeneration process. Altogether, the data presented here validates this endocrine-like protein drug delivery from synthetic disintegrating protein depots as a powerful and versatile platform for topical application in dermatological disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Red Blood Cell Fatty Acid Patterns and Cognitive Functions in Adolescents, A Pooled Analyses with Two Cohort Study Data Sets

  • Ayala-Aldana, Nicolas|||0000-0002-3530-6734
  • Pinar-Martí, Ariadna|||0000-0002-2602-3396
  • Ruiz-Rivera, Marina|||0009-0004-4537-8944
  • Lázaro, Iolanda|||0000-0002-6172-9845
  • Sala-Vila, Aleix|||0000-0002-5038-2794
  • Healy, Darren|||0000-0002-0084-2289
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Casanova, Jordi
  • Sola-Valls, Nuria
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Júlvez, Jordi|||0000-0003-0818-4003
Objective: Fatty acids (FAs) play a pivotal role in brain development and cognitive functions during adolescence. We aimed to investigate the association of red blood cell (RBC) FA patterns and several high order neuropsychological functions in adolescents. Methods: The study followed a cross-sectional design. Principal component analysis was applied to 22 FA species previously measured in RBC membranes (exposure variable) to identify FA principal components (PCs) from two cohorts of adolescents in Catalonia, Spain (mean age = 14.53 years). Multiple linear regression was then used to examine associations between PC FAs and cognitive outcomes-working memory, fluid intelligence, and risky decision-making (gain and loss domains). Regression models were adjusted for child sex, age, body mass index, maternal education, and cohort enrollment. Results: Three FA PCs (eigenvalues.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein

  • Álamo, Patricia|||0000-0003-0510-5701
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Favaro, Marianna T.P.|||0000-0003-2942-247X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
Endocrine-like dynamic protein depots can be fabricated in vitro through the coordination of divalent zinc ions (Zn) with solvent-exposed histidine residues on functional proteins, leading to their controlled aggregation. The resulting microparticles, under physiological conditions, undergo progressive disintegration due to spontaneous Zn dilution, enabling a time-sustained release of the protein components. These chemically pure protein-based materials represent promising drug delivery platforms, with demonstrated efficacy in oncology, vaccinology, tissue regeneration, and antibacterial therapies. To enable systemic delivery of the embedded protein, alternative administration routes are potentially suited, but their effectiveness in terms of biodistribution and accumulation in target tissues remains unexplored. Using a CXCR4 cancer mouse model, we investigated the tumor targeting and permanence of a self-assembling, CXCR4-binding fluorescent protein administered in the form of secretory granules via subcutaneous, intramuscular, or intraperitoneal injection. Our data reveal that subcutaneous administration supports prolonged protein retention at the injection site, its release within the local draining lymphatic vessels, extended circulation time, and significantly higher tumor accumulation 10 days post-injection. Compared to intramuscular and intraperitoneal routes, the subcutaneous pathway presents clear advantages, potentially allowing reduced dosing frequency in protein-based therapies aimed at maintaining steady systemic and target tissue levels.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring the interplay of neuropsychological functions, psychological wellbeing, and lifestyle through principal component analysis, a comprehensive study

  • Ayala-Aldana, Nicolas|||0000-0002-3530-6734
  • Ruiz-Rivera, Marina|||0009-0004-4537-8944
  • Pinar-Martí, Ariadna|||0000-0002-2602-3396
  • López-Vicente, Mónica|||0000-0002-5090-7538
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Júlvez, Jordi|||0000-0003-0818-4003
A balanced psychological wellbeing and healthy lifestyle-which includes regular physical activity and the prevention of alcohol and tobacco use-are relevant for neuropsychological functioning. We aimed to analyze the association between adolescent psychological wellbeing, physical activity, and ever having used alcohol and tobacco with neuropsychological principal components (PC). This cross-sectional research used the baseline data from a sample of 523 healthy adolescents enrolled in the Walnuts Smart Snack Dietary Intervention Trial from Barcelona. We performed principal components analysis (PCA) to determine neuropsychological PC using working memory, fluid intelligence, emotional recognition, risky decision-making and attention deficit hyperactivity disorder (ADHD) symptoms. Multiple linear regression was used to analyze the relationship between psychological wellbeing, physical activity, and ever used alcohol and tobacco with neuropsychological PC. Regression models were adjusted by child sex, age, maternal education, and socioeconomic status. Two neuropsychological PC, "ADHD symptoms" and "hot executive function," were identified in PCA analyses (eigenvalues.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César|||0000-0002-3181-4731
  • López-Carrilero, Raquel|||0000-0003-4110-794X
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Catalan, Ana|||0000-0002-0418-7904
  • Aymerich, Claudia|||0000-0003-0040-1608
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Gutiérrez-Zotes, Alfonso|||0000-0002-4858-1487
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • del-Castillo-Serrano, Manuel
  • Vilella, Elisabet|||0000-0002-1887-5919
  • García-Álvarez, Leticia
  • Ochoa, Susana|||0000-0001-6792-1080
  • Correa-Ghisays, Patricia|||0000-0002-1752-7349
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
  • Vicent Sánchez-Ortí, Joan|||0000-0002-8209-6688
  • Pousa Tomàs, Esther|||0000-0003-4423-6739
  • Miret, Salvador|||0000-0002-2275-8272
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael|||0000-0002-0842-898X
  • García-Cabeza, Ignacio|||0000-0002-7542-4321
  • Campos-Rodriguez, Carlos|||0000-0002-6982-1339
  • Crosas Armengol, Josep Maria|||0000-0002-0734-2957
  • Cobo Gomez, Jesus Vicente|||0000-0002-2032-9343
  • Pardina-Torner, Helena|||0000-0002-0720-3412
  • Perona-Garcelán, Salvador|||0000-0002-7771-7857
  • Muñoz-Caracuel, Manuel|||0000-0003-1667-5646
  • Yorca-Ruiz, Ángel|||0000-0002-2701-3755
  • Ortiz García de la Foz, Víctor|||0000-0002-0627-1827
  • Ayesa-Arriola, Rosa|||0000-0003-0570-5352
The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls. A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald's omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education. Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ 2 = 108.88, p.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood speckle imaging for the assessment of aortic valve velocity in healthy children, Reproducibility and comparison with Doppler echocardiography

  • Freixa-Benavente, Andrea|||0000-0001-9235-1788
  • Garrido-Oliver, Juan|||0000-0002-5806-2031
  • Roses Noguer, Ferran|||0000-0002-5955-7490
  • Dux-Santoy, Lydia|||0000-0001-8736-2095
  • Guala, Andrea|||0000-0002-5006-8164
  • Rodríguez Palomares, José Fernando|||0000-0002-8822-5532
  • Sabaté-Rotés, Anna|||0000-0002-3127-7673
Introduction: Blood speckle imaging (BSI) in paediatrics is a promising novel echocardiography technique that allows complex blood flow assessment via qualitative visualization and analysis of vorticity, energy loss and kinetic energy. However, velocity quantification using BSI has scarcely been studied in vivo. Methodology: Maximum aortic valve velocities by conventional Doppler echocardiography were compared with those derived from BSI in healthy children. BSI-derived velocities were extracted via a custom Python code. Agreement between methods was assessed using Pearson correlation and Bland-Altman analysis. Inter-observer reproducibility of BSI analysis was evaluated in a randomly selected subset. Results: Seventy-seven Doppler acquisitions from 33 patients were analysed. The median age was 84 months, and maximum velocity was 1.19 m/s. Modest correlation (R = 0.53, p-value<0.001) was found between BSI and Doppler velocities. Age-stratified analysis showed good correlation in younger children (<6.5 years; R = 0.59, p-value<0.001), whereas no significant correlation was found in older subjects. A non-significant trend towards BSI underestimating velocities, more marked in older children, was noted. Discrepancies between methods increased at higher velocities. Inter-observer reproducibility of BSI velocities was good (R = 0.7, p-value = 0.006). Discussion and conclusion: Aortic valve velocities by BSI technique show moderate correlation with Doppler in healthy children, with better performance in younger subjects, and good inter-observer reproducibility. Overall, the findings support BSI echocardiography for aortic valve maximum velocity assessment in healthy children, but further research is warranted to determine its utility in patients with aortic valve disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A pilot study of an online MBCT adaptation to enhance mental health in university students

  • Martínez-Rubio, David|||0000-0002-9346-3869
  • Rodríguez Freire, Carla|||0009-0006-6728-5778
  • Navarrete Hidalgo, Jaime|||0000-0002-9482-4822
  • Colomer Pérez, Natura|||0000-0002-5973-9876
  • Escamilla Robla, Cristina|||0000-0002-7195-2063
  • Solé, Sílvia|||0000-0001-6960-5364
  • Moreno Sigüenza, Yolanda|||0000-0002-1810-7282
  • Montero-Marín, Jesús|||0000-0001-5677-1662
  • Luciano, Juan Vicente|||0000-0003-0750-1599
University students are particularly vulnerable to mental health problems due to factors like stage of the life span and high academic pressure. The current study aimed to assess the feasibility and effectiveness of the online version of the Mindfulness- and Compassion-Based Program (MCBP) for University Life, a promising 6-week instructor-led mindfulness- and compassion-based program tailored for university students. The study followed an uncontrolled design. A total of 21 higher education students (76.2% women; 25 ± 5.68 years old) from the European University of Valencia (Spain) participated in the study. Participants were assessed with self-report measures at baseline, at the end of the 6-week intervention, and at 6-month follow-up. Participants engaged well with the course and formal home practice, attending at least 5 sessions and meditating nearly 4 days per week. There were significant improvements in well-being, psychological distress, insomnia, self-compassion, mindfulness skills, decentering, and self-critical rumination. All those changes remained significant at follow-up except for insomnia levels. Changes in well-being were significantly correlated with changes in self-compassion and decentering. Changes in psychological distress were significantly correlated with changes in self-critical rumination levels. This online intervention could be feasible and effective for enhancing mental health among university students. However, additional robust research with a larger sample size plus a control group is needed to further validate these outcomes. The study was not registered in a clinical trials registry, as it was designed as a pilot feasibility study.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates

  • Rueda, Ariana|||0000-0001-7588-9279
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Arena, Lourdes Ailen|||0009-0006-1863-3895
  • Mendoza, Julian Ignacio|||0000-0002-1975-3606
  • Aviñó, Ana|||0000-0003-3047-738X
  • Fabrega, Carme|||0000-0003-3816-7634
  • Eritja, Ramon|||0000-0001-5383-9334
  • Paez, David|||0000-0002-5596-6588
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
Precision targeting is a hot topic in cancer nanomedicine, as conventional chemotherapies cause systemic toxicities, creating an urgent need for more selective treatments. Although antibody-drug conjugates (ADCs) are the current gold standard in targeted therapy, their clinical performance remains limited. As an alternative, we previously developed a multivalent protein nanocarrier (T22-GFP-H6) displaying the CXCR4-targeting peptide T22, which offers super-selective tumor accumulation driven by CXCR4 overexpression. This innovative nanovehicle showed favorable biodistribution for targeted delivery of antitumor drugs, including monomethyl auristatin E (MMAE), in a first-generation stochastic nanoconjugate format. However, unlike ADCs, where conjugation strategy is known to influence pharmacokinetics and efficacy, these parameters remain largely unexplored in non-antibody multivalent nanocarriers. Here, we evaluated the impact of precise payload accommodation using two site-specific strategies that attach a single MMAE molecule at distinct structural sites, and we compared them with first-generation nanoconjugates. The conjugation strategy substantially affected the biodistribution and antitumor efficacy, with a solvent-exposed cysteine-conjugation distal to the targeting ligand proving most effective. At equimolar nanocarrier dosing, this construct achieved tumor control similar to the stochastic conjugate in a disseminated hematologic malignancy despite an approximately 4-fold lower MMAE load (drug-to-protein ratio, DPR = 1 vs DPR ≈ 4). Moreover, at equimolar MMAE dosing, it clearly outperformed both the stochastic conjugate and the alternative site-directed design. These findings align with trends in advanced ADCs and provide practical design rules for rational, site-specific conjugation in next-generation protein-based nanomedicines aimed at enabling dose-sparing in oncology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs

  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Arena, Lourdes Ailen|||0009-0006-1863-3895
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
The biological activity of therapeutic proteins, upon intracellular delivery, is dramatically minimized by lysosomal proteolytic digestion. This is a limitation when developing cell-targeted pharmaceuticals that penetrate target cells via receptor recognition and endosomal engulfment. Since proteins benefit from functional and conformational versatility, editable by genetic engineering, endosomolytic protein domains are often fused to the functional polypeptide to promote their cytosolic delivery, aiming at minimizing proteolysis in mature lysosomes. This straightforward strategy has, however, rendered irregular results, linked to the fusogenic nature of most of the tested domains. Alternatively, proteolysis of protein drugs might be controlled by bypassing the lysosomal route, forcing an unconventional traffic of the uptaken protein material to be secreted from the endoplasmic reticulum (ER). This possibility, used in nature by several plant and microbial proteins, has been evaluated here by functionalizing a protein-only antitumoral drug, based on a cell-targeted diphtheria toxin, with a C-terminal KDEL motif. Thus, if KDEL were able to reprogram the intracellular trafficking, KDEL-tagged cell delivered proteins would be expected to avoid the lysosomal degradation, resulting in enhanced stability and activity. The obtained results validate this hypothesis and point out KDEL as a promising functional agent in cell-targeted protein drugs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Associations between air pollution and surrounding greenness with internalizing and externalizing behaviors among schoolchildren

  • Zubizarreta-Arruti, Uxue
  • Bosch, Rosa|||0000-0002-7596-183X
  • Soler Artigas, María|||0000-0002-3213-1107
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Carabí-Gassol, Pau
  • Macias-Chimborazo, Valeria
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Prat, Raquel|||0000-0001-8097-6617
  • Rivas, Cristina|||0000-0002-8074-9550
  • Pagespetit, Èlia
  • Puigbó, Júlia
  • Español-Martín, Gemma|||0000-0002-2362-8189
  • Raimbault, B.|||0000-0003-0226-0220
  • Valentín, Antònia|||0000-0002-9275-7101
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
  • Foraster, Maria|||0000-0003-4450-4123
  • Gascon, Mireia|||0000-0003-4537-8472
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
Air pollution and greenness are emerging as modifiable risk and protective factors, respectively, in child psychopathology. However, research shows inconsistencies. Here, we examined associations between air pollution and surrounding greenness with internalizing and externalizing behaviors. In addition, the potential modifying role of the genetic susceptibility for these traits and socioeconomic status (SES) was explored. This population-based study included 4485 schoolchildren aged 5-18 years from Spain. Internalizing and externalizing behaviors were assessed using the Child Behavior Checklist (CBCL). Average air pollution (NO, PM, PM, PM, and PM absorbance) and surrounding greenness (NDVI within 100-m, 300-m, and 500-m buffers) school exposure were estimated for 12 months before outcome assessment. Genetic liability was assessed by computing polygenic risk scores (PRS) and SES was calculated using the Hollingshead Four-Factor Index. Associations were analyzed using negative binomial mixed-effects models. Although no associations survived multiple testing, we found that increases of 5.48 μg/m 3 in PM and 2.93 μg/m 3 in PM were associated with a 6% (Mean Ratio (MR) = 1.06; 95% CI: 1.01-1.12) and a 4% (MR = 1.04; 95% CI: 1.00-1.09) increase in internalizing behavior scores. A 0.1 increase in NDVI within a 100-m buffer was associated with a 6% decrease in externalizing behavior (MR = 0.94; 95% CI: 0.89-0.99). Neither differences by sex or age, or moderation effects by PRS or SES, were observed. We found preliminary evidence of detrimental effects of air pollution on internalizing behavior and protective effects of greenness on externalizing behavior, which were not modified by sex, age, SES, or genetic liability. If confirmed, these results reinforce the need for improving air quality, especially around schools, as part of preventive strategies focused on childhood psychopathology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Precision targeting of CXCR4+ leukemia cells by a humanized MMAE-nanoconjugate in an AML mouse model

  • Garcia León, Annabel|||0000-0003-3007-9306
  • Mendoza, Julian Ignacio|||0000-0002-1975-3606
  • Rueda, Ariana|||0000-0001-7588-9279
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Sierra, Jorge|||0000-0002-7966-0356
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Acute myeloid leukemia (AML) presents major clinical challenges due to chemoresistance and high relapse rates, primarily driven by therapy-resistant leukemic stem cells (LSCs) within the bone marrow. To address this issue, we developed T22-HSNBT-H6-MMAE, a novel humanized nanoconjugate designed to target CXCR4 cells while delivering the cytotoxic payload monomethyl auristatin E (MMAE). CXCR4 signaling pathway plays a critical role in LSC survival by preserving stem-like properties and activating protective mechanisms that promote treatment resistance. Moreover, CXCR4 is overexpressed in approximately 50 % of AML patients and is associated with poor prognosis and high relapse rates. We evaluated the therapeutic potential of T22-HSNBT-H6-MMAE using in vitro assays with AML cell lines and primary patient samples, as well as in vivo studies in a disseminated AML mouse model. Our results demonstrated that T22-HSNBT-H6-MMAE exerts a CXCR4-dependent cytotoxic effect through mitotic catastrophe and apoptosis induction in CXCR4 AML cell lines. In vivo evaluation in a disseminated CXCR4 AML mouse model showed potent antineoplastic activity, with complete suppression of leukemic dissemination and significantly prolonged survival, all without systemic toxicity. Notably, the nanoconjugate remained effective even in models with extensive bone marrow involvement and exhibited activity against diverse patient-derived CXCR4 AML blasts, while sparing healthy donor bone marrow and peripheral blood mononuclear cells (PBMCs) from significant toxicity. Collectively, these findings highlight T22-HSNBT-H6-MMAE as a promising therapeutic candidate for a broad range of AML patients, offering selective antineoplastic activity against CXCR4 leukemic cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Nanotoxin induces in situ pyroptosis to sensitize αPD1 to ablate metastases in microsattellite stable colorectal cancer

  • Carrasco-Díaz, Luis Miguel|||0000-0003-0567-2802
  • Otero-Mateo, Marc
  • Álamo, Patricia|||0000-0003-0510-5701
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Virgili Manrique, Anna Cristina|||0000-0001-9733-6034
  • Paez, David|||0000-0002-5596-6588
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Mangues, Ramon|||0000-0003-2661-9525
Nanomedicine has not generated anticancer immunotherapies because of insufficient targeted specificity, lack of immunity, and associated toxicity. We developed a T22-DITOX-H6 (TDX) nanotoxin to selectively release the diphtheria toxin in the cancer cells in immunosuppressed CXCR4-overexpressing (CXCR4 +) colorectal (CRC) models, inducing pyroptosis and anticancer effect. Microsatellite stable (MSS) CRC patients do not respond to current immunotherapy. Since pyroptosis is highly immunogenic, we treated with TDX immunocompetent CXCR4 + CT26 MSS metastatic CRC models to selectively deliver the toxin to induce in situ pyroptosis mediated by the activation of NLRP3, Caspase-1 GSDMD and IL-1β. In contrast to immunosuppressed, in situ pyroptosis by TDX in immunocompetent models trigger CD8 + T cell recruitment, activation and killing of cancer cells in tissues, mimicking the pyroptosis that the host induces to kill diphtheria-infected cells. The combination of TDX and αPD1 further increases CD8 + recruitment and perforin secretion, achieving a tissue-specific antimetastatic activity in mesentery, peritoneum, and lung, and especially in liver metastases, without systemic toxicity. This is the first time that a novel nanomedicine achieves local T cell activation and antimetastatic effect mediated by pyroptosis and immunogenic cell death, whereas the combination with αPD1 enhances T cell activation, reaching a synergistic response in MSS CRC models.
Repisalud
Publicación Artículo científico (JournalArticle)

Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis.

  • García-Pascual, Carmen Maria
  • Martínez, Jessica
  • Calvo, Paula
  • Ferrero, Hortensia
  • Villanueva, Ana
  • Pozuelo-Rubio, Mercedes
  • Soengas, MS
  • Tormo, Damiá
  • Simón, Carlos
  • Pellicer, Antonio
  • Gómez, Raúl
To assess the therapeutic potential of polyinosine-polycytidylic acid, a double-stranded RNA molecule with selective proapoptotic and antiangiogenic activity, complexed with polyethyleneimine (pIC(PEI)) in treating endometriosis.
Repisalud
Publicación Artículo científico (JournalArticle)

Multicohort Epigenome-Wide Association Study of All-Cause Cardiovascular Disease and Cancer Incidence: A Cardio-Oncology Approach

  • Domingo-Relloso, Arce
  • Riffo-Campos, Angela L
  • Zhao, Naisi
  • Ayala, Guillermo
  • Haack, Karin
  • Manterola, Carlos
  • Rhoades, Dorothy A
  • Umans, Jason G
  • Fallin, M Daniele
  • Herreros-Martinez, Miguel
  • Pollan-Santamaria, Marina
  • Boerwinkle, Eric
  • Platz, Elizabeth A
  • Jones, Miranda R
  • Bressler, Jan
  • Joehanes, Roby
  • Ryan, Calen P
  • Gonzalez, Juan R
  • Levy, Daniel
  • Belsky, Daniel W
  • Cole, Shelley A
  • Michaud, Dominique S
  • Tellez-Plaza, Maria
  • Navas-Acien, Ana
Background: Emerging evidence reveals a complex relationship between cardiovascular disease (CVD) and cancer, which share common risk factors and biological pathways. Objectives: The aim of this study was to evaluate common epigenetic signatures for CVD and cancer incidence in 3 ethnically diverse cohorts: Native Americans from the SHS (Strong Heart Study), European Americans from the FHS (Framingham Heart Study), and European Americans and African Americans from the ARIC (Atherosclerosis Risk In Communities) study. Methods: A 2-stage strategy was used that included first conducting untargeted epigenome-wide association studies for each cohort and then running targeted models in the union set of identified differentially methylated positions (DMPs). We also explored potential molecular pathways by conducting a bioinformatics analysis. Results: Common DMPs were identified across all populations. In a subsequent meta-analysis, 3 and 1 of those DMPs were statistically significant for CVD only and both cancer and CVD, respectively. No meta-analyzed DMPs were statistically significant for cancer only. The enrichment analysis pointed to interconnected biological pathways involved in cancer and CVD. In the DrugBank database, elements related to 1-carbon metabolism and cancer and CVD medications were identified as potential drugs for target gene products. In an additional analysis restricted to the 950 SHS participants who developed incident CVD, the C index for incident cancer increased from 0.618 (95% CI: 0.570-0.672) to 0.971 (95% CI: 0.963-0.978) when adjusting the models for the combined cancer and CVD DMPs identified in the other cohorts. Conclusions: These results point to molecular pathways and potential treatments for precision prevention of CVD and cancer. Screening based on common epigenetic signatures of incident CVD and cancer may help identify patients with newly diagnosed CVD at increased cancer risk.
Repisalud
Publicación Artículo científico (JournalArticle)

Risk of neuroblastoma and residential proximity to industrial and urban sites: A case-control study.

  • García-Pérez, Javier
  • Morales-Piga, Antonio
  • Gomez-Barroso, Diana
  • Tamayo-Uria, Ibon
  • Pardo Romaguera, Elena
  • Fernandez-Navarro, Pablo L
  • Lopez-Abente, Gonzalo
  • Ramis, Rebeca
Background: Neuroblastoma is the most common extracranial solid tumor in children but its etiology is not clearly understood. While a small fraction of cases might be attributable to genetic factors, the role of environmental pollution factors needs to be assessed. Objectives: To ascertain the effect of residential proximity to both industrial and urban areas on neuroblastoma risk, taking into account industrial groups and toxic substances released. Methods: We conducted a population-based case-control study of neuroblastoma in Spain, including 398 incident cases gathered from the Spanish Registry of Childhood Tumors (period 1996-2011), and 2388 controls individually matched by year of birth, sex, and region of residence. Distances were computed from the respective subject's residences to the 1271 industries and the 30 urban areas with ≥75,000 inhabitants located in the study area. Using logistic regression, odds ratios (ORs) and 95% confidence intervals (95%CIs) for categories of distance (from 1km to 5km) to industrial and urban pollution sources were calculated, with adjustment for matching variables and socioeconomic confounders. Results: Excess risk (OR; 95%CI) of neuroblastoma was detected for the intersection between industrial and urban areas: (2.52; 1.20-5.30) for industrial distance of 1km, and (1.99; 1.17-3.37) for industrial distance of 2km. By industrial groups, excess risks were observed near 'Production of metals' (OR=2.05; 95%CI=1.16-3.64 at 1.5km), 'Surface treatment of metals' (OR=1.89; 95%CI=1.10-3.28 at 1km), 'Mines' (OR=5.82; 95%CI=1.04-32.43 at 1.5km), 'Explosives/pyrotechnics' (OR=4.04; 95%CI=1.31-12.42 at 4km), and 'Urban waste-water treatment plants' (OR=2.14; 95%CI=1.08-4.27 at 1.5km). Conclusions: These findings support the need for more detailed exposure assessment of certain substances released by these industries.
Repisalud
Publicación Artículo científico (JournalArticle)

Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs.

  • Maiques-Diaz, A
  • Chou, F S
  • Wunderlich, M
  • Gómez-López, G
  • Jacinto, F V
  • Rodriguez Perales, Sandra
  • Larrayoz, M J
  • Calasanz, M J
  • Mulloy, J C
  • Cigudosa, J C
  • Alvarez, S
The AML1-ETO fusion protein, which is present in 10-15% of cases of acute myeloid leukemia, is known to repress myeloid differentiation genes through DNA binding and recruitment of chromatin-modifying proteins and transcription factors in target genes. ChIP-chip analysis of human hematopoietic stem/progenitor cells transduced with the AML1-ETO fusion gene enabled us to identify 1168 AML1-ETO target genes, 103 of which were co-occupied by histone deacetylase 1 (HDAC1) and had lost the hyperacetylation mark at histone H4, and 264 showed a K9 trimethylation at histone H3. Enrichment of genes involved in hematopoietic differentiation and in specific signaling pathways was observed in the presence of these epigenetic modifications associated with an 'inactive' chromatin status. Furthermore, AML1-ETO target genes had a significant correlation between the chromatin marks studied and transcriptional silencing. Interestingly, AML1 binding sites were absent on a large number of selected AML1-ETO promoters and an Sp1 binding site was found in over 50% of them. Reversible silencing induced by the fusion protein in the presence of AML1 and/or Sp1 transcription factor binding site was confirmed. Therefore, this study provides a global analysis of AML1-ETO functional chromatin modifications and identifies the important role of Sp1 in the DNA binding pattern of AML1-ETO, suggesting a role for Sp1-targeted therapy in this leukemia subtype.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A score model for the continuous grading of early allograft dysfunction severity

  • Pareja, Eugenia
  • Cortes, Miriam
  • Mir, José
  • Valdivieso, Andrés
  • Castell, Jose Vicente
  • Lahoz Rodríguez, Agustín Gerardo
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] Early allograft dysfunction (EAD) dramatically influences graft and patient outcomes. A lack of consensus on an EAD definition hinders comparisons of liver transplant outcomes and management of recipients among and within centers. We sought to develop a model for the quantitative assessment of early allograft function [Model for Early Allograft Function Scoring (MEAF)] after transplantation. A retrospective study including 1026 consecutive liver transplants was performed for MEAF score development. Multivariate data analysis was used to select a small number of postoperative variables that adequately describe EAD. Then, the distribution of these variables was mathematically modeled to assign a score for each actual variable value. A model, based on easily obtainable clinical parameters (ie, alanine aminotransferase, international normalized ratio, and bilirubin) and scoring liver function from 0 to 10, was built. The MEAF score showed a significant association with patient and graft survival at 3-, 6- and 12-month follow-ups. Hepatic steatosis and age for donors; cold/warm ischemia times and postreperfusion syndrome for surgery; and intensive care unit and hospital stays, Model for End-Stage Liver Disease and Child-Pugh scores, body mass index, and fresh frozen plasma transfusions for recipients were factors associated significantly with EAD. The model was satisfactorily validated by its application to an independent set of 200 patients who underwent liver transplantation at a different center. In conclusion, a model for the quantitative assessment of EAD severity has been developed and validated for the first time. The MEAF provides a more accurate graft function assessment than current categorical classifications and may help clinicians to make early enough decisions on retransplantation benefits. Furthermore, the MEAF score is a predictor of recipient and graft survival., This work was supported by the Carlos III Institute of Health of the Spanish Ministry of Science and Innovation (PI11/02942). Agustin Lahoz is grateful for a Miguel Server contract (CP08/00125) from the Spanish Ministry of Science and Innovation/Carlos III Institute of Health
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Fluoroquinolone photodegradation influences specific basophil activation

  • Mayorga, Cristobalina
  • Aranda, Ana
  • Doña, Inmaculada
  • Montañez, M. Isabel
  • Blanca-López, Natalia
  • Ariza, Adriana
  • Nuin Plá, Neus Edurne
  • Blanca, Miguel
  • Miranda Alonso, Miguel Ángel
  • Torres, Mª José
  • Andreu, Inmaculada|||0000-0003-3409-9443
Fluoroquinolones (FQs) are photoreactive drugs, but it is not known whether laboratory light exposure can influence the induction of photoproducts and modify in vitro test results. The basophil activation test (BAT) has proven to be useful for evaluating immunoglobulin E (IgE)-mediated hypersensitivity to FQs, with a higher percentage of positive responders with ciprofloxacin (CIP) than with moxifloxacin (MOX). We studied the effect of laboratory light on CIP and MOX degradation, and drug-protein conjugate formation, and its influence on the BAT for evaluating IgE-mediated hypersensitivity to FQs. The results showed an important decrease in fluorescence emission intensity under light compared to dark conditions for MOX, and that BAT positivity was lower in light (17.9%) than in dark (35.7%) conditions. No changes were found for CIP in either fluorescence emission intensity or BAT results (46.4% in both conditions). We can conclude that light exposure is a critical factor in BAT results when photolabile drugs like MOX are used. Therefore, light is important when interpreting in vitro results. Copyright (C) 2012 S. Karger AG, Basel, We thank Ian Johnstone for his help with the English language version of the manuscript, and Jose Luis Rodriguez-Bada and Lidia Melendez for their technical support. This study was funded by the FIS-Thematic Networks and Co-operative Research Centres: RIRAAF (RD07/0064) and the Spanish Health Ministry (FIS PS09/01768, PI11/01416 and M Servet contract CP11/00154 for I.A.), the Andalusia Health Ministry (PI-0545-2010), and the Andalusia Economic Innovation and Science Ministry (CTS 06603).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Anti-Inflammatory and Anti-Fibrotic Profile of Fish Oil Emulsions Used in Parenteral Nutrition-Associated Liver Disease

  • Pastor-Clérigues, Alfonso
  • Martí-Bonmatí, Ezequiel
  • Milara, Javier
  • Cortijo, Julio
  • Almudéver-Folch, Patricia|||0000-0003-3138-0862
[EN] Home parenteral nutrition (PN) is associated with many complications including severe hepatobiliary dysfunction. Commercial omega-6 fatty acid-soybean based-lipid emulsions in PN may mediate long term PN associate liver disease (PNALD) whereas omega-3-fish oil parenteral emulsions have shown to reverse PNALD in children. However, its clinical effectiveness in adults has been scarcely reported. In this work, we study the role of soybean and fish oil lipid commercial emulsions on inflammatory and profibrotic liver markers in adults with long term PNALD and in in vitro cellular models. Inflammatory and profibrotic markers were measured in serum of ten adults with long term PNALD and in culture supernatants of monocytes. Liver epithelial to mesenchymal transition (EMT) was induced by transforming growth factor beta 1 (TGF beta 1) to evaluate in vitro liver fibrosis. Omegaven (R), a 100% fish oil commercial emulsion, was infused during four months in two patients with severe long term PNALD reversing, at the first month, the inflammatory, profibrotic and clinical parameters of PNALD. The effect was maintained during the treatment course but impaired when conventional lipid emulsions were reintroduced. The other patients under chronic soybean oil-based PN showed elevated inflammatory and profibrotic parameters. In vitro human monocytes stimulated with lipopolysaccharide induced a strong inflammatory response that was suppressed by Omegaven (R), but increased by soybean emulsions. In other experiments, TGFb1 induced EMT that was suppressed by Omegaven (R) and enhanced by soybean oil lipid emulsions. Omegaven (R) improves clinical, anti-inflammatory and anti-fibrotic parameters in adults with long-term home PNALD., This work was supported by grants from "proyecots de investigacion fundamental no orientada (SAF) 2011-26443 (JC)'', "fondo de investigaciones sanitarias (FIS) CP11/00293(JM)'', "centro de investigacion biomedica en red de enfermedades respiratorias (CIBERES) CB06/06/0027'', Spanish Government ADE10/00020 (JC), as well as research grants from Regional Government Prometeo II/2013/014 (JC, JM) "Generalitat Valenciana.'' Support from the "centro para el desarrollo tecnologico e industrial (CENIT)'' programme (Spanish Government) was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Drug-drug interactions within protein cavities probed by triplet-triplet energy transfer

  • Nuin Plá, Neus Edurne
  • Miranda Alonso, Miguel Ángel
  • Jiménez, M Consuelo|||0000-0002-8057-4316
  • Sastre Navarro, German Ignacio|||0000-0003-0496-6331
  • Andreu, Inmaculada|||0000-0003-3409-9443
A new direct and noninvasive methodology based on transient absorption spectroscopy has been developed to probe the feasibility of drug-drug interactions within a common protein binding site. The simultaneous presence of (R)-cinacalcet (CIN) and (S)-propranolol (PPN) within human or bovine alpha(1)-acid glycoproteins (AAGs) is revealed by detection of (CIN)-C-3* as the only transient species after laser flash photolysis of CIN/PPN/AAG mixtures at 308 nm. This is the result of triplet-triplet energy transfer from (PPN)-P-3* to CIN, which requires close contact between the two drugs within the same biological compartment. Similar results are obtained with nabumetone and CIN as donor/acceptor partners. This new methodology can, in principle, be extended to a variety of drug/drug/biomolecule combinations., Financial support from the Spanish Government (CTQ2009-13699, CTQ2010-14882) and from the Carlos III Institute of Health (Grant RIRAAF, RETICS program, and Miguel Servet Contract CP11/00154 for I.A.) is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Configuration-dependent photoinduced electron transfer in diastereomeric naphthalene-amino-naphthalene triads

  • Nuin Pla, Neus Edurne
  • Pischel, Uwe
  • Miranda Alonso, Miguel Ángel
  • Sastre Navarro, German Ignacio|||0000-0003-0496-6331
  • Andreu, Inmaculada|||0000-0003-3409-9443
[EN] Novel diastereomeric triads containing two naphthalene chromophores have been designed in which an electron-donating amine moiety is covalently integrated into the connecting bridge. Photophysical studies (steady-state and time-resolved fluorescence) in solvents of different polarity have been performed. A remarkable stereodifferentiation in the intramolecular fluorescence quenching was found in acetonitrile. Laser flash photolysis gave rise to naphthalene-derived radical cations, which were also quenched by the amine with an even higher degree of stereodifferentiation. The results are in agreement with thermodynamic estimations and indicate that photoinduced electron transfer (PET) is the main quenching pathway. Furthermore, theoretical calculations have allowed us to explain the experimentally observed stereodifferentiation in PET quenching., Financial support from the Generalitat Valenciana (Prometeo Program), the Carlos III Institute of Health (Grant RIRAAF, RETICS program, Miguel Servet Contract CP11/00154 for I. A.), and the Spanish government for the provision of the "Severo Ochoa" excellence project (SEV 2012-0267) is gratefully acknowledged. G.S. thanks ASIC-UPV for computing time.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

NUTRARET: Effect of 2-Year Nutraceutical Supplementation on Redox Status and Visual Function of Patients With Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Trial

  • Olivares-González, Lorena
  • Salom, David
  • González-García, Emilio
  • Mejía-Chiqui, Natalia
  • Melero, Mar
  • Velasco, Sheyla
  • Muresan, Bianca Tabita
  • Campillo, Isabel
  • Vila-Clérigues, Nieves
  • Lopez-Briz, Eduardo
  • Merino-Torres, Juan Francisco
  • Millán, José María
  • Soriano del Castillo, José Miguel
  • Rodrigo, Regina
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] Oxidative stress plays a major role in the pathogenesis of retinitis pigmentosa (RP). The main goal of this study was to evaluate the effect of 2-year nutritional intervention with antioxidant nutraceuticals on the visual function of RP patients. Secondly, we assessed how nutritional intervention affected ocular and systemic redox status. We carried out a randomized, double-blind, placebo-controlled study. Thirty-one patients with RP participated in the study. RP patients randomly received either a mixture of nutraceuticals (NUT) containing folic acid, vitamin B6, vitamin A, zinc, copper, selenium, lutein, and zeaxanthin or placebo daily for 2 years. At baseline and after 2-year of the nutritional supplementation, visual function, dietetic-nutritional evaluations, serum concentration of nutraceuticals, plasma and aqueous humor concentration of several markers of redox status and inflammation were assessed. Retinal function and structure were assessed by multifocal electroretinogram (mfERG), spectral domain-optical coherence tomography (SD-OCT) and automated visual field (VF) tests. Nutritional status was estimated with validated questionnaires. Total antioxidant capacity, extracellular superoxide dismutase (SOD3), catalase (CAT), and glutathione peroxidase (GPx) activities, protein carbonyl adducts (CAR) content, thiobarbituric acid reactive substances (TBARS) formation (as indicator of lipid peroxidation), metabolites of the nitric oxide (NOX) and cytokine (interleukin 6 and tumor necrosis factor alpha) concentrations were assessed by biochemical and immunological techniques in aqueous humor or/and blood. Bayesian approach was performed to determine the probability of an effect. Region of practical equivalence (ROPE) was used. At baseline, Bayesian analysis revealed a high probability of an altered ocular redox status and to a lesser extent systemic redox status in RP patients compared to controls. Twenty-five patients (10 in the treated arm and 15 in the placebo arm) completed the nutritional intervention. After 2 years of supplementation, patients who received NUT presented better retinal responses (mfERG responses) compared to patients who received placebo. Besides, patients who received NUT showed better ocular antioxidant response (SOD3 activity) and lower oxidative damage (CAR) than those who received placebo. This study suggested that long-term NUT supplementation could slow down visual impairment and ameliorate ocular oxidative stress., This work was supported by the Spanish Ministry of Economy, Industry, and Competitiveness (MINECO) Carlos III Health Institute (ISCIII) (Grant numbers: PI15/00052 and PI18/00252) and co-funded by the European Regional Development Fund (FEDER)/European Social Fund ¿A way to make Europe¿/¿Investing in your future.¿ It was also supported by the IIS La Fe-UV PROGRAMA VLC-BIOMED-I (NUTRARET) and by RETINA COMUNIDAD VALENCIANA. LO-G had an ISCIII CIBERER research contract CB06/07/1030; RR had an ISCIII Spanish National Health System (SNS) Miguel Servet Type II research contract (code: CP15/00019).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Tissue and peripheral T cell receptor repertoire predicts immunotherapy response and progression-free survival in NSCLC patients

  • Pino-Gonzalez, Manuel
  • Lazaro-Quintela, Martin
  • Alonso-Alvarez, Irene
  • Gallardo-Gomez, Maria
  • Juaneda-Magdalena, Laura
  • Francisco-Fernandez, Alejandro
  • Calabuig-Farinas, Silvia
  • Martinez-Fernandez, Monica
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] Immunotherapy has opened new avenues of treatment for patients with advanced non-small cell lung cancer (NSCLC) without previous hope of survival. Unfortunately, only a small percentage of patients benefit from it and there is not an effective biomarker to predict patients' response. Since T cells are key effectors of antitumor immunity, T cell receptor (TCR) has emerged as a potential predictive biomarker. Here, we evaluated the potential of baseline TCR repertoire, as a predictive biomarker in advanced NSCLC patients treated with pembrolizumab at first-line. After obtaining peripheral blood and tissue samples at baseline, next-generation sequencing targeting TCR beta/gamma was performed. We found an uneven tumor-infiltrating TCR beta repertoire, and the use of various tumor-infiltrating and circulating TRBV/J genes were able of predicting the immunotherapy response. Our results support the potential of evaluating tissue and circulating TCR beta repertoire prior to pembrolizumab, revealing it as a promising immunotherapy response biomarker in NSCLC patients., This work was supported by the Instituto de Salud Carlos III (ISCIII) and cofunded by European Union under Grants PI21/00348 and CP20/00188. MPG is currently supported by the predoctoral fellowship from Ministerio de Ciencia, Innovacion y Universidaders (FPU23/00744) and previously supported by the Axencia Galega de Innovacion-GAIN (Xunta de Galicia) under Grant for the predoctoral stage IN606A-2024/017. MGG is currently supported by the Axencia Galega de Innovacion-GAIN (Xunta de Galicia) under Grant for the postdoctoral stage IN606B-2024/014. MMF is currently supported by the Instituto de Salud Carlos III (ISCIII) under the Miguel Servet program CP20/00188.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Channeled scaffolds implanted in adult rat brain

  • Martínez-Ramos, Cristina|||0000-0002-6540-4714
  • Vallés Lluch, Ana|||0000-0002-7896-8666
  • Gómez Ribelles, José Luís|||0000-0001-9099-0885
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
  • García Verdugo, José Manuel
  • Barcia Albacar, Juan Antonio
  • Baiget Orts, María Amparo
  • Soria Lopez, Jose Miguel
Scaffolds with aligned channels based on acrylate copolymers, which had previously demonstrated good com- patibility with neural progenitor cells were studied as coloniz- able structures both in vitro with neural progenitor cells and in vivo, implanted without cells in two different locations, in the cortical plate of adult rat brains and close to the subven- tricular zone. In vitro, neuroprogenitors colonize the scaffold and differentiate into neurons and glia within its channels. When implanted in vivo immunohistochemical analysis by confocal microscopy for neural and endothelial cells markers demonstrated that the scaffolds maintained continuity with the surrounding neural tissue and were colonized by GFAP- positive cells and, in the case of scaffolds implanted in con- tact with the subventricular zone, by neurons. Local angio- genesis was evidenced in the interior of the scaffolds pores. New axons and neural cells from the adult neural niche abundantly colonized the biomaterial s inner structure after 2 months, and minimal scar formation was manifest around the implant. These findings indicate the biocompatibility of the polymeric material with the brain tissue and open possi- bilities to further studies on the relevance of factors such as scaffold structure, scaffold seeding and scaffold placement for their possible use in regenerative strategies in the central nervous system. The development of neural interfaces with minimized glial scar and improved tissue compatibility of the implants may also benefit from these results., Contract grant sponsors: Fundacion Ramon Areces; Copernicus Program of University CEU-Cardenal Herrera; Regenerative Medicine Program Agreement between the Generalitat Valenciana and the Spanish National Health Institute Carlos III
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A new 8-oxo-7,8-2 &apos, deoxyguanosine nanoporous anodic alumina aptasensor for colorectal cancer diagnosis in blood and urine

  • Pla, Luis
  • Bañuls, Celia
  • Estañ, Nuria
  • Botello-Marabotto, Marina Dolores
  • Sáez, Guillermo
  • Santiago-Felipe, Sara
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Many important human diseases, and especially cancer, have been related to the overproduction of 8-oxo-7,8-dihydro-2 '-deoxyguanosine (8-oxo-dG). This molecule is a product of oxidative stress processes over nucleophilic bases in DNA. In this work, an aptasensor for the rapid, selective and accurate detection of this oncomarker is presented. The aptasensor consists of a nanoporous anodic alumina material loaded with a dye and is functionalized with an aptamer-based "molecular gate". In the presence of target 8-oxo-dG, the capping aptamer displaces from the surface due to the high affinity of the analyte with the capping aptamer, thus inducing delivery of the preloaded fluorescent dye. In contrast, in the absence of 8-oxo-dG, a poor payload delivery is accomplished. This aptamer-based nanodevice has great sensitivity for 8-oxo-dG, resulting in a LOD of 1 nM and a detection time of ca. 60 min. Moreover, the aptasensor is able to accurately detect 8-oxo-dG in unmodified urine and serum without pre-concentration treatments. This diagnostic tool is validated in a set of 38 urine and serum samples from patients diagnosed of colorectal cancer and control patients. These samples are also analyzed using a standardized and specific ELISA kit. The aptasensor displays excellent sensitivity (95.83/100%) and specificity (80/100%) for 8-oxo-dG detection in serum and urine samples, respectively. Our results may serve as a basis for the development of generalized fluorogenic diagnostic platforms for the easy diagnosis of cancer in biofluids as well as for monitoring therapeutic treatments and detection of relapses without the use of expensive equipment or trained personnel., This study was supported by the Spanish Government (project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE)), the Generalitat Valenciana (project PROMETEO/2018/024) and the Universitat Politecnica de Valencia - Hospital Universitari Doctor Peset POLISABIO collaboration program (UPV-FISABIO) (NanOdGSens_2.0). FISABIO Grupos Emergentes (UGP-19-037). Red Tematica Biologia y Medicina Redox. S.S. thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support "Sara Borrell" (CD16/000237). C.B. thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support "Miguel Servet Tipo I" (CP19/00077). L.P. thanks Ministerio de Economia, Industria y Competitividad for his FPI grant. We acknowledge the support of the Electron Microscopy Service of Universitat Politecnica de Valencia (UPV).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Mutant PRPF8 Causes Widespread Splicing Changes in Spliceosome Components in Retinitis Pigmentosa Patient iPSC-Derived RPE Cells

  • Arzalluz-Luque, Ángeles
  • Cabrera, Jose Luis
  • Skottman, Heli
  • Benguria, Alberto
  • Bolinches-Amorós, Arantxa
  • Cuenca, Nicolás
  • Lupo, Vincenzo
  • Dopazo, Ana
  • Delás, Bárbara
  • Carballo, Miguel
  • Pascual, Beatriz
  • Hernán, Imma
  • Erceg, Slaven
  • Lukovic, Dunja
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] Retinitis pigmentosa (RP) is a rare, progressive disease that affects photoreceptors and retinal pigment epithelial (RPE) cells with blindness as a final outcome. Despite high medical and social impact, there is currently no therapeutic options to slow down the progression of or cure the disease. The development of effective therapies was largely hindered by high genetic heterogeneity, inaccessible disease tissue, and unfaithful model organisms. The fact that components of ubiquitously expressed splicing factors lead to the retina-specific disease is an additional intriguing question. Herein, we sought to correlate the retinal cell-type-specific disease phenotype with the splicing profile shown by a patient with autosomal recessive RP, caused by a mutation in pre-mRNA splicing factor 8 (PRPF8). In order to get insight into the role of PRPF8 in homeostasis and disease, we capitalize on the ability to generate patient-specific RPE cells and reveal differentially expressed genes unique to RPE cells. We found that spliceosomal complex and ribosomal functions are crucial in determining cell-type specificity through differential expression and alternative splicing (AS) and that PRPF8 mutation causes global changes in splice site selection and exon inclusion that particularly affect genes involved in these cellular functions. This finding corroborates the hypothesis that retinal tissue identity is conferred by a specific splicing program and identifies retinal AS events as a framework toward the design of novel therapeutic opportunities., This work was supported by Institute of Health Carlos III/ERDF (European Regional Development Fund), Spain [PI16/00409 (DL), PI20/01119 (DL), CP18/00033 (DL), PI15/00227 (MC), CPII16/00037 (SE), and PI18-00286 (SE)], Platform for Proteomics, Genotyping and Cell Lines; PRB3 of ISCIII (PT17/0019/0024); National Science Foundation GACR 18-04393S and the project "Centre of Reconstructive Neuroscience", registration number CZ.02.1.01/0.0./0.0/15_003/0000419PI15/00227; Spanish Ministry of Economy and Competitiveness grant BES-2016-076994 (AA-L); and Academy of Finland (HS).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Alteration of the Mitochondrial Effects of Ceria Nanoparticles by Gold: An Approach for the Mitochondrial Modulation of Cells Based on Nanomedicine

  • Gutiérrez-Carcedo, Patricia
  • Simó, Rafael
  • Setoain, Xavier
  • Aparicio-Gómez, Carolina
  • Abasolo, Ibane
  • Victor, Victor Manuel
  • Herance, José Raúl
  • Navalón Oltra, Sergio|||0000-0001-8423-0759
  • García Gómez, Hermenegildo|||0000-0002-9664-493X
[EN] Ceria nanoparticles are cell compatible antioxidants whose activity can be enhanced by gold deposition and by surface functionalization with positive triphenylphosphonium units to selectively target the mitochondria. The antioxidant properties of these nanoparticles can serve as the basis of a new strategy for the treatment of several disorders exhibiting oxidative stress, such as cancer, diabetes or Alzheimer's disease. However, all of these pathologies require a specific antioxidant according with their mechanism to remove oxidant species excess in cells and diminish their effect on mitochondrial function. The mechanism through which ceria nanoparticles neutralize oxidative stress and their effect on mitochondrial function have not been characterized yet. In the present study, the mitochondria antioxidant effect of ceria and ceria-supported gold nanoparticles, with or without triphenylphosphonium functionalization, was assessed in HeLa cells. The effect caused by ceria nanoparticles on mitochondria function in terms of mitochondrial membrane potential (Delta Psi m), adenosine triphosphate (ATP) production, nuclear respiratory factor 1 (NRF1) and nuclear factor erythroid-2 like 1 (NFE2L1) was reversed by the presence of gold. Furthermore, this effect was enhanced when nanoparticles were functionalized with triphenylphosphonium. Our study illustrates how the mitochondrial antioxidant effect induced by ceria nanoparticles can be modulated by the presence of gold., This research was funded by Carlos III Health Institute and the European Regional Development Fund, grant number CP13/00252 and PI16/1083; the Catalonian Agency for Management of University and Research Grants, grant number 2017SGR1303; the Ministry of Education of the Valencian Regional Government, grant number PROMETEO/2019/027, The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, grant number Nanobetes2.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Assessment of drug entrapment within liposomes using photophysical probes

  • Oliverio, Filomena
  • Nuin Plá, Neus Edurne
  • Ragno, Gaetano
  • Miranda Alonso, Miguel Ángel
  • Andreu, Inmaculada|||0000-0003-3409-9443
The photophysical and photochemical behavior of (R)-cinacalcet (CIN) and (S)-naproxen (NPX) entrapped within liposomes has been studied. For this purpose, liposome encapsulated drugs have been prepared through thin layer evaporation and characterized by transmission electron microscopy, cryoscopy scanning electron microscopy and dynamic light scattering. Steady state and time-resolved fluorescence experiments showed similar spectra, emission quantum yields, singlet energies and lifetimes for the selected drugs, outside and inside liposomes. By contrast, laser flash photolysis experiments revealed an important enhancement of the triplet lifetimes for entrapped drugs inside liposomes, indicating the spatial confinement existing in the microenvironment prevailing in these biomimetic entities. Thus, this photophysical property shows potential as a non-invasive, direct and valuable tool to monitor encapsulation of photoactive drugs and to probe the intraliposome environment. In addition, it provides a new quantitative indicator of the capability of liposomes to act as drug carriers., We gratefully acknowledge financial support from the Carlos III Institute of Health (Servet Contract CP11/00154 for I.A. and Red RETICS de investigacion de Reacciones Adversas a Alergenos y Farmacos, RIRAAF) and from Ministero dell'Istruzione, dell'Universita e della Ricerca (M.I.U.R. Italy).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole

  • Martínez, Carmen
  • Amo, Gemma
  • Miranda Alonso, Miguel Ángel
  • Esguevillas, Gara
  • Torres, María José
  • Blanca López, Natalia
  • Blanca, Miguel
  • Garcia Martin, Elena
  • Agúndez, José A.G.
  • Andreu, Inmaculada|||0000-0003-3409-9443
Metamizole is a pain-killer drug that has been banned in some countries because of its toxicity, but it is still used in many countries due to its effective analgesic and antispasmodic properties. Although large variability in the biodisposition and adverse effects of metamizole are known, factors underlying this variability are poorly understood. We analyzed the urinary recovery of metabolites, as well as the association of these profiles with genetic and non-genetic factors, in a group of 362 healthy individuals. Gender and functional polymorphisms are strongly related to metabolic profiles. N-demethylation of the active metabolite MAA is diminished in carriers of the CYP2C19*2 allele and in NAT2-slow acetylators. Acetylation of the secondary metabolite AA is decreased in men, in drinkers and in NAT2-slow acetylators with a differential effect of NAT2*5 and NAT2*6 alleles. The formylation of MAA is diminished in older subjects and in carriers of defect CYP2C9 and CYP2C19 alleles. Two novel arachidonoyl metabolites were identified for the first time in humans. Women and NAT2-slow acetylators show higher concentrations, whereas the presence of the rapid CYP2C19*17 allele is associated with lower concentrations of these metabolites. All genetic associations show a gene-dose effect. We identified for the first time genetic and non-genetic factors related to the oxidative metabolism of analgesic drug metamizole, as well as new active metabolites in humans. The phenotypic and genetic factors identified in this study have a potential application as biomarkers of metamizole biotransformation and toxicity., We are grateful to Prof. James McCue for assistance in language editing. Financed by grants PS09/00943, PS09/00469, PI12/00241, PI12/00324 and RETICS RD07/0064/0016 and RD12/0013/0002 and RD12/0013/0009 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Madrid, Spain; GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. I.A. is supported by a Servet Contract CP11/00154.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway

  • Lupo,Vincenzo
  • Martínez-Rubio, Dolores
  • Sevilla, Teresa
  • Vílchez, Juan José
  • Palau, Francesc
  • Espinós-Armero, Carmen Ángeles
  • Galindo, Máximo Ibo|||0000-0001-8448-9760
[EN] Mutations in SH3TC2 (KIAA1985) cause Charcot-Marie-Tooth disease (CMT) type 4C, a demyelinating inherited neuropathy characterized by early-onset and scoliosis. Here we demonstrate that the SH3TC2 protein is present in several components of the endocytic pathway including early endosomes, late endosomes and clathrin-coated vesicles close to the trans-Golgi network and in the plasma membrane. Myristoylation of SH3TC2 in glycine 2 is necessary but not sufficient for the proper location of the protein in the cell membranes. In addition to myristoylation, correct anchoring also needs the presence of SH3 and TPR domains. Mutations that cause a stop codon and produce premature truncations that remove most of the TPR domains are expressed as the wild-type protein. In contrast, missense mutations in or around the region of the first-TPR domain are absent from early endosomes, reduced in plasma membrane and late endosomes and are variably present in clathrin-coated vesicles. Our findings suggest that the endocytic and membrane trafficking pathway is involved in the pathogenesis of CMT4C disease. We postulate that missense mutations of SH3TC2 could impair communication between the Schwann cell and the axon causing an abnormal myelin formation., This work was supported by the Fondo de Investigacion Sanitaria [grant numbers PI08/90857, PI08/0889, CP08/00053] and the Spanish Ministry Science and Innovation [grant number SAF2006-01047]. V. L. is a recipient of JAE predoctoral fellowship from the Spanish Scientific Research Council (CSIC). M. I. G. has a `Ramon y Cajal' contract funded by the Ministry of Science and Innovation. C. E. has a `Miguel Servet' contract funded by the Fondo de Investigacion Sanitaria. Both CIBERER and CIBERNED are initiatives from the Instituto de Salud Carlos III. We are grateful to patients and their families for their kind collaboration. We thank B. Alarcón for his technical assistance and also anonymous reviewers for their invaluable insight and suggestions
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Plasma fibroblast activation protein is decreased in acute heart failure despite cardiac tissue upregulation

  • Delgado-Arija, Marta
  • Genovés, Patricia
  • Pérez-Carrillo, Lorena
  • González-Torrent, Irene
  • Giménez-Escamilla, Isaac
  • Martínez-Dolz, Luis
  • Portolés, Manuel
  • Tarazón, Estefanía
  • Roselló-Lletí, Esther
[EN] Background Cardiac fibroblast activation protein (FAP) has an emerging role in heart failure (HF). A paradoxical reduction in its levels in pathological conditions associated with acute processes has been observed. We aimed to identify FAP cardiac tissue expression and its relationship with the main cardiac fibrosis-related signaling pathways, and to compare plasma FAP levels in acute and chronic HF patients. Methods Transcriptomic changes were assessed via mRNA/ncRNA-seq in left ventricle tissue from HF patients (n¿=¿57) and controls (n¿=¿10). Western blotting and immunohistochemistry were used to explore FAP protein levels and localization in cardiac tissue. ELISA was performed to examine plasma FAP levels in acute HF (n¿=¿48), chronic HF (n¿=¿15) and control samples (n¿=¿7). Results FAP overexpression in cardiac tissue is related to the expression of molecules directly involved in cardiac fibrosis, such as POSTN, THBS4, MFAP5, COL1A2 and COL3A1 (P¿<¿0.001), and is directly and inversely related to pro- and antifibrotic microRNAs, respectively. The observed FAP overexpression is not reflected in plasma. Circulating FAP levels were lower in acute HF patients than in controls (P¿<¿0.05), while chronic HF patients did not show significant changes. The clinical variables analyzed, such as functional class or etiology, do not affect plasma FAP concentrations. Conclusions We determined that in HF cardiac tissue, FAP is related to the main cardiac fibrosis signaling pathways as well as to pro- and antifibrotic microRNAs. Additionally, an acute phase of HF decreases plasma FAP levels despite the upregulation observed in cardiac tissue and regardless of other clinical conditions., This work was supported by the National Institute of Health Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III [Projects: PI20/01469 and PI20/00071 co-funded by European Union; Miguel Servet contracts: CP18/00145 co-funded by European Union, European Social Fund (ESF) The ESF invests in your future and CP21/00041 co-funded by European Union; contract FI21/00186 and FI21/00034]; Consorcio Centro de Investi&#8209; gación Biomédica en Red [CIBERCV, under Grant CB16/11/00261]; Ministry of Universities and the European Recovery, Transformation and Resilience Plan (PRTR, Next Generation EU) [ Ayuda Margarita Salas para la formación de jóvenes doctores : contract: MS21-162]; Ministry of Science and Innovation (MCIN, 10.13039/501100011033) and State Investigation Agency (AEI) [Project CNS2022-135769] co-funded by European Union Next Generation EU and PRTR; Conselleria de educación, universidades y empleo [Project CIA&#8209; ICO/2022/246, contract CIACIF/2022/429].
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.

  • López-Palacios, Alba|||0000-0002-4397-277X
  • Caballos-Gómez, María Isabel
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Aranda-Sobrino, María Nieves
  • Calbuig, Eva
  • Gómez-Ruiz, María Dolores
  • Tormo-Mas, M.A.
  • Peman, Javier
  • Climent Terol, Estela
[EN] We describe herein a sensor containing nanoporous anodic alumina (NAA) as sensing platform to identify SARSCOV-2 RNA using a gating mechanism. The system is based on NAA that contains a fluorescent dye (Rhodamine B; RhB) and is capped with an oligonucleotide sequence that hybridize specifically a region of SARS-CoV-2 genome. In the presence of RNA from SARS-COV-2 virus, the oligonucleotide of the surface is displaced, uncapping the pores, and producing a delivery of RhB. The detection of the virus is achieved measuring the fluorescence of the fluorophore. The nanosensor demonstrates to be highly sensitive and selective in aqueous buffers and in biological media, having a limit of detection (LOD) of 50 ± 30 copies mL-1 of SARS-CoV-2 RNA extracted from patients. Moreover, preliminary results using 18 real nasopharyngeal swab samples indicate the potential of the system to differentiate between infected and non-infected patients. Compared to the conventional RT-PCR method, in our system there is no need for sample pretreatment or RNA isolation, providing diagnostic outcomes within 60 mins while maintaining a high level of reliability, This study was sponsored by the Spanish Government (projects PID2021-126304OB-C41 (DOROTHY), PID2021-128141OB-C22 (ANTIVIBEM), and PID2021-122875OB-100 (MCUI/AEI/ FEDER, UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/ 2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat Polit`ecnica de Val`encia&#8722; Instituto de Investigacion ¿ Sanitaria La Fe (IISLaFe) (SARS-COV-2-SEEKER and VISION-COV projects). This research project has received funding from the European Union s HORIZON-CL4- 2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor th e granting authority can be held responsible for them. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). Also, the project has received funding from the European Union s HORIZON-CL4-2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project. A.L.P. thanks the Ministerio de Universidades for his predoctoral grant (FPU20/05297). E. C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086). Scheme 1 was done with BioRender.com. The Medicaments Research Ethics Committee, CEIm of University and Polytechnic La Fe Hospital of Valencia (2021-012-1) approved the use of samples from human patients.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease

  • Milara, Javier
  • Lluch, Javier
  • Freire, Jose
  • Xiaozhong, Qian
  • Cortijo, Julio
  • Almudéver-Folch, Patricia|||0000-0003-3138-0862
[EN] Background: Glucocorticoid functions are markedly impaired in patients with chronic obstructive pulmonary disease (COPD). The phosphodiesterase 4 inhibitor roflumilast N-oxide (RNO) is the active metabolite of roflumilast approved as a treatment to reduce the risk of exacerbations in patients with severe COPD. Objective: We sought to characterize the differential effects of RNO versus corticosteroids and their potential additive/synergistic effect in neutrophils from patients with COPD, thus providing scientific rationale for the combination of roflumilast with corticosteroids in the clinic. Methods: Peripheral blood neutrophils were isolated from patients with COPD (n = 32), smokers (n = 7), and healthy nonsmokers (n = 25). Levels of IL-8, matrix metallopeptidase 9 (MMP-9), and biomarkers of glucocorticoid resistance were determined by using ELISA and RT-PCR. Neutrophils were incubated with dexamethasone (0.1 nmol/L to 1 mu mol/L), RNO (0.1 nmol/L to 1 mu mol/L), or the combination of 1nmol/L RNO plus 10 nmol/L DEX and stimulated with LPS (1 mu g/mL) or cigarette smoke extract 5%; levels of IL-8, MMP-9, and other biomarkers were measured at the end of the incubation period. Results: Peripheral neutrophils from patients with COPD showed a primed phenotype with an increased basal release of IL-8 and MMP-9 and expressed a corticosteroid resistance molecular profile characterized by an increase in phosphoinositide 3-kinase delta, macrophage migration inhibitory factor, and glucocorticoid receptor beta expression and a decrease in HDAC activity and mitogen-activated protein kinase phosphatase 1 expression. RNO demonstrated robust anti-inflammatory effects on neutrophils from patients with COPD, reversing their resistance to corticosteroids. The combination of RNO and dexamethasone showed additive/synergistic effects, which were consistent with the reversal of corticosteroid-resistant molecular markers by RNO. Conclusion: RNO reverses corticosteroid resistance and shows strong anti-inflammatory effects alone or in combination with corticosteroids on neutrophils from patients with COPD., Supported by grants SAF2011-26443 (to J.C.), FIS CP11/00293 (to J.M.), CIBERES (CB06/06/0027), ADE10/00020 (Spanish government), and research grants from the Regional Government (Prometeo II/2013/014 to J.C. and J.M.), "Generalitat Valenciana.'' Support from the CENIT programme (Spanish Government) was obtained as well.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Software de investigación Software (Software)

InGenio eLearning Platform, InGenio System

  • De-Siqueira, J.M.|||0000-0002-4579-1147
  • Gimeno-Sanz, Ana|||0000-0003-3366-0729
  • Navarro Laboulais, Cristina Teresa|||0000-0001-8620-4087
  • Torres Molins, Sergio
Plataforma de eLearning desarrollada en la Universitat Politècnica de València que permite la creación, gestión y evaluación automatizada de contenidos interactivos (herramienta de autor), especialmente orientada a la enseñanza de lenguas extranjeras, que integra una arquitectura modular y escalable, análisis cuantitativo de resultados académicos y funcionalidades avanzadas de evaluación digital validadas en proyectos de I+D+i. InGenio eLearning Platform es una plataforma de aprendizaje en línea desarrollada en la Universitat Politècnica de València (UPV) bajo la dirección de la Dra. Ana Gimeno Sanz y el liderazgo técnico del Dr. Jose Macario de Siqueira Rocha, concebida como un sistema integral para la creación, gestión, distribución y evaluación de materiales didácticos digitales, especialmente en el ámbito del aprendizaje de lenguas y su evaluación. La primera versión pública fue distribuida en 2005, incorporando funcionalidades de autoría de contenidos multimedia interactivos, generación automática de ejercicios adaptados a las lenguas maternas de los estudiantes, grabación de audio, almacenamiento estructurado de resultados y seguimiento individualizado del aprendizaje. En 2012 se publicó una versión ampliada con nuevas funcionalidades de evaluación adaptativa, módulos de autoevaluación, gestión avanzada de bases de datos, nuevas herramientas para profesores y autores, así como utilidades para la creación de datasets y el análisis empírico de las respuestas y resultados de los estudiantes en cada ejercicio interactivo. También se incorporaron las primeras herramientas para la evaluación de audios grabados durante la ejecución de los ejercicios y para el análisis ergonómico y cognitivo de la interacción del estudiante. La arquitectura del sistema fue diseñada desde una perspectiva de ingeniería de software escalable y modular, permitiendo: • Creación estructurada de contenidos multimedia interactivos. • Diseño de actividades autoevaluables con corrección automática. • Generación de bancos de ítems reutilizables. • Monitorización del rendimiento del estudiante mediante registros persistentes. • Exportación de datos para análisis estadístico y estudios de investigación. • Integración con entornos institucionales y proyectos europeos de innovación educativa. La plataforma fue desarrollada por la Universitat Politècnica de València y utilizada en el marco de los proyectos europeos CALL@C&S, PAULEX y PAU-ER, así como para diversos proyectos docentes universitarios, sirviendo como infraestructura tecnológica para la formación en línea de miles de estudiantes en contextos reales. El sistema permite la experimentación con modelos de evaluación síncrona a través de Internet en pruebas oficiales de acceso y certificación lingüística, contribuyendo a la modernización de los procesos evaluativos en educación superior. Desde el punto de vista científico, InGenio ha sido objeto de validación empírica en diversas publicaciones académicas indexadas, en las que se analizan sus modelos de evaluación, su arquitectura tecnológica y los resultados cuantitativos derivados de su uso real por parte de estudiantes y docentes. En línea con los principios de ciencia abierta, este depósito incluye: • Código fuente raíz de la plataforma (versión documentada). • Guías básicas de uso para estudiantes, docentes y administradores. • Posibilidad de acceso a datasets anonimizados de resultados académicos para fines de investigación, que se generan a través de las base de datos que archiva cada iteración de cada estudiante en cada ejercicio interactivo (previa solicitud razonada). Idiomas de interfaz y de adaptación al idioma materno del estudiante: inglés, español, catalán/valenciano, italiano, francés, checo, eslovaco y portugués. Fecha de primera distribución pública: 2005. Actualización funcional ampliada: 2012., •Comisión Europea - CALL@C&S - ONLINE COURSEWARE FOR LEARNERS OF CZECH AND SLOVAK (114034-CP-1-2004-1-ES-LINGUA-L). •Gobierno de España - Proyecto PAULEX, ESTUDIO DE LOS PROCESOS DE CAMBIO Y AUTOMATIZACION DE LAS PRUEBAS DE ACCESO A LA UNIVERSIDAD EN MATERIA DE LENGUAS EXTRANJERAS A PARTIR DEL DESARROLLO DE HERRAMIENTAS ESPECIFICAS A TRAVES DE INTERNET. (HUM2007-66479-C02-01). •Gobierno de España - Proyecto PAU-ER, HERRAMIENTA TELEMATICA PARA LA REALIZACION DE PRUEBAS DE ACCESO A LA UNIVERSIDAD. (HUM2007-66479-C02-02).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Capítulo o parte de un libro (BookPart)

Student Assessment in the Online Language Learning Materials Developed and Delivered Through the InGenio System

  • Sevilla Pavón, Ana Mercedes
  • Martínez Sáez, Antonio
  • De-Siqueira, J.M.|||0000-0002-4579-1147
[EN] Assessment, the "dynamic developmental process which develops and changes as the needs arise and as understanding of the process improves" ( Brown and Glasner 2003 , preface), is considered as one of the key aspects in education. The importance of assessment derives from both its infl uence in the way teachers and students address language teaching and learning and the changes it might introduce as far as methodologies, approaches and behaviour of all participants in the language learning process are concerned. The assessment process has a very important and remarkable effect on the way educators and learners face the whole teaching process. Therefore, specifi c adaptations and also general changes are made and are introduced into the classroom context as well as into the teaching methodologies with a view to facing the fi nal evaluation process in a more effi cient manner
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Development of Decellularized Oviductal Hydrogels as a Support for Rabbit Embryo Culture

  • Francés-Herrero, Emilio
  • De Miguel-Gómez, Lucía
  • López-Martínez, Sara
  • Campo, Hannes
  • Garcia-Dominguez, Ximo
  • Diretto, Gianfranco
  • Faus, Amparo
  • Cervelló, Irene
  • Vicente Antón, José Salvador|||0000-0003-0481-3802
  • Marco-Jiménez, Francisco|||0000-0002-5226-4118
[EN] The oviducts (fallopian tubes in mammals) function as the site of fertilization and provide necessary support for early embryonic development, mainly via embryonic exposure to the tubal microenvironment. The main objective of this study was to create an oviduct-specific extracellular matrix (oviECM) hydrogel rich in bioactive components that mimics the native environment, thus optimizing the developmental trajectories of cultured embryos. Rabbit oviducts were decellularized through SDS treatment and enzymatic digestion, and the acellular tissue was converted into oviductal pre-gel extracellular matrix (ECM) solutions. Incubation of these solutions at 37 degrees C resulted in stable hydrogels with a fibrous structure based on scanning electron microscopy. Histological staining, DNA quantification and colorimetric assays confirmed that the decellularized tissue and hydrogels contained no cellular or nuclear components but retained important components of the ECM, e.g. hyaluronic acid, glycoproteins and collagens. To evaluate the ability of oviECM hydrogels to maintain early embryonic development, two-cell rabbit embryos were cultured on oviECM-coated surfaces and compared to those cultured with standard techniques. Embryo development was similar in both conditions, with 95.9% and 98% of the embryos reaching the late morula/early blastocyst stage by 48 h under standard culture and oviECM conditions, respectively. Metabolomic analysis of culture media in the presence or absence of embryos, however, revealed that the oviECM coating may include signalling molecules and release compounds beneficial to embryo metabolism., This study was supported by Instituto de Salud Carlos III (PI17/01039-CP19/00149 [Irene Cervello]), Ministry of Economy, Industry and Competitiveness (AGL2017-85162-C2-1-R [Francisco Marco], BES-2015-072429 [Ximo Garcia]), Ministry of Science, Innovation and Universities (FPU18/06327 [Emilio Frances]) and Generalitat Valenciana (PROMETEO/2018/137 [Irene Cervello, Lucia de Miguel], ACIF/2017/118 [Sara Lopez]). The proteomics laboratory is a member of ProteoRed, PRB3, and is supported by grant PT17/0019 of the State Plan I+D+i 2013-2016, funded by Instituto de Salud Carlos III and European Regional Development Fund.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease

  • Sivera, Rafael
  • Espinós-Armero, Carmen Ángeles
  • Vílchez, Juan J.
  • Mas, Fernando
  • Martínez-Rubio, Dolores
  • Chumillas, María José
  • Mayordomo, Fernando
  • Muelas, Nuria
  • Bataller, Luis
  • Palau, Francesc
  • Sevilla, Teresa
[EN] Mutations in the ganglioside-induced-differentiation-associated protein 1 gene (GDAP1) can cause Charcot-Marie-Tooth (CMT) disease with demyelinating (CMT4A) or axonal forms (CMT2K and ARCMT2K). Most of these mutations present a recessive inheritance, but few autosomal dominant GDAP1 mutations have also been reported. We performed a GDAP1 gene screening in a clinically well-characterized series of 81 index cases with axonal CMT neuropathy, identifying 17 patients belonging to 4 unrelated families in whom the heterozygous p.R120W was found to be the only disease-causing mutation. The main objective was to fully characterize the neuropathy caused by this mutation. The clinical picture included a mild-moderate phenotype with onset around adolescence, but great variability. Consistently, ankle dorsiflexion and plantar flexion were impaired to a similar degree. Nerve conduction studies revealed an axonal neuropathy. Muscle magnetic resonance imaging studies demonstrated selective involvement of intrinsic foot muscles in all patients and a uniform pattern of fatty infiltration in the calf, with distal and superficial posterior predominance. Pathological abnormalities included depletion of myelinated fibers, regenerative clusters and features of axonal degeneration with mitochondrial aggregates. Our findings highlight the relevance of dominantly transmitted p.R120W GDAP1 gene mutations which can cause an axonal CMT with a wide clinical profile., We are grateful to the propositi and their relatives for their kind collaboration. We also want to thank I. Llopis and M. Escutia for their help with sample management. This work was supported by the Instituto de Salud Carlos III [PI08/90857, PI08/0889, CP08/00053 and PS09/00095], the Fundacion para la Investigacion del Hospital Universitari La Fe [CM06/00154], the Spanish Ministry Science and Innovation [grant number SAF2006-01047], and the Generalitat Valenciana [grant no. Prometeo/2009/05]. Dr. C. Espinos has a "Miguel Servet'' contract funded by the Fondo de Investigacion Sanitaria. Both Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) and Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) are initiatives from the Instituto de Salud Carlos III.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Outcomes of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in the Valencian Community

  • Berzal-Serrano, Alba
  • García-Bohorquez, Belén
  • Aller, Elena
  • Jaijo, Teresa
  • Pitarch-Castellano, Inmaculada
  • Rausell, Dolores
  • García-García, Gema
  • Millán, José M.
[EN] Spinal muscular atrophy (SMA) is a degenerative neuromuscular condition resulting from a homozygous deletion of the survival motor neuron 1 (SMN1) gene in 95% of patients. A timely diagnosis via newborn screening (NBS) and initiating treatment before the onset of symptoms are critical for improving health outcomes in affected individuals. We carried out a screening test by quantitative PCR (qPCR) to amplify the exon seven of SMN1 using dried blood spot (DBS) samples. From October 2021 to August 2024, a total of 31,560 samples were tested in the Valencian Community (Spain) and 4 of them were positive for SMA, indicating an incidence of 1/7890. Genetic confirmation was performed using multiplex ligation-dependent probe amplification (MLPA) and AmplideX PCR/CE SMN1/2 Plus kit, in parallel obtaining concordant results in survival motor neuron 2 (SMN2) gene copy number. Within the first few weeks of their lives, two of the four patients detected by NBS showed signs of severe hypotonia, becoming ineligible for treatment. The other two patients were the first presymptomatic patients with two copies of SMN2 to receive treatment with Risdiplam in Spain. In order to treat positive cases in their early stages, we conclude that the official deployment of SMA newborn screening is necessary., This research was funded by Novartis Gene Therapies through the project Newborn screening for Spinal Muscular Atrophy and Severe Combined Inmunodeficiency (reference 2020-517- 1). A.B.-S. is the recipient of a predoctoral contract from the Valencian Government (ACIF/2021/057). G.G.-G acknowledges two grants from the Carlos III Health Institute (CP22/00028 and PI22/01371) co-funded by the European Union and is the recipient of a project from Foundation Mutua Madrileña.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series

  • Sivera, Rafael
  • Sevilla, T.
  • Vílchez, Juan Jesús
  • Martínez-Rubio, Dolores
  • Chumillas, María José
  • Vázquez, Juan Francisco
  • Muelas, Nuria
  • Bataller, Luis
  • Millán, José María
  • Palau, Francesc
  • Espinós-Armero, Carmen Ángeles
[EN] Objectives: To determine the genetic distribution and the phenotypic correlation of an extensive series of patients with Charcot-Marie-Tooth disease in a geographically well-defined Mediterranean area. Methods: A thorough genetic screening, including most of the known genes involved in this disease, was performed and analyzed in this longitudinal descriptive study. Clinical data were analyzed and compared among the genetic subgroups. Results: Molecular diagnosis was accomplished in 365 of 438 patients (83.3%), with a higher success rate in demyelinating forms of the disease. The CMT1A duplication (PMP22 gene) was the most frequent genetic diagnosis (50.4%), followed by mutations in the GJB1 gene (15.3%), and in the GDAP1 gene (11.5%). Mutations in 13 other genes were identified, but were much less frequent. Sixteen novel mutations were detected and characterized phenotypically. Conclusions: The relatively high frequency of GDAP1 mutations, coupled with the scarceness of MFN2 mutations (1.1%) and the high proportion of recessive inheritance (11.6%) in this series exemplify the particularity of the genetic distribution of Charcot-Marie-Tooth disease in this region., This collaborative joint project is awarded by IRDiRC and funded by the Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigacion within the framework of the National R+D+I Plan (grants IR11/TREAT-CMT, PI08/90857, PI08/0889, CP08/00053, PI12/00453, and PI12/0946), cofunded with FEDER funds, and the Generalitat Valenciana (grant Prometeo/2009/051). The Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) and the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) are initiatives from the ISCIII.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Decoding the Genetic Basis of Inherited Retinal Dystrophies for Precision Medicine

  • Barberán Martínez, Pilar
[ES] Las distrofias hereditarias de la retina (DHR) constituyen un grupo de enfermedades raras caracterizadas por la degeneración progresiva de las células retinianas y la consecuente pérdida visual. Presentan una elevada heterogeneidad clínica y genética, con más de 400 genes asociados a formas sindrómicas y no sindrómicas. A pesar del uso de distintas estrategias de secuenciación de nueva generación (NGS), aproximadamente un 30-40% de los pacientes permanecen sin diagnóstico genético. Esta tesis doctoral se centró en el estudio genético de familias con diagnóstico clínico de DHR mediante diferentes aproximaciones basadas en NGS, combinadas con estudios funcionales para evaluar la patogenicidad de variantes de significado incierto y mejorar la interpretación clínica. En la primera parte del trabajo se realizó la secuenciación del exoma clínico (Clinical Exome Sequencing, CES) en 143 familias, alcanzando una tasa de diagnóstico genético del 68,53%. Se identificaron 35 genes causales distintos, con predominio del patrón de herencia autosómico recesivo (AR), así como 45 variantes noveles, ampliando el espectro mutacional conocido de las DHR. Posteriormente, en los casos no resueltos mediante CES u otras estrategias de NGS previas, se realizó la secuenciación del genoma completo (Whole Genome Sequencing, WGS). Este estudio permitió identificar mecanismos patogénicos que escapan a las técnicas convencionales en 16 familias, incluyendo tres variantes intrónicas profundas y una variante estructural compleja en PRPF31, caracterizada mediante PCRs y secuenciación de lectura larga. Además, la WGS permitió detectar variantes en genes no incluidos en análisis previos, así como en regiones previamente estudiadas, pero no identificadas debido a limitaciones técnicas o analíticas, como ORF15 del gen RPGR. En determinados casos, los hallazgos genéticos se complementaron con estudios funcionales para demostrar la patogenicidad de variantes que afectan al splicing. Se realizó un ensayo de minigen para la variante ABCA4: c.1299A>G detectada mediante CES, así como estudios de ARNm en sangre periférica o células epiteliales nasales en pacientes analizados mediante WGS, con variantes intrónicas profundas en los genes CHM, BBS4 y CEP78. Los resultados confirmaron su efecto sobre el procesamiento del ARNm, en concordancia con las predicciones bioinformáticas de SpliceAI. La integración de los resultados clínicos, genéticos y funcionales permitió además la reclasificación clínica de algunos pacientes e identificar nuevas asociaciones genotipo-fenotipo, como FAM161A con distrofia de conos-bastones y GUCY2D con enfermedad de Stargardt. De especial relevancia, este trabajo ha permitido asociar por primera vez el gen POMT2 con retinosis pigmentaria (RP) AR no sindrómica, gen de la vía de O-manosilación previamente asociado principalmente a distrofias musculares. En esta tesis se diagnosticaron ocho familias con RP y variantes bialélicas en este gen, todas portadoras de las variantes p.Val660Phe o p.Tyr662His en homocigosis o heterocigosis compuesta. Estudios estructurales in silico localizaron estas variantes en el sitio activo de la proteína, mientras que ensayos funcionales in vitro demostraron una pérdida parcial de la actividad enzimática, apoyando su efecto hipomórfico. Estos hallazgos podrían explicar la afectación retiniana aislada y amplían el conocimiento de la vía de O-manosilación en las enfermedades retinianas. En conjunto, los resultados de esta tesis demuestran que la aplicación de estrategias genómicas avanzadas, especialmente la WGS, incrementan el rendimiento diagnóstico en enfermedades altamente heterogéneas como las DHR. Asimismo, evidencian que la combinación de estudios genéticos, clínicos y funcionales es fundamental para establecer el papel patogénico de nuevas variantes y descubrir relaciones genotipo-fenotipo no descritas, fortaleciendo la comprensión global de estas enfermedades y avanzando hacia una medicina de precisión en las DHR., [EN] Inherited retinal dystrophies (IRDs) constitute a group of rare diseases characterized by the progressive degeneration of retinal cells and the consequent loss of vision. These disorders are distinguished by marked clinical and genetic heterogeneity, with more than 400 associated genes described to date, encompassing both syndromic and non-syndromic forms. Despite the implementation of various next-generation sequencing (NGS) strategies, approximately 30-40% of patients remain without a genetic diagnosis. This doctoral thesis focused on the genetic study of families with a clinical diagnosis of IRDs using different NGS-based approaches, combined with functional studies to evaluate the pathogenicity of variants of uncertain significance and improve clinical interpretation. In the first part of the work, clinical exome sequencing (CES) was performed in 143 families, achieving a genetic diagnostic yield of 68.53% and identifying 35 different causal genes, with a predominance of the autosomal recessive (AR) inheritance pattern. The study also described 45 novel variants (26.47% of the total), expanding the known mutational spectrum of IRDs. Subsequently, in cases unsolved by CES or other previous NGS strategies, whole genome sequencing (WGS) was performed. This study allowed the identification of pathogenic mechanisms that escape conventional techniques in 16 families. These findings included three deep intronic variants and a complex structural variant in the PRPF31 gene, which was fully characterized using PCR and long-read sequencing. WGS also enabled the detection of variants in genes not included in previous analyses, as well as in previously studied genes and regions that were not identified due to technical or analytical limitations, including the highly repetitive ORF15 region of the RPGR gene. In certain cases, the genetic findings were complemented with functional studies to demonstrate the pathogenicity of variants affecting splicing. These included a minigene assay for the ABCA4: c.1299A>G variant detected by CES, as well as mRNA studies in peripheral blood or nasal epithelial cells from patients who underwent WGS, where deep intronic variants were detected in the CHM, BBS4, and CEP78 genes. The results confirmed the impact on mRNA processing, consistent with SpliceAI predictions, thereby supporting the classification of these variants as causal. The integration of clinical, genetic, and functional results also allowed the clinical reclassification of some patients and the identification of new genotype-phenotype associations, such as FAM161A associated with cone-rod dystrophy and GUCY2D associated with Stargardt disease. Notably, this work establishes the first association of the POMT2 gene with non-syndromic AR retinitis pigmentosa (RP). Until now, POMT2 has been predominantly linked with muscular dystrophies, as a component of the O-mannosylation pathway. In this thesis, eight families (nine patients) with RP and biallelic variants in this gene were molecularly diagnosed, all carrying the p.Val660Phe or p.Tyr662His variants in either homozygous or compound heterozygous states. In silico structural studies revealed the location of these variants in the protein's active site, while in vitro functional assays demonstrated a partial loss of enzymatic activity, supporting a hypomorphic effect. These findings may explain the isolated retinal involvement and expand knowledge of the O-mannosylation pathway in the context of retinal diseases. Overall, the results of this thesis demonstrate that the use of advanced genomic strategies, especially WGS, increases diagnostic yield in highly heterogeneous diseases such as IRDs. Furthermore, they highlight the importance of integrating genetic, clinical, and functional studies to establish the pathogenic role of novel variants and uncover previously undescribed genotype-phenotype relationships, enhancing our understanding of these diseases and advancing precision medicine in IRDs., [CA] Les distròfies hereditàries de la retina (DHR) constitueixen un grup de malalties rares caracteritzades per la degeneració progressiva de les cèl·lules retinianes i la consegüent pèrdua visual. Es distingeixen per la seua elevada heterogeneïtat clínica i genètica, amb més de 400 gens associats a formes sindròmiques i no sindròmiques. Malgrat la implementació de diferents estratègies de seqüenciació de nova generació (NGS), aproximadament un 30-40% dels pacients continuen sense diagnòstic genètic. Aquesta tesi doctoral s'ha centrat en l'estudi genètic de famílies amb diagnòstic clínic de DHR mitjançant diferents aproximacions basades en NGS, combinades amb estudis funcionals per a avaluar la patogenicitat de variants de significat incert i millorar la interpretació clínica. En la primera part del treball es va realitzar la seqüenciació de l'exoma clínic (Clinical Exome Sequencing, CES) en 143 famílies, assolint una taxa de diagnòstic genètic del 68,53%. Es van identificar 35 gens causals, amb predomini de l'herència autosòmica recessiva (AR), i 45 variants noves, ampliant l'espectre mutacional conegut en les DHR. Posteriorment, en aquells casos no resolts mitjançant CES o altres estratègies de NGS prèvies, es va dur a terme la seqüenciació del genoma complet (Whole Genome Sequencing, WGS). Aquest estudi va permetre identificar mecanismes patogènics que escapen a les tècniques convencionals en 16 famílies. Entre aquestes troballes s'inclouen tres variants intròniques profundes i una variant estructural complexa en PRPF31, caracteritzada mitjançant PCRs i seqüenciació de lectura llarga. La WGS també va permetre detectar variants en gens no inclosos en anàlisis prèvies, així com en gens i regions prèviament estudiades però no identificades per limitacions tècniques o analítiques, com ORF15 del gen RPGR. En alguns casos, les troballes genètiques es van complementar amb estudis funcionals per a demostrar la patogenicitat de variants que afecten el splicing. Es va dur a terme un assaig de minigen per a la variant ABCA4: c.1299A>G detectada mitjançant CES, així com estudis d'ARNm en sang perifèrica o cèl·lules epitelials nasals de pacients analitzats mitjançant WGS, amb variants intròniques profundes en els gens CHM, BBS4 i CEP78. Els resultats van confirmar l'efecte sobre el processament de l'ARNm, en concordança amb les prediccions bioinformàtiques de SpliceAI. La integració dels resultats clínics, genètics i funcionals va permetre també la reclasificació clínica d'alguns pacients i la identificació de noves associacions genotip-fenotip, com FAM161A amb distròfia de cons-bastons i GUCY2D amb Stargardt. De particular rellevància, aquest treball ha permès associar per primera vegada el gen POMT2 amb retinosi pigmentària (RP) AR no sindròmica, gen que forma part de la via d'O-manosilació i que s'ha relacionat principalment amb distròfies musculars. En aquesta tesi es van diagnosticar vuit famílies amb RP i variants bial·lèliques en aquest gen, tots portadors de les variants p.Val660Phe o p.Tyr662His en homozigosi o heterozigosi composta. Estudis estructurals in silico van localitzar aquestes variants en el lloc actiu de la proteïna, mentre que assaigs funcionals in vitro van mostrar una pèrdua parcial de l'activitat enzimàtica, recolzant el seu efecte hipomòrfic. Aquestes troballes podrien explicar l'afectació retiniana aïllada i amplien el coneixement de la via d'O-manosilació en el context de les malalties retinianes. En conjunt, els resultats d'aquesta tesi posen de manifest que l'aplicació d'estratègies genòmiques avançades, especialment la WGS, incrementa el rendiment diagnòstic en malalties altament heterogènies com les DHR. Així mateix, evidencien que la combinació d'estudis genètics, clínics i funcionals resulta fonamental per a establir el paper patogènic de noves variants i descobrir relacions genotip-fenotip no descrites, reforçant la comprensió global d'aquestes malalties i avançant cap a una medicina de precisió en les DHR, Supported by grants from Instituto de Salud Carlos III (ISCIII) (PI22/00213 and AC21_2/00022) and FORT23/00021 co-funded by the European Union (J.M.M.), grant CIPROM/2023/26 from Conselleria de Educación, Cultura, Universidades y Empleo (J.M.M.); grants FPU20/04736 (P.B.M.) and FPU22/01124 (M.B.) from Ministerio de Universidades; and grants from ISCIII (CP22/00028 and PI22/01371), co-funded by the European Union (G.G.-G.).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Topological control in radical reactions of cholesterol in model dyads

  • Neshchadin, Dmytro
  • Palumbo, Fabrizio
  • Sinicropi, M. Stefania
  • Gescheidt, Georg
  • Miranda Alonso, Miguel Ángel
  • Andreu, Inmaculada|||0000-0003-3409-9443
Cholesterol is one of the most important building blocks of cell membranes. It is also one of the main targets for oxidation via Type I hydrogen abstraction (HA), which leads to a variety of physiological consequences in the human body. To provide a deeper understanding of the oxidation mechanism, steady-state H-1 CIDNP, steady-state and laser-flash photolysis in combination with quantum mechanical calculations were applied to study HA in three model systems. The experiments involved photoinduced reactions in a cholesterol-benzophenone mixture and two derivatives, in which aminocholestene and benzophenone are covalently coupled yielding a dyad. It has been found, that a specific orientation of the benzophenone moiety toward the allylic hydrogens of cholesterol/aminocholestene is crucial for the efficient HA. Such a confined topology may play an important role for the particular oxidation of cholesterol in cell membranes., Financial support from the MICINN (Grants CTQ2009-13699 and CTQ2010-14882), from the Generalitat Valenciana (Grisolia fellowship for F. P.) from the Carlos III Institute of Health (Grant RIRAAF, RETICS program and Miguel Servet Contract CP11/00154 for I. A.) and TU Graz is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Targeted detection of Mycobacterium tuberculosis MPT64 antigen using an antibody-coated nanoporous anodic alumina biosensor: A novel approach for tuberculosis screening

  • Caballos, Isabel
  • Climent Terol, Estela
  • Gil-Brusola, Ana
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
[EN] Tuberculosis (TB) is a chronic condition caused by Mycobacterium tuberculosis. According to WHO's Global Tuberculosis Report 2024, TB has again become the leading cause of death from a single infectious agent, surpassing COVID-19 in 2023 and 2024 in terms of infectious disease deaths. Due to its high infectivity and serious effects, timely diagnosis and treatment are crucial for controlling its spread. This study presents a fluorogenic biosensor for detecting M. tuberculosis MPT64 antigen using gated nanoporous anodic alumina (NAA). NAA material is loaded with rhodamine B and capped with an antibody against MPT64 protein. The presence of MPT64 induces antibody displacement due to the specific recognition and subsequent release of rhodamine B to the medium that is detected by fluorescence measurement. The biosensor is physicochemically characterized by scanning electron microscopy and X-ray spectroscopy. The biosensor achieves a limit of detection (LOD) of 1.32 nM (0.032 mg L-1) for MPT64 protein and demonstrated high selectivity through testing against various antigens from other viral pathogens and bacterial species. The efficacy of the biosensor is further validated with grown mycobacteria from clinical samples. The developed approach offers three key aspects: (i) selective detection of active TB by targeting the secreted MPT64 protein using gated nanomaterials; (ii) a rapid response (60 min); and (iii) a cost-effective design suitable for resource-limited settings. This biosensor shows great potential as a tool for the clinical diagnosis of active tuberculosis., We thank PID2024-155683OB-C41 and PID2021-126304OB-C41 from the Ministerio de Ciencia, Innovacion y Universidades and AEI/10.13039/501100011033 (co-financed by the European Regional Development Fund) , and CIPROM/2021/007 (to R. M.-M.) from the Generalitat Valenciana. This research was also supported by CIBER, Instituto de Salud Carlos III (group CB07/01/2012) . I.-C. thanks the Instituto de Salud Carlos III for her predoctoral fellowship (IFI21/00008) . We thank electron microscopy service of UPV for their support. R.M.M. thanks to the European Union's Horizon EUROPE research and innovation programme under grant agreement No 101093042. E. C. thanks the Instituto de Salud Carlos III for funding the proyects Miguel Servet 2023 CP23/00086 and PI24_01239, both co-funded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

The Effectiveness of Glutathione Redox Status as a Possible Tumor Marker in Colorectal Cancer

  • Acevedo-León, Delia
  • Monzó-Beltrán, Lidia
  • Gómez-Abril, Segundo Ángel
  • Estañ-Capel, Nuria
  • Camarasa-Lillo, Natalia
  • Pérez-Ebri, Marisa Luisa
  • Escandón-Álvarez, Jorge
  • Alonso-Iglesias, Eulalia
  • Santaolaria-Ayora, María Luisa
  • Carbonell-Moncho, Araceli
  • Ventura-Gayete, Josep
  • Pla, Luis
  • Bagán-Debón, Leticia
  • Viña-Almunia, Aurora
  • Martínez-Santamaría, M. Amparo
  • Ruiz-Luque, María
  • Alonso-Fernández, Jorge
  • Bañuls, Celia
  • Sáez. Guillermo
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The role of oxidative stress (OS) in cancer is a matter of great interest due to the implication of reactive oxygen species (ROS) and their oxidation products in the initiation of tumorigenesis, its progression, and metastatic dissemination. Great efforts have been made to identify the mechanisms of ROS-induced carcinogenesis; however, the validation of OS byproducts as potential tumor markers (TMs) remains to be established. This interventional study included a total of 80 colorectal cancer (CRC) patients and 60 controls. By measuring reduced glutathione (GSH), its oxidized form (GSSG), and the glutathione redox state in terms of the GSSG/GSH ratio in the serum of CRC patients, we identified significant changes as compared to healthy subjects. These findings are compatible with the effectiveness of glutathione as a TM. The thiol redox state showed a significant increase towards oxidation in the CRC group and correlated significantly with both the tumor state and the clinical evolution. The sensitivity and specificity of serum glutathione levels are far above those of the classical TMs CEA and CA19.9. We conclude that the GSSG/GSH ratio is a simple assay which could be validated as a novel clinical TM for the diagnosis and monitoring of CRC., This work was partially supported by grants GST, UGP-19-037 FISABIO, Universitat Politecnica de Valencia-the Hospital Universitario Doctor Peset POLISABIO collaboration program (UPV-FISABIO) NanOdGSens-2, the Spanish Government project RTI2018-100910-B-C41 (MCUI/AEI/FEDER, UE), the Generalitat Valenciana project PROMETEO/2018/024 and PI18/00932 by Instituto de Salud Carlos III and co-funded by the European Regional Development Fund (ERDF "A way to build Europe"). C.B. is a recipient of a Miguel Servet contract (CP19/00077) from the Instituto de Salud Carlos III.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Phosphatidylcholine liposomes as carriers to improve topical ascorbic acid treatment of skin disorders

  • Serrano, Gabriel
  • Serrano, Juan-Manuel
  • Milara, Javier
  • Torrens, Ana
  • Expósito, Inmaculada
  • Cortijo, Julio
  • Almudéver-Folch, Patricia|||0000-0003-3138-0862
[EN] Liposomes have been intensively investigated as carriers for different applications in dermatology and cosmetics. Ascorbic acid has potent antioxidant and anti-inflammatory properties preventing photodamage of keratinocytes; however, due to its instability and low skin penetration, an appropriate carrier is mandatory to obtain desirable efficacy. The present work investigates the ability of a specific ascorbate phosphatidylcholine (PC) liposome to overcome the barrier of the stratum corneum and deliver the active agent into the dermis to prevent photodamage. Abdominal skin from ten patients was used. Penetration of PC liposomes was tested ex vivo in whole skin, epidermis, and dermis by means of fluorescein and sodium ascorbate. Histology and Franz diffusion cells were used to monitor the percutaneous absorption. Ultraviolet (UV)-high performance liquid chromatography was used to analyze diffusion of sodium ascorbate through the different skin layers, while spectrofluorimetry and fluorescent microscopy were used for fluorescein monitoring. UVA/UVB irradiation of whole skin was applied to analyze the antioxidant capacity by Trolox assay and anti-inflammatory effects by tumor necrosis factor alpha and interleukin 1 beta enzyme-linked immunoassay. PC liposomal formulation improved skin penetration of fluorescein and ascorbate. Fluorescein PC liposomes showed better diffusion through epidermis than dermis while ascorbate liposomes showed better diffusion through the dermis than the epidermis. Ascorbate PC liposomes showed preventive antioxidant and anti-inflammatory properties on whole human skin irradiated with UVA/UVB. In summary, ascorbate PC liposomes penetrate through the epidermis and allow nonstable hydrophilic active ingredients reach epidermis and dermis preventing skin photodamage., This work was supported by grants SAF2011-26443 (JC), FIS CP11/00293 (JM), FIS PI14/01733 (JM), CIBERES (CB06/06/0027), ADE10/00020 (Spanish Government), as well as research grants from Regional Government Prometeo II/2013/014 (JC, JM) "Generalitat Valenciana". Sesderma laboratories partially support this work.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Designing feedback to support language acquisition using the InGenio authoring tool

  • Gimeno-Sanz, Ana|||0000-0003-3366-0729
  • De-Siqueira, J.M.|||0000-0002-4579-1147
[EN] The increasing demand for high quality innovative foreign language teaching and learning materials led the CAMILLE R&D Group at the Universidad Politécnica de Valencia (Spain) to design a completely online language-independent authoring tool and content manager to allow teachers from around the world to design and deliver tailor-made online courseware that would suit their learners' needs and which could be immediately modified or updated according to particular needs. This system is known as the InGenio System and comprises four modules: the authoring tool, the delivery platform, an online tutoring system and a module to allow authors to adapt their materials into different support languages. This paper aims to describe the specific functionalities that are embedded in InGenio designed to integrate specific feedback to support language acquisition in the language courses designed with the InGenio authoring tool.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

  • Grau-Perez, Maria
  • Martinez-Arroyo, Olga
  • Rubia-Martinez, Marta
  • Flores-Chova, Ana
  • Rodríguez-Hernández, Zulema
  • Fernández-Navarro, Pablo
  • Gonzalez-Neira, Anna
  • Alonso, María Rosario
  • Pita, Guillermo
  • Pineda, Silvia
  • Martin-Escudero, Juan C.
  • Redon, Josep
  • Tellez-Plaza, Maria
  • Cortes, Raquel
  • Guasque Ortega, Ana|||0000-0002-2900-8466
[EN] Background: Circulating microRNAs (miRNAs) are emerging markers for cardiovascular prevention and control. miRNAs associated to vascular damage are candidates to play a causal role in the microvascular dysfunction of heart failure (HF). The aim was to evaluate the observational and causal (Mendelian randomization) association of miRNAs related with vascular alterations (miR-126-3p, miR-1260b and miR-374a-5p) with HF incidence in a sample from the general population. Methods: Plasma miRNAs levels were measured in 985 Hortega Study participants using real time quantitative polymerase chain reaction (RT-qPCR). Single nucleotide polymorphisms (SNPs) were genotyped with the TOPMED imputable Illumina GSA array. We identified genetic instrumental variables for miR-126-3p (33 SNPs), miR-1260b (22 SNPs) and miR-374a-5p (35 SNPs) and run several Mendelian randomization approaches. Results: The hazard ratio (95 % confidence interval) of HF by a 10-fold increase in miR-126-3p, miR-1260b and miR-374a-5p was 1.53 (1.09, 2.14), 1.38 (1.03, 1.86), and1.30 (1.09, 1.57), respectively. The corresponding rate differences were 9.7 (-0.1, 19.5), 12.0 (0.4, 23.6) and 9.1 (1.2, 17.1) per 10000 person-years. In flexible dose-response analysis, increased miRNAs levels were associated with higher HF risk, both in the relative and additive scale. In Mendelian randomization analysis, consistently suggestive positive causal associations were found with HF for increased miR-126-3p and miR-1260b levels, but not for miR-374a-5p. Conclusions: In observational analysis, miR-126-3p, miR-1260b and miR-374a-5p levels were positively associ-ated with HF incidence. Mendelian randomization analysis supported a causal role for miR-126-3p and miR-1260b, thus suggesting a potential use as prognostic and therapeutic targets for HF prevention and control., We thank Nuria Alvarez y Belen Herraez, from the Human Genotyping-CEGEN Unit, at the National Center for Cancer Research from the Carlos III Health Institutes, in Madrid (Spain) , for their contribution in the genotyping procedure. This research was funded by health sciences research grants from the Carlos III Health Institute (grant numbers PI19/01796 to J.R.; PI21/00249 and CP22/00069 to R.C.; PI23/01179 to A.O.; FI20/00096 to O.M.-A; and FI22/00032 to A.F.-C.; PI15/00071 and PI22CIII/00029 to M.T.-P.) . This work was also sup-ported by the State Agency for Research (PID2019-108973RB-C21 to M. T.-P.) . Grant IJC2020-045308-I, Juan de la Cierva Incorporacion funded by MCIN/AEI/10.13039/501100011033 and by ESF-Investing in Your Future (to A.O.) ; CNS2022-136175, Research Consolidation Grants, funded by MCIN/AEI/10.13039/501100011033 and European Union "Next Generation EU"/PRTR" (to R.C) .; FP7-HEALTH 11 (grant number no 278249) . It was co-funded by the European Union (the European Regional Development Fund (ERDF) and the European Social Fund (FSE) ) ; CIBER of Obesity and Nutrition Physiopathology (CIBEROBN) (grant numbers CIBER-02-08-2009, CB06/03 and CB12/03/30016) . CIBER of Cardiovascular diseases (CIBERCV) (grant number CB16/11/00261) . CIBEROBN and CIBERCV are co-funded with European Funds for Regional Development (FEDER) , and IDIFEDER/2021/072, CIAICO/2022/181 and INVEST/2023/180 from the Generalitat Valenciana of Spain. Z.R.-H. received a fellowship associated to a Spain National Investigation Agency project (PRE2020-093926) . The genotyping service was carried out at the Genotyping Unit-CEGEN in the Spanish Na-tional Cancer Research Centre (CNIO) , supported by Instituto de Salud Carlos III (ISCIII) , Ministerio de Ciencia e Innovacion. CEGEN is part of the initiative IMPaCT GEN oMICA (IMP/00009) cofunded by ISCIII and the European Regional Development Fund (ERDF)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Anxiety and depressive symptoms, and stress biomarkers in pregnant women after in vitro fertilization: a prospective cohort study

  • García Blanco, Ana
  • Diago, Vicente
  • Ghosn, Farah
  • Vento, Máximo
  • Cháfer-Pericás, Consuelo
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] STUDY QUESTION: Does in vitro fertilization (IVF) affect the course of anxiety and depressive symptoms as well as physiological stress from pregnancy to postpartum period?, MV funded by FIS PI17/0131 grant from the Instituto de Salud Carlos III (ISCIII) and RETICS funded by the PN 2018-2011, and the European Regional Development Fund, reference RD16/0022/0001; AG-B funded by a 'Juan Rodes' Grant (JR17/00003) from the ISCIII. CC-P funded by a 'Miguel Servet I' Grant (CP16/00082) from the ISCIII.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Cumulative life stressors and stress response to threatened preterm labour as birth date predictors

  • Campos-Berga, Laura
  • Moreno-Giménez, Alba
  • Vento, Máximo
  • Diago, Vicente
  • Sáenz, Pilar
  • Cháfer-Pericás, Consuelo
  • García-Blanco, Ana
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] Purpose Preterm birth represents one of the main causes of neonatal morbimortality and a risk factor for neurodevelopmental disorders. Appropriate predictive methods for preterm birth outcome, which consequently would facilitate prevention programs, are needed. We aim to predict birth date in women with a threatened preterm labour (TPL) based on stress response to TPL diagnosis, cumulative life stressors, and relevant obstetric variables. Methods A prospective cohort of 157 pregnant women with TPL diagnosis between 24 and 31 weeks gestation formed the study sample. To estimate the stress response to TPL, maternal salivary cortisol, alpha-amylase levels, along with anxiety and depression symptoms were measured. To determine cumulative life stressors, previous traumas, social support, and family functioning were registered. Then, linear regression models were used to examine the effect of potential predictors of birth date. Results Lower family adaptation, higher Body Mass Index (BMI), higher cortisol levels and TPL diagnosis week were the main predictors of birth date. Gestational week at TPL diagnosis showed a non-linear interaction with cortisol levels: TPL women with middle- and high-cortisol levels before 29 weeks of gestation went into imminent labour. Conclusion A combination of stress response to TPL diagnosis (salivary cortisol) and cumulative life stressors (family adaptation) together with obstetric factors (TPL gestational week and BMI) was the best birth date predictor. Therefore, a psychosocial therapeutic intervention program aimed to increase family adaptation and decrease cortisol levels at TPL diagnosis as well as losing weight, may prevent preterm birth in symptomatic women., Prior to study initiation, a grant was awarded by the Instituto de Salud Carlos III (PI18/01352). To achieve this grant, the project was assessed by an external peer review panel, guaranteeing scientific quality and ethical integrity. MV acknowledges PI17/0131 grant from the Instituto de Salud Carlos III (Spanish Ministry of Economy and Competitiveness) (ISCIII; Plan Estatal de I + D + I 2013-2016) and co-financed by the European Development Regional Fund "A way to achieve Europe" (ERDF); and RETICS funded by the PN 2018-2011 (Spain), ISCIII-Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (FEDER), RD16/0022/0001.VD acknowledges PI18/01352 grant from the ISCIII. CC-P acknowledges a "Miguel Servet I" grant (CP16/00082) from the ISCIII. AG-B acknowledges a "Juan Rodes" grant (JR17/00003) and a health research project (PI18/01352) from the ISCIII. LC-B acknowledges a "Rio Hortega" grant (CM20/00143) from the ISCIII.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Metformin intake associates with better cognitive function in patients with Huntington&apos, s disease

  • Hervás-Marín, David|||0000-0003-0635-4961
  • Fornés-Ferrer, Victoria
  • Gómez-Escribano, Ana Pilar
  • Dolores Sequedo, Maria
  • Peiró, Carmen
  • Millán, José María
  • Vázquez-Manrique, Rafael P.
[EN] Huntington's disease (HD) is an inherited, dominant neurodegenerative disorder caused by an abnormal expansion of CAG triplets in the huntingtin gene (htt). Despite extensive efforts to modify the progression of HD thus far only symptomatic treatment is available. Recent work suggests that treating invertebrate and mice HD models with metformin, a well-known AMPK activator which is used worldwide to treat type 2-diabetes, reduces mutant huntingtin from cells and alleviates many of the phenotypes associated to HD. Herein we report statistical analyses of a sample population of participants in the Enroll-HD database, a world-wide observational study on HD, to assess the effect of metformin intake in HD patients respect to cognitive status using linear models. This cross-sectional study shows for the first time that the use of metformin associates with better cognitive function in HD patients., RVM holds a "Miguel Servet" fellowship (Ref: CP11/00090) funded by the Institute de Salud Carlos III (ISCIII, Madrid, Spain), a grant from the ISCIII (PI14/00949) and Fundacio Telemarato de la TV3 (ref: 559). The funds from the ISCIII are partially supported by the European Regional Development Fund. RVM is also a Marie Curie fellow (CIG322034, EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the Enroll-HD Study team, its collaborators (see haps://www.enroll-hd,org/for-researchers/technical-support/ for Site Principle Investigators and Study Coordinators) and study participants. Enroll-HD is a longitudinal observational study for Huntington's disease families intended to accelerate progress towards therapeutics; it is sponsored by CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to developing therapeutics for HD. Enroll-HD would not be possible without the vital contribution of the research participants and their families.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Influence of drug encapsulation within mixed micelles on the excited state dynamics and accessibility to ionic quenchers

  • Nuin Plá, Neus Edurne
  • Gómez Mendoza, Miguel
  • Miranda Alonso, Miguel Ángel
  • Marín García, Mª Luisa|||0000-0002-9789-8894
  • Andreu, Inmaculada|||0000-0003-3409-9443
Photophysical techniques, specifically time-resolved fluorescence and laser flash photolysis, have proven to be noninvasive, straightforward, and valuable tools to demonstrate how drug encapsulation into biomimetic mixed micelles (MM) influences the dynamics of excited states and their accessibility to ionic quenchers. This concept has been illustrated by choosing a set of currently administered drugs containing a common naphthalene chromophore, namely, (S)-naproxen and its methyl ester, (R)-cinacalcet and (S)-propranolol. A remarkable increase of their triplet lifetimes is noticed when experiments are performed in MM, indicating efficient entrapment of the drugs in these supramolecular entities. Furthermore, a decrease of 1 order of magnitude in the quenching rate constant of the singlet and triplet excited states (by iodide or nitrite, respectively) is observed upon encapsulation into MM. This approach can in principle be extended to other microenvironments capable of incorporating photoactive compounds. © 2013 American Chemical Society., Financial support from the Generalitat Valenciana (Prometeo Program), the Spanish Government (Red RETICS de Investigacion de Reacciones Adversas a Alergenos y Farmacos (RIRAAF), Servet Contract CP11/00154 for I.A., CTQ2009-13699, CTQ2010-14882, CTQ2012-38754-C03-03 and Pre-doctoral FPU fellowship AP2008-03295 for M.G.-M.) is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Photosensitivity to Triflusal: Formation of a Photoadduct with Ubiquitin Demonstrated by Photophysical and Proteomic Techniques

  • Nuin Pla, Neus Edurne
  • Pérez-Sala, Dolores
  • Miranda Alonso, Miguel Ángel
  • Lhiaubet, Virginie Lyria|||0000-0002-8205-8892
  • Andreu, Inmaculada|||0000-0003-3409-9443
[EN] Triflusal is a platelet aggregation inhibitor chemically related to acetylsalicylic acid, which is used for the prevention and/or treatment of vascular thromboembolisms, which acts as a prodrug. Actually, after oral administration it is absorbed primarily in the small intestine, binds to plasma proteins (99%) and is rapidly biotransformed in the liver into its deacetylated active metabolite 2-hydroxy-4-trifluoromethylbenzoic acid (HTB). In healthy humans, the half-life of triflusal is ca. 0.5 h, whereas for HTB it is ca. 35 h. From a pharmacological point of view, it is interesting to note that HTB is itself highly active as a platelet anti-aggregant agent. Indeed, studies on the clinical profile of both drug and metabolite have shown no significant differences between them. It has been evidenced that HTB displays ability to induce photoallergy in humans. This phenomenon involves a cell-mediated immune response, which is initiated by covalent binding of a light-activated photosensitizer (or a species derived therefrom) to a protein. In this context, small proteins like ubiquitin could be appropriate models for investigating covalent binding by means of MS/MS and peptide fingerprint analysis. In previous work, it was shown that HTB forms covalent photoadducts with isolated lysine. Interestingly, ubiquitin contains seven lysine residues that could be modified by a similar reaction. With this background, the aim of the present work is to explore adduct formation between the triflusal metabolite and ubiquitin as model protein upon sunlight irradiation, combining proteomic and photophysical (fluorescence and laser flash photolysis) techniques. Photophysical and proteomic analysis demonstrates monoadduct formation as the major outcome of the reaction. Interestingly, addition can take place at any of the E-amino groups of the lysine residues of the protein and involves replacement of the trifluoromethyl moiety with a new amide function. This process can in principle occur with other trifluoroaromatic compounds and may be responsible for the appearance of undesired photoallergic side effects., Financial support from the Generalitat Valenciana (Prometeo Program), the Spanish Government (MINECO CTQ2015-70164-P to VL-V and SAF2012-36519 to DP-S) and the Carlos III Institute of Health (Grant RIRAAF, RETICS program, RD12/0013/0009 to MM and RD12/0013/0008 to DP-S, and Miguel Servet Contract CP11/00154 for IA) is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Clinical, Genetic, Morphological and Functional Correlations in a Large Series of Patients with Primary Ciliary Dyskinesia: A Heterogeneous Disease with a Controversial Diagnosis

  • Carretero-Vilarroig, Lidon
  • Blanco-Máñez, Rosana
  • Muñoz-Fernández, Noelia
  • Ibáñez, Isabel
  • Berzal-Serrano, Alba
  • Ana Reula
  • Garcia-Bohórquez, Belen
  • Aller, Elena
  • García-García, Gema
  • MIllán, Jose M.
  • Armengot-Carceller, Miguel
  • Jaijo, Teresa
[EN] Background and Objective Primary ciliary dyskinesia (PCD) is a rare genetic condition characterised by abnormal ciliary motility, primarily affecting the respiratory tract. Despite its clinical significance, there is currently no gold standard for PCD diagnosis. This study aims to address this diagnostic challenge by evaluating a comprehensive approach in a large cohort of patients with suspected PCD. Methods We conducted a retrospective analysis of 128 patients with suspected PCD at a specialised clinical reference unit. A thorough anamnesis was performed, followed by a triad of diagnostic tests: (i) a high-speed video analysis of ciliary beat pattern; (ii) transmission electron microscopy for ciliary ultrastructure examination; and (iii) a genetic analysis, primarily through clinical exome sequencing. Correlations between the clinical, morphological and genetic findings were studied. Functional assays on RNA were performed to assess new splicing variants. Pearson's chi-square test was used to compare categorical variables and comparisons of means were performed using the Student's t-test. Results A definitive PCD diagnosis was established in 72% of the studied patients. Notably, only 58% of the diagnosed cases showed positive results across all three diagnostic tests. Patients with immotile cilia have a higher frequency of neonatal respiratory distress and had a higher likelihood of receiving a genetic diagnosis. A high-speed video analysis was altered in 116 patients, 53 of them with immotile cilia. A transmission electron microscopy revealed ultrastructural alterations in 67 patients, with class 1 defects being more common. DNAH5, RSPH1 and DNAH11 were the most represented genes among the 18 causal genes found. Among the 71 causal genetic variants found, we highlight the overrepresentation of the c.85G>T in RSPH1 and describe the aberrant effect on RNA of the splicing variants DNAH11:c.11497-6T>G, DNAH9:c.2596-2dup, CCDC40:c.2597A>G and CCDC40:c.2832G>A. Finally, we describe a severe phenotype associated with the RSPH1 gene, contrary to previously reported data. Conclusions This comprehensive analysis of a large cohort of patients with PCD underscores the challenges in achieving a definitive diagnosis and emphasises the need for a multi-faceted diagnostic approach. This study enhances our understanding of this rare condition, including the identification of new splicing variants and an unexpected severe phenotype associated with RSPH1, challenging previous assumptions about genotype-phenotype correlations in PCD., This study was funded by the Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion [PI19/00949; PI22/01010]. The funder played no role in the study design, data collection, analysis or interpretation, or writing of this article. Part of the equipment employed in this work was funded by the University of Valencia. Alba Berzal-Serrano is the recipient of a predoctoral contract from the Valencian Government (ACIF/2021/057). Gema Garcia-Garcia acknowledges two grants from the Instituto de Salud Carlos III, "CP22/00028" and "PI22/01371", co-funded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Towards Tailored Gut Microbiome-Based and Dietary Interventions for Promoting the Development and Maintenance of a Healthy Brain

  • Larroya, Ana
  • Pantoja, Jorge
  • Codoñer-Franch, Pilar
  • Cenit, Maria Carmen
[EN] Mental health is determined by a complex interplay between the Neurological Exposome and the Human Genome. Multiple genetic and non-genetic (exposome) factors interact early in life, modulating the risk of developing the most common complex neurodevelopmental disorders (NDDs), with potential long-termconsequences on health. To date, the understating of the precise etiology underpinning these neurological alterations, and their clinical management pose a challenge. The crucial role played by diet and gut microbiota in brain development and functioning would indicate that modulating the gut-brain axis may help protect against the onset and progression of mental-health disorders. Some nutritional deficiencies and gut microbiota alterations have been linked to NDDs, suggesting their potential pathogenic implications. In addition, certain dietary interventions have emerged as promising alternatives or adjuvant strategies for improving the management of particular NDDs, at least in particular subsets of subjects. The gut microbiota can be a key to mediating the effects of other exposome factors such as diet on mental health, and ongoing research in Psychiatry and Neuropediatrics is developing Precision Nutrition Models to classify subjects according to a diet response prediction based on specific individual features, including microbiome signatures. Here, we review current scientific evidence for the impact of early life environmental factors, including diet, on gut microbiota and neuro-development, emphasizing the potential long-term consequences on health; and also summarize the state of the art regarding the mechanisms underlying diet and gut microbiota influence on the brain¿gut axis. Furthermore, we describe the evidence supporting the key role played by gut microbiota, diet and nutrition in neurodevelopment, as well as the effectiveness of certain dietary and microbiome-based interventions aimed at preventing Larroya et al. Gut Microbiota for Healthy Brain Development or treating NDDs. Finally, we emphasize the need for further research to gain greater insight into the complex interplay between diet, gut microbiome and brain development. Such knowledge would help towards achieving tailored integrative treatments, including personalized nutrition., The Miguel Servet Grant (CP19/00143) from the Spanish Institute of Health Carlos III (ISCIII) to MC is fully acknowledged. The FDGENT grant from the Ministry of the Valencian Generalitat is fully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Anthracene-Modified Nanoporous Silica Nanoparticles for ATP Detection and Salivary Diagnostics in Parkinson&apos, s Disease

  • Ahi, E.E.
  • Climent Terol, Estela
  • Beyret, Cansu
  • Caglayan, Mehmet Gokhan
  • Coban, Burak
  • Yilmaz, Rezzak
  • Durmus, Mahmut
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] ATP is an essential biological molecule, and abnormal levels are linked to various diseases. In this study, we developed an optical sensor array consisting of an anthracene-modified MCM-41 mesoporous nanoparticle-based hybrid organic-inorganic material to detect ATP in a TRIS-HCl buffer (pH 7). To create the sensor, we synthesized MCM-41 silica nanoparticles and functionalized them with aminoanthracene and imidazolium-anthracene groups. The fluorescence responses of the optical sensor array were recorded and analyzed by using a pattern recognition protocol, specifically linear discriminant analysis, to distinguish between ATP, ADP, AMP, and potential interferents. Quantitative regression analysis of ATP in TRIS-HCl was performed using artificial neural networks, which yielded an acceptable error rate of 7.8%. The sensor array was also evaluated for discrimination of Parkinson's disease (PD) from healthy controls, based on pattern recognition of ATP-related analytes in saliva samples from 24 patients with PD and 23 healthy controls. The results showed that the MCM-41 mesoporous silica nanoparticle-based sensor array can discriminate PD by pattern recognition with 73.7% sensitivity and 83.3% specificity., The diagnostic part of this study is supported by the Ankara University Scientific Research Projects Coordination Office (TSA-2023-2648 and TSA-2025-3825). V.M.-C. acknowledges financial support from the Project CIDEGENT/2020/031 funded by the Generalitat Valenciana, Project ESGENT/2024/ 001 funded by the Generalitat Valenciana, project PID2024- 157188OB-I00 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/ 501100011033, and project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. R.M.-M. acknowledges the European Union s Horizon EUROPE research and innovation program under grant agreement no. 101093042, project PID2024-155683OB-C41 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, and project PROMETEO CIPROM/2021/007 funded by Generalitat Valenciana. E.C. thanks the Instituto de Salud Carlos III for founding the projects Miguel Servet 2023 CP23/00086 and PI24_01239, both cofunded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Ceria nanoparticles with rhodamine B as a powerful theranostic agent against intracellular oxidative stress

  • Apostolova, Nadezda
  • Rovira-Llopis, Susana
  • Baldovi, Herme G.
  • Asiri, Abdullah M.
  • Victor, Victor M.
  • Herance Camacho, Jose Raul
  • Navalón Oltra, Sergio|||0000-0001-8423-0759
  • García Gómez, Hermenegildo|||0000-0002-9664-493X
Ceria nanoparticles with rhodamine B groups covalently attached on their surface (RhB-CeNPs) were successfully prepared to simultaneously exhibit antioxidant activity and the ability to detect oxidant species. In order to use them for biomedical purposes, the nanoparticles were internalized in two human cell lines (HeLa and Hep3B), confirmed by confocal microscopy. In addition, their biocompatibility was assessed by performing proliferation, viability and apoptosis assays, in which they showed a remarkable lack of toxicity. Thereafter, the antioxidant activity of RhB-CeNPs against reactive oxygen species (ROS) in a model of oxidative stress was demonstrated in HeLa cells using the dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay. RhB-CeNPs exhibited higher cytosolic antioxidant activity than the well-established ceria nanoparticles. Surprisingly, the antioxidant capacity of RhB-CeNPs was evident when the ROS content of the cells increased notably (and was, therefore, harmful for those cells). Furthermore, the ability of RhB-CeNPs as ROS-content sensors was evaluated by measuring oxidative stress in HeLa cells using the intrinsic fluorescence of the rhodamine B groups present on the nanoparticles. The results with respect to the detection and quantification of ROS were similar to those obtained with DCFH-DA, a typical method of quantifying intracellular ROS. Our results demonstrate the potential of RhB-CeNPs as remarkably biocompatible theranostic agents with application in the field of oxidative stress., The present work was supported by the grant CP13/00252, PI13/1025 from Carlos III Health Institute, and by the European Regional Development Fund (ERDF). In addition, this study was financed by the Spanish Ministry of Economy and Competitiveness (Severo Ochoa and CTQ2012-32315), the Generalitat Valenciana (Prometeo 2012-013), Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (UGP-14-095) and supported by the Spanish Ministry of Science and Innovation.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Photooxygenation mechanisms in naproxen-amino acid linked systems

  • Vayá Pérez, Ignacio|||0000-0003-1682-9342
  • Andreu, Inmaculada|||0000-0003-3409-9443
  • Jiménez, M Consuelo|||0000-0002-8057-4316
  • Miranda Alonso, Miguel Ángel
The photooxygenation of model compounds containing the two enantiomers of naproxen (NPX) covalently linked to histidine (His), tryptophan (Trp) and tyrosine (Tyr) has been investigated by steady state irradiation, fluorescence spectroscopy and laser flash photolysis. The NPX–His systems presented the highest oxygen-mediated photoreactivity. Their fluorescence spectra matched that of isolated NPX and showed a clear quenching by oxygen, leading to a diminished production of the NPX triplet excited state ( 3 NPX*–His). Analysis of the NPX–His and NPX–Trp photolysates by UPLC-MS–MS revealed in both cases the formation of two photoproducts, arising from the reaction of singlet oxygen (1 O2) with the amino acid moiety. The most remarkable feature of NPX–Trp systems was a fast and stereoselective intramolecular fluorescence quenching, which prevented the efficient formation of 3 NPX*–Trp, thus explaining their lower reactivity towards photooxygenation. Finally, the NPX–Tyr systems were nearly unreactive and exhibited photophysical properties essentially coincident with those of the parent NPX. Overall, these results point to a type II photooxygenation mechanism, triggered by generation of 1 O2 from the 3 NPX* chromophore, Financial support from the Spanish Government (CTQ2010-14882, JCI-2011-09926, Miguel Servet CP11/00154), from the EU (PCIG12-GA-2012-334257), from the Universitat Politecnica de Valencia (SP20120757) and from the Conselleria de Educacio, cultura i Esport (PROMETEOII/2013/005, GV/2013/051) is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines

  • Esteve-Sánchez, Yoel|||0000-0002-6845-1110
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Tormo-Mas, M.A.
  • Peman, Javier
  • Eva Calbuig
  • Gomez, Maria Dolores
  • Climent Terol, Estela
[EN] Methods to detect naturally infected individuals, especially during or after a pandemic, are valuable in populations with a high rate of vaccination. Having in mind that after the COVID-19 pandemic people has been vaccinated against the virus by Spike protein (S)-based vaccines, we present in this paper a novel nanosensor based on gated nanoporous anodic alumina (NAA) material to detect naturally infected individuals in populations with high rates of vaccination. The nanosensor developed is based on a protein-capped nanomaterial for the identification of IgG antibodies that can detect nucleocapsid protein (N) of SARS-CoV-2. The NAA material has been loaded with an indicator (Rhodamine B (RhB)) and the pores of the material have been blocked with SARS-CoV-2 nucleocapsid protein (N) attached to a specific aptamer. In presence of antibodies against this antigen, the pores are uncapped, triggering the dye release and a fluorescent signal as a result. The biosensor has been tested in vitro and simulated serum for IgG detection, proving a detection limit of 1 mu g/mL. Moreover, specificity assays with N proteins from other coronaviruses have proved the robustness and efficacy of this nanosensor. Finally, the system has been tested on samples from patients that contained SARS-CoV-2 antibodies, demonstrating its potential for the discrimination of individuals that have been vaccinated or infected by SARS-CoV-2 virus., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2021-122875OB-100 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This work was also funded by the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/2021/007) , Santander and CRUE Supera COVID-19 Fund (DIACOVID project) , the Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (IIS-LaFe) (SARS-COV-2-SEEKER and VISION-COV projects) . R.M thanks to the European Union's Horizon EUROPE Research and Innovation Program (grant agreement No 101093042) . Y.E.-S. acknowledges the Ministerio de Universidades for his predoctoral grant (FPU20/05297) . E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) . Scheme 1 done with BioRender.com . The use of clinical samples from patients was approved by the Drug Research Ethics Committee, CEIm of Hospital Universitari i Politecnic La Fe of Valencia (2021-012-1) . In all cases was obtained an informed oral consent from all participants or next of kin prior to the research.r E.-S. acknowledges the Ministerio de Universidades for his predoctoral grant (FPU20/05297) . E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) . Scheme 1 done with BioRender.com . The use of clinical samples from patients was approved by the Drug Research Ethics Committee, CEIm of Hospital Universitari i Polite`cnic ` cnic La Fe of Valencia (2021-012-1) . In all cases was obtained an informed oral consent from all participants or next of kin prior to the research.